advise	 Dose adjustment of <e1> DRUG1 </e1> may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ; 	Sensipar	itraconazole
other	 <e1> DRUG1 </e1> therapy should be monitored , particularly during the first few weeks , after initiating therapy with DRUG0 in patients receiving <e2> DRUG2 </e2> or similar agents . 	Anticoagulant	warfarin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	phenylbutazone	temazepam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	fenoprofen	sulindac
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxolinic acid	trimethoprim
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	carbamazepine	rifampin
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and <e2> DRUG2 </e2> (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	antidepressants	Type 1C antiarrhythmics
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methyldopa	oxyphenbutazone
advise	 Other DRUG0 Concomitant use of other <e1> DRUG1 </e1> within 24 hours of treatment with <e2> DRUG2 </e2> is contraindicated . 	5-HT1B/1D agonists	AXERT
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Felbatol	prednisolone
other	 therefore , it is theoretically possible that DRUG0 may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g . DRUG0 , <e1> DRUG1 </e1> esters , <e2> DRUG2 </e2> salts , DRUG0 ) . 	ampicillin	iron
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of DRUG0 are the following : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (2) , DRUG0 , DRUG0 , and DRUG0 Thus , if a patient has been titrated to a stable dosage on <e2> DRUG2 </e2> , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for DRUG0 may be necessary . 	doxorubicin HCL	EQUETROTM
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and <e1> DRUG1 </e1> , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	tetracycline	Crixivan
other	 In large , well controlled trials in patients with schizophrenia or related psychoses , <e1> DRUG1 </e1> 5 to 20 mg/day was significantly superior to <e2> DRUG2 </e2> 5 to 20 mg/day in overall improvements in psychopathology rating scales and in the treatment of depressive and negative symptoms , and was comparable in effects on positive psychotic symptoms . 	olanzapine	haloperidol
other	 DRUG0 (CNS) drugs including <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , blood pressure medications ( DRUG0 , DRUG0 , DRUG0 ) , motion sickness medications , DRUG0 , DRUG0 , DRUG0 , sleeping pills and <e2> DRUG2 </e2> 	alcohol	tranquilizers
other	 DRUG0 : Co-administration of 200 mg twice-daily <e1> DRUG1 </e1> with DRUG0 resulted in an approximate 80% increase in plasma levels of <e2> DRUG2 </e2> . 	ketoconazole	aliskiren
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 overdosage . 	quinine	sulfamethoxazole
other	 However , in the second study , administration of 12 g DRUG0 1 hour before the evening meal and 0.3 mg <e1> DRUG1 </e1> approximately 4 hours after the same evening meal resulted in a decrease in the <e2> DRUG2 </e2> AUC of less than 8% , and a decrease in Cmax of about 30% when compared to dosing DRUG0 alone . 	cerivastatin sodium	cerivastatin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	dopamine	ethionamide
other	 No interactions have been observed with DRUG0 , <e1> DRUG1 </e1> , DRUG0 and <e2> DRUG2 </e2> and DRUG0 . 	calcium antagonists	loop diuretics
other	 <e1> DRUG1 </e1> / <e2> DRUG2 </e2> : The coadministration of DRUG0 or DRUG0 will not affect plasma concentrations of DRUG0 , but may reduce endogenous plasma levels of DRUG0 /ergocalcitriol by accelerating metabolism . 	Phenytoin	Phenobarbital
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	quinine	salicylates
other	 Drug Interactions : DRUG0 may interact with some drugs , like DRUG0 ( DRUG0 ) : <e1> DRUG1 </e1> could theoretically affect DRUG0 pharmacodynamics - DRUG0 - Eproxindine - DRUG0 : DRUG0 and DRUG0 cause additive CNS depression - <e2> DRUG2 </e2> : DRUG0 increases the effect of DRUG0 	MAOI	Tricyclic antidepressants
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ]) or 	Phenergan	Vesprin
other	 DRUG0 : Increased serum DRUG0 levels and symptoms of <e1> DRUG1 </e1> toxicity have been reported in patients receiving <e2> DRUG2 </e2> during therapy with DRUG0 . 	lithium	ACE inhibitors
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e2> DRUG2 </e2> , DRUG0 . 	protease inhibitors	verapamil
other	 DRUG0 in combination with other <e1> DRUG1 </e1> , general DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , or other DRUG0 (including DRUG0 ) has additive depressant effects . 	narcotic analgesics	sedative-hypnotics
other	 Avoid the use of preparations such as DRUG0 and local <e1> DRUG1 </e1> which contain any DRUG0 (e.g. , <e2> DRUG2 </e2> , DRUG0 ) , since it has been reported that DRUG0 can potentiate the effects of catecholamines . 	anesthetics	epinephrine
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (5) , DRUG0 , and DRUG0 . 	clobazam	warfarin
other	 <e1> DRUG1 </e1> : Concomitant administration of DRUG0 may reduce plasma levels of <e2> DRUG2 </e2> . 	Antacids	diflunisal
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute <e1> DRUG1 </e1> intake , DRUG0 , chboramphenicol , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 	alcohol	cimetidine
other	 DRUG0 - and/or <e1> DRUG1 </e1> -containing DRUG0 , products containing DRUG0 ( DRUG0 ) , DRUG0 containing <e2> DRUG2 </e2> or other metal cations , or DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	aluminum	zinc
other	 - <e1> DRUG1 </e1> ( DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Anabolic steroids	Anabolin
other	 Certain <e1> DRUG1 </e1> , especially <e2> DRUG2 </e2> , DRUG0 and DRUG0 , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block . 	antibiotics	neomycin
other	 <e1> DRUG1 </e1> and DRUG0 increased blood <e2> DRUG2 </e2> at different times after the DRUG0 overload . 	Fluoxetine	glucose
other	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and <e1> DRUG1 </e1> ) DRUG0 (sometimes prescribed to control blood sugar in type 2 diabetes) DRUG0 (used to control inflammation associated with Crohns disease and ulcerative colitis) DRUG0 (a DRUG0 ) DRUG0 There has been concern about the interaction between DRUG0 and <e2> DRUG2 </e2> . 	primidone	folic acid
other	 DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , <e1> DRUG1 </e1> / DRUG0 , DRUG0 / <e2> DRUG2 </e2> , DRUG0 / DRUG0 , and DRUG0 / DRUG0 . 	phenobarbital	lidocaine
other	 If DRUG0 is given concomitantly with <e1> DRUG1 </e1> , the DRUG0 dose should be reduced (by approx . 50%) , because <e2> DRUG2 </e2> amplifies the therapeutic actions and side-effects of DRUG0 massively . 	opioids	chlorprothixene
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxyphenbutazone	sulfonamides
other	 Other nephrotoxic medications : agents such as DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> may enhance the potential for drug-induced renal toxicity , and should be used concomitantly only with great caution . 	cyclosporine	pentamidine
other	 DRUG0 may interact with DRUG0 , DRUG0 s , DRUG0 (allergy , cold , and sinus medicines) , diabetic drugs , DRUG0 , DRUG0 , <e1> DRUG1 </e1> like DRUG0 or <e2> DRUG2 </e2> , and high blood pressure medications . 	NSAIDs	Ibuprofen
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	indomethacin
other	 Example inhibitors include DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	clarithromycin	verapamil
other	 In monkeys , the effects of DRUG0 , but not <e1> DRUG1 </e1> or DRUG0 , were antagonized by <e2> DRUG2 </e2> ; 	(+)-NANM	naloxone
mechanism	 <e1> DRUG1 </e1> generally should not be given with <e2> DRUG2 </e2> because they reduce its renal clearance and add a high risk of DRUG0 toxicity . 	Lithium	diuretics
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	carbamazepine	nitroprusside
int	 <e1> DRUG1 </e1> may interact with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	Chlorotrianisene	cyclosporine
other	 However , in clinical studies the consequences of concomitant <e1> DRUG1 </e1> on the pharmacodynamics of <e2> DRUG2 </e2> were negligible . 	irbesartan	warfarin
other	 Before taking DRUG0 , tell your doctor if you are taking any of the following medicines : - <e1> DRUG1 </e1> or another DRUG0 such as DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 , others) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	aspirin	Trilisate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	glucagon	trimethoprim
other	 The concentrations of <e1> DRUG1 </e1> , the active metabolite of DRUG0 , were on average 33% higher in patients receiving bolus-IFL in combination with <e2> DRUG2 </e2> when compared with bolus-IFL alone . 	SN38	AVASTIN
other	 Drug-Drug Interactions <e1> DRUG1 </e1> - DRUG0 should be administered with caution to patients being treated with systemically-administered (oral or intravenous) DRUG0 (or other <e2> DRUG2 </e2> ) because the action of DRUG0 on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure . 	Albuterol	beta2 agonists
advise	 <e1> DRUG1 </e1> should not be administered concomitantly with DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , or DRUG0 . 	Azlocillin	ciprofloxacin
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	adrenocortical steroids	contraceptives
other	 DRUG0 and DRUG0 : <e1> DRUG1 </e1> and DRUG0 containing DRUG0 or <e2> DRUG2 </e2> , as well as formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with DRUG0 and interfere with its bioavailability . 	Sucralfate	aluminum
other	 In clinical studies , coadministration of <e1> DRUG1 </e1> with <e2> DRUG2 </e2> , DRUG0 , or DRUG0 did not interfere with the lipid-lowering activity of the DRUG0 . 	WelChol	atorvastatin
effect	 A rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of <e1> DRUG1 </e1> ( DRUG0 ) and agents for migraine therapy , such as DRUG0 ( DRUG0 ) and <e2> DRUG2 </e2> . 	selective serotonin reuptake inhibitors	dihydroergotamine
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the DRUG0 , DRUG0 , DRUG0 , and DRUG0 (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 with <e2> DRUG2 </e2> plus DRUG0 ) without receiving DRUG0 therapy . 	teniposide	vincristine
other	 Cardiac effects of DRUG0 are antagonized by DRUG0 , such as <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	propranolol	metoprolol
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , local DRUG0 (e.g. , DRUG0 and <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	lidocaine	multivitamins
effect	 Drugs that reportedly may increase oral <e1> DRUG1 </e1> response , ie , increased prothrombin response , in man include : DRUG0 *; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anticoagulant	allopurinol
effect	 Additive CNS depression may occur when <e1> DRUG1 </e1> are administered concomitantly with other DRUG0 including <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	antihistamines	barbiturates
other	 Other No clinically important pharmacokinetic interactions occurred when <e1> DRUG1 </e1> was administered concomitantly with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or <e2> DRUG2 </e2> . 	Lotensin	cimetidine
other	 <e1> DRUG1 </e1> and <e2> DRUG2 </e2> : DRUG0 and DRUG0 can reduce absorption of DRUG0 ; 	Antacids	kaolin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	miconazole	triclofos sodium
other	 <e1> DRUG1 </e1> ) , DRUG0 (e.g . DRUG0 ) , and DRUG0 (e.g . DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) should have their dose of DRUG0 or DRUG0 adjusted . 	ketoconazole	saquinavir
other	 Interactions may also occur with the following : DRUG0 / DRUG0 , drugs used to treat an overactive thyroid , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 pain medication (e.g. , <e2> DRUG2 </e2> ) , drugs used to aid sleep , drowsiness-causing DRUG0 (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	guanadrel	codeine
mechanism	 Agents with Increased Levels in the Presence of DRUG0 : <e1> DRUG1 </e1> increases the plasma levels of the following agents : <e2> DRUG2 </e2> , DRUG0 (6) , and DRUG0 Thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with DRUG0 , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary . 	EQUETROTM	Clomipramine HCl
other	 DRUG0 : <e1> DRUG1 </e1> produced an elevation of plasma DRUG0 levels and a reduction in renal <e2> DRUG2 </e2> clearance in a study of eleven normal volunteers . 	Ibuprofen	lithium
other	 The plasma maximum concentration and area under the plasma concentration-time curve of DRUG0 , DRUG0 , and DRUG0 were unchanged after coadministration of <e1> DRUG1 </e1> , and no potentiation of the effects of <e2> DRUG2 </e2> on diastolic or systolic blood pressure or on the electrocardiographic parameters was seen . 	sirolimus	diltiazem
other	 The results from a study in which eight HIV-infected individuals were treated with <e1> DRUG1 </e1> , 8 +/- 0.4 mg/kg/day , showed that the pharmacokinetics of DRUG0 were not affected during concomitant administration of <e2> DRUG2 </e2> , 100 mg b.i.d . 	zidovudine	Itraconazole
other	 Using in situ hybridization , we observed that <e1> DRUG1 </e1> caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist DRUG0 but not by an <e2> DRUG2 </e2> DRUG0 . 	METH	atypical neuroleptic
other	 Interactions may also occur with the following : <e1> DRUG1 </e1> / DRUG0 , drugs used to treat an overactive thyroid , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 pain medication (e.g. , DRUG0 ) , drugs used to aid sleep , drowsiness-causing DRUG0 (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	anti-depressants	guanadrel
other	 Since <e1> DRUG1 </e1> is extensively metabolized by cytochrome P-450 isoenzymes , caution should be exercised when DRUG0 is coadministered with inhibitors of C.P.A . such as DRUG0 and DRUG0 or inhibitors of CYP2C19 such as <e2> DRUG2 </e2> . 	PLETAL	omeprazole
other	 poor metabolizers of DRUG0 : Interactions of <e1> DRUG1 </e1> with strong inhibitors of CYP2D6 (such as DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of DRUG0 . 	carvedilol	paroxetine
other	 Monitor <e1> DRUG1 </e1> levels or the therapeutic effect for which <e2> DRUG2 </e2> is given; 	salicylate	aspirin
advise	 DRUG0 and oral DRUG0 : Concomitant administration of DRUG0 and/or other oral <e1> DRUG1 </e1> with <e2> DRUG2 </e2> must be avoided because of the risk of hypervitaminosis A . 	retinoids	acitretin
advise	 Close supervision and careful adjustment of the dosage are required when <e1> DRUG1 </e1> is used with other DRUG0 or <e2> DRUG2 </e2> . 	nortriptyline hydrochloride	sympathomimetic drugs
other	 <e1> DRUG1 </e1> or Oral <e2> DRUG2 </e2> : DRUG0 may enhance the blood-sugar-reducing effect of DRUG0 and oral DRUG0 . 	Insulin	Hypoglycemics
other	 In a clinical pharmacology study , <e1> DRUG1 </e1> or DRUG0 was administered to hypertensive patients receiving <e2> DRUG2 </e2> . 	indomethacin	VASOTEC
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	barbiturates	carbamazepine
effect	 Toxicology studies of <e1> DRUG1 </e1> -related deaths reveal frequent involvement of other DRUG0 , including <e2> DRUG2 </e2> , DRUG0 such as DRUG0 ( DRUG0 ) , and , to a rising degree , DRUG0 . 	heroin	alcohol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	naproxen
other	 DRUG0 / <e1> DRUG1 </e1> , DRUG0 / DRUG0 , DRUG0 / DRUG0 , <e2> DRUG2 </e2> / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , and DRUG0 / DRUG0 . 	theophylline	phenobarbital
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> DRUG1 </e1> are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	EQUETROTM	niacinamide
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 . 	clofibrate	phenytoin
other	 DRUG0 : Immediate Release Capsules : Since there have been isolated reports of patients with elevated DRUG0 levels , and there is a possible interaction between DRUG0 and <e1> DRUG1 </e1> , it is recommended that <e2> DRUG2 </e2> levels be monitored when initiating , adjusting , and discontinuing DRUG0 to avoid possible over- or under-digitalization . 	nifedipine	digoxin
other	 DRUG0 : The concomitant use of DRUG0 ( DRUG0 transdermal system) with other <e1> DRUG1 </e1> , including but not limited to other DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , general DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death . 	central nervous system depressants	skeletal muscle relaxants
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	antidepressants	haloperidol
other	 <e1> DRUG1 </e1> / DRUG0 : The coadministration of DRUG0 or DRUG0 will not affect plasma concentrations of <e2> DRUG2 </e2> , but may reduce endogenous plasma levels of DRUG0 /ergocalcitriol by accelerating metabolism . 	Phenytoin	vitamin D
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and <e1> DRUG1 </e1> , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	tetracycline	Fortovase
other	 <e1> DRUG1 </e1> / DRUG0 / DRUG0 / <e2> DRUG2 </e2> : Co-administration of DRUG0 with DRUG0 , DRUG0 , DRUG0 , and DRUG0 is likely to lead to an enhancement of effects . 	Anesthetics	Opioids
other	 Drug Interactions with DRUG0 Administration of 120 mg of DRUG0 (2 x 60 mg capsule) within 15 minutes of an <e1> DRUG1 </e1> and DRUG0 containing DRUG0 ( <e2> DRUG2 </e2> ) decreased DRUG0 AUC by 41% and cmax by 43% . 	aluminum	Maalox
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anabolic steroids	methylphenidate
other	 DRUG0 : Immediate Release Capsules : Since there have been isolated reports of patients with elevated <e1> DRUG1 </e1> levels , and there is a possible interaction between DRUG0 and <e2> DRUG2 </e2> , it is recommended that DRUG0 levels be monitored when initiating , adjusting , and discontinuing DRUG0 to avoid possible over- or under-digitalization . 	digoxin	nifedipine
other	 Drug-Drug Interactions DRUG0 - DRUG0 should be administered with caution to patients being treated with systemically-administered (oral or intravenous) DRUG0 (or other <e1> DRUG1 </e1> ) because the action of <e2> DRUG2 </e2> on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure . 	beta2 agonists	albuterol
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	haloperidol	zonisamide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	itraconazole	risperidone
other	 - DRUG0 ( <e1> DRUG1 </e1> [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	nandrolone	Anabolin
other	 The effect of <e1> DRUG1 </e1> on the pharmacokinetics of <e2> DRUG2 </e2> administered orally has not been investigated . 	ceftibuten	theophylline
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	aminosalicylic acid	anesthetics
other	 <e1> DRUG1 </e1> , DRUG0 : e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 	Calcium Channel Blockers	nifedipine
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all DRUG0 (eg , DRUG0 , DRUG0 , DRUG0 , other DRUG0 , general DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) may result in additive central nervous system depressant effects . 	tricyclic antidepressants	antihistamines
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	nortriptyline	Phenytoin
other	 <e1> DRUG1 </e1> also should be used cautiously with other drugs (e.g. , DRUG0 , DRUG0 ) that sensitize the myocardium to the actions of <e2> DRUG2 </e2> . 	Epinephrine	sympathomimetic drugs
other	 Drug Interactions : DRUG0 may interact with some drugs , like DRUG0 ( DRUG0 ) : DRUG0 could theoretically affect <e1> DRUG1 </e1> pharmacodynamics - DRUG0 - Eproxindine - DRUG0 : DRUG0 and DRUG0 cause additive CNS depression - <e2> DRUG2 </e2> : DRUG0 increases the effect of DRUG0 	flupenthixol	Tricyclic antidepressants
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , <e1> DRUG1 </e1> ) , and DRUG0 (e.g. , <e2> DRUG2 </e2> , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	metoprolol	propafenone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	antibiotics	sulfonamides
other	 When concomitant administration of <e1> DRUG1 </e1> with DRUG0 occurs , <e2> DRUG2 </e2> dose should be reduced to one-half of its normal dose . 	ketoconazole	aripiprazole
mechanism	 <e1> DRUG1 </e1> , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , certain DRUG0 , DRUG0 , <e2> DRUG2 </e2> and DRUG0 , thereby delaying elimination and increasing blood levels of these drugs . 	Tagamet	theophylline
mechanism	 DRUG0 -Concomitant intake of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> may reduce the absorption of DRUG0 . 	cholestyramine	vitamin K
other	 The principal drugs given (number of patients in parentheses) were : DRUG0 (115) , DRUG0 and DRUG0 (103) , DRUG0 (52) , oral <e1> DRUG1 </e1> (45) , cough and cold preparations (45) , DRUG0 (38) , DRUG0 (29) , DRUG0 (24) , oral DRUG0 (18) , DRUG0 (13) , <e2> DRUG2 </e2> (10) , and DRUG0 (10) . 	hypoglycemics	insulin
other	 - Drugs whose efficacy is impaired by DRUG0 include : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> . 	estrogens	vitamin D
mechanism	 Because oral <e1> DRUG1 </e1> may interfere with the hepatic metabolism of <e2> DRUG2 </e2> , toxic levels of the DRUG0 may occur when an oral DRUG0 and DRUG0 are administered concurrently . 	anticoagulants	phenytoin
other	 DRUG0 : In vitro and/or in vivo data indicate that <e1> DRUG1 </e1> , DRUG0 , and oral <e2> DRUG2 </e2> markedly inhibit the metabolism of DRUG0 , which can result in an increase in plasma DRUG0 levels and prolongation of the QT interval on the ECG . 	fluconazole	ketoconazole
other	 If DRUG0 is to be combined with other DRUG0 such as DRUG0 or <e1> DRUG1 </e1> / DRUG0 , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of DRUG0 and <e2> DRUG2 </e2> (e.g. , DRUG0 or DRUG0 ) are additive . 	sedative	benzodiazepines
other	 <e1> DRUG1 </e1> should be used with caution , if at all , when potent inhalational DRUG0 such as DRUG0 are employed because of potential to sensitize the myocardium to effects of <e2> DRUG2 </e2> . 	ISUPREL	sympathomimetic amines
other	 therefore , it is theoretically possible that DRUG0 may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g . DRUG0 , <e1> DRUG1 </e1> esters , DRUG0 salts , <e2> DRUG2 </e2> ) . 	ampicillin	digoxin
other	 Therefore , interactions could occur following concomitant administration of <e1> DRUG1 </e1> (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) . 	psychotropic drugs	analgesics
other	 DRUG0 and DRUG0 : <e1> DRUG1 </e1> and DRUG0 containing <e2> DRUG2 </e2> or DRUG0 , as well as formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with DRUG0 and interfere with its bioavailability . 	Sucralfate	magnesium
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 drugs (e.g. , DRUG0 ) , DRUG0 , DRUG0 . 	aminoglycosides	amphotericin B
other	 DRUG0 Supplements and <e1> DRUG1 </e1> : <e2> DRUG2 </e2> can attenuate potassium loss caused by DRUG0 . 	Potassium-Sparing Diuretics	Fosinopril sodium
other	 DRUG0 : Administration of <e1> DRUG1 </e1> 2 hours prior to or concurrent with oral DRUG0 was associated with a 111 (114)% increase in the steady-state AUC of <e2> DRUG2 </e2> (n = 12) . 	VIDEX	didanosine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	amiodarone	clofibrate
other	 If <e1> DRUG1 </e1> or other hepatic enzyme inducers are taken concurrently with DRUG0 or DRUG0 , lower plasma levels of <e2> DRUG2 </e2> may occur . 	phenytoin	disopyramide
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Thorazine	prochlorperazine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	salicylates	tolbutamide
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , <e1> DRUG1 </e1> , DRUG0 (acidic) or DRUG0 (basic) , as well as DRUG0 <e2> DRUG2 </e2> , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and DRUG0 , and DRUG0 . 	warfarin	penicillin G
other	 Exposed histidines on DRUG0 are available for <e1> DRUG1 </e1> chelation , and these have been exploited in the development of a novel purification protocol for <e2> DRUG2 </e2> using DRUG0 -chelating chromatography . 	zinc	toxin A
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , local <e1> DRUG1 </e1> (e.g. , DRUG0 and DRUG0 ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	anesthetics	Pronestyl
other	 DRUG0 : DRUG0 is known to interact with the metabolism or renal tubular excretion of many drugs (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 agents , DRUG0 , and <e2> DRUG2 </e2> ) . 	bumetanide	zidovudine
other	 In clinical trials , <e1> DRUG1 </e1> was used with DRUG0 , DRUG0 , <e2> DRUG2 </e2> , oral DRUG0 , and supplemental DRUG0 .In a pharmacokinetic substudy in patients with congestive heart failure receiving DRUG0 or DRUG0 in whom therapy with DRUG0 was initiated , apparent oral clearance values for DRUG0 (n = 23) and DRUG0 (n = 30) were decreased by 13% and 15% , respectively , on the second day of therapy and had returned to baseline values by day 87 . 	FLOLAN	anticoagulants
other	 Nephrotoxic agents : Concomitant administration of DRUG0 and agents with nephrotoxic potential [e.g. , intravenous <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 , <e2> DRUG2 </e2> , intravenous DRUG0 , DRUG0 , and DRUG0 ] is contraindicated . 	aminoglycosides	foscarnet
mechanism	 Administration of <e1> DRUG1 </e1> with DRUG0 containing DRUG0 , DRUG0 , or DRUG0 , with DRUG0 , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or <e2> DRUG2 </e2> , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	quinolones	zinc
other	 <e1> DRUG1 </e1> : DRUG0 , given concomitantly with DRUG0 , produces a reduction in urinary potassium and chloride excretion compared to <e2> DRUG2 </e2> alone . 	Diuretic	hydrochlorothiazide
advise	 If concomitant treatment with <e1> DRUG1 </e1> and an DRUG0 (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) is clinically warranted , appropriate observation of the patient is advised . 	sumatriptan	paroxetine
other	 <e1> DRUG1 </e1> significantly decreased the AUC(ss) of DRUG0 by 82% , but <e2> DRUG2 </e2> had no effect on DRUG0 pharmacokinetics . 	Rifampin	amprenavir
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 DRUG0 ( DRUG0 ) <e1> DRUG1 </e1> ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( <e2> DRUG2 </e2> ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	cimetidine	Sporanox
other	 DRUG0 : Combination DRUG0 may decrease the clearance of some DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) . 	alprazolam	temazepam
other	 The administration of local <e1> DRUG1 </e1> containing DRUG0 or <e2> DRUG2 </e2> to patients receiving DRUG0 or DRUG0 may produce severe , prolonged hypertension . 	anesthetic solutions	norepinephrine
other	 DRUG0 or <e1> DRUG1 </e1> : No formal pharmacokinetic studies have been performed examining the addition of <e2> DRUG2 </e2> to regimens containing DRUG0 or DRUG0 . 	Primidone	tiagabine
other	 Both DRUG0 and DRUG0 have been compared to triple therapy with the DRUG0 <e1> DRUG1 </e1> over 48 weeks as initial therapy , with similar responses being observed with <e2> DRUG2 </e2> regimens and superiority observed with DRUG0 . 	indinavir	nevirapine
other	 <e1> DRUG1 </e1> :Clinical evidence has shown that <e2> DRUG2 </e2> can be formed with concurrent ingestion of DRUG0 and DRUG0 . 	Ethanol	etretinate
effect	 DRUG0 : DRUG0 toxicity has been reported in patients receiving <e1> DRUG1 </e1> concomitantly with drugs which cause elimination of sodium , including <e2> DRUG2 </e2> . 	lithium	ACE inhibitors
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	mirtazapine	praziquantel
advise	 Close observation of the patient is recommended when a <e1> DRUG1 </e1> is administered to patients receiving catecholamine-depleting drugs such as <e2> DRUG2 </e2> , because of possible additive effects and the production of hypotension and/or marked bradycardia , which may produce vertigo , syncope , or postural hypotension . 	beta-blocker	reserpine
other	 No drug interaction studies have been conducted for <e1> DRUG1 </e1> , however the use of orally administered <e2> DRUG2 </e2> could , theoretically , interfere with the release of DRUG0 in the colon . 	COLAZAL	antibiotics
advise	 Therefore you may need to take a <e1> DRUG1 </e1> supplement while taking <e2> DRUG2 </e2> . 	vitamin B12	aminosalicylic acid
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving DRUG0 metabolized similarly to <e1> DRUG1 </e1> or on the basis of in vitro studies with DRUG0 or other DRUG0 (caution is recommended during coadministration with DRUG0 ) : Available data from clinical studies of DRUG0 other than DRUG0 suggest a possible drug interaction with DRUG0 for the following : DRUG0 , <e2> DRUG2 </e2> , DRUG0 such as DRUG0 and DRUG0 , and grapefruit juice . 	alprazolam	isoniazid
other	 Drug Interactions : The central DRUG0 syndrome can occur when DRUG0 agents such as DRUG0 are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain DRUG0 such as DRUG0 , the DRUG0 and other DRUG0 , DRUG0 , certain DRUG0 such as the <e1> DRUG1 </e1> salts , and <e2> DRUG2 </e2> . 	quinidine	antihistamines
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diazoxide	phenytoin
advise	 Therefore , co-administration of <e1> DRUG1 </e1> with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	bupropion	imipramine
other	 <e1> DRUG1 </e1> : In a study of 7 healthy male volunteers , <e2> DRUG2 </e2> treatment potentiated the blood glucose lowering effect of DRUG0 (a DRUG0 similar to DRUG0 ) in 3 of the 7 subjects . 	Glibenclamide	acitretin
other	 - a DRUG0 ( <e1> DRUG1 </e1> ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	NSAID	Indocin
other	 Drug-Drug Interactions DRUG0 - <e1> DRUG1 </e1> should be administered with caution to patients being treated with systemically-administered (oral or intravenous) DRUG0 (or other <e2> DRUG2 </e2> ) because the action of DRUG0 on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure . 	STRATTERA	beta2 agonists
other	 It is recommended that DRUG0 not be used concomitantly with <e1> DRUG1 </e1> Because the effects of concomitant administration of DRUG0 with most other <e2> DRUG2 </e2> have not been studied , the concomitant use of DRUG0 with other CNS-active drugs should be approached with caution . 	MAO inhibitors	psychotropic drugs
other	 Concurrent use of DRUG0 with DRUG0 (e.g. , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 ) may result in increased <e2> DRUG2 </e2> effects . 	barbiturates	central nervous system depressant
mechanism	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma <e1> DRUG1 </e1> concentrations include : acute DRUG0 intake , DRUG0 , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> 	phenytoin	trazodone
mechanism	 The following are examples of drugs known to inhibit the metabolism of other related <e1> DRUG1 </e1> , presumably through inhibition of CYP3A : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and some <e2> DRUG2 </e2> . 	benzodiazepines	macrolide antibiotics
other	 <e1> DRUG1 </e1> may decrease thyroidal uptake of DRUG0 , a rebound in uptake may occur up to 5 days after sudden withdrawal of <e2> DRUG2 </e2> . 	Antithyroid agents	Carbimazole
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	danazol	salbutamol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e1> DRUG1 </e1> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diflunisal	phenylbutazone
other	 The principal drugs given (number of patients in parentheses) were : DRUG0 (115) , DRUG0 and DRUG0 (103) , DRUG0 (52) , oral DRUG0 (45) , cough and cold preparations (45) , <e1> DRUG1 </e1> (38) , <e2> DRUG2 </e2> (29) , DRUG0 (24) , oral DRUG0 (18) , DRUG0 (13) , DRUG0 (10) , and DRUG0 (10) . 	NSAIDs	antihyperlipidemics
other	 The availability of potent <e1> DRUG1 </e1> ( DRUG0 )-based regimens for DRUG0 therapy and concerns regarding DRUG0 ( <e2> DRUG2 </e2> )-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection . 	non-nucleoside reverse transcriptase inhibitor	PI
other	 As with other DRUG0 , the antihypertensive effect of <e1> DRUG1 </e1> may be blunted by the <e2> DRUG2 </e2> DRUG0 	losartan	non-steroidal anti-inflammatory drug
other	 Serum <e1> DRUG1 </e1> concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUG0 , <e2> DRUG2 </e2> ( DRUG0 or DRUG0 ) and aminosalicylates . 	infliximab	antibiotics
other	 Oral DRUG0 : DRUG0 , when given once daily for 14 days as a 100-mg capsule with an oral <e1> DRUG1 </e1> containing 35 mcg of DRUG0 and 1 mg of DRUG0 , decreased the AUC of DRUG0 by 43% , and decreased the AUC of <e2> DRUG2 </e2> by 8%; 	contraceptive	norethindrone
other	 Agents Affecting Sympathetic Activity The sympathetic nervous system may be especially important in supporting blood pressure in patients receiving <e1> DRUG1 </e1> alone or with <e2> DRUG2 </e2> . 	captopril	diuretics
other	 Drugs which may enhance the neuromuscular blocking action of DRUG0 include : DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;certain DRUG0 , especially the DRUG0 and <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 salts; DRUG0 ;and DRUG0 . 	halothane	polymyxins
other	 DRUG0 / <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 and DRUG0 combinations , DRUG0 , <e2> DRUG2 </e2> ) . 	anti-inflammatory	indomethacin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	ethionamide	resorcinol
other	 No interactions have been observed between DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	theophylline	warfarin
other	 Potential interactions between DRUG0 , a substrate of CYP3A4 , and DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> ) , which are substrates and/or inhibitors of CYP3A4 , have not been evaluated in clinical trials . 	indinavir	nelfinavir
int	 A potential interaction between oral <e1> DRUG1 </e1> and oral <e2> DRUG2 </e2> leading to severe hypoglycemia has been reported . 	miconazole	hypoglycemic agents
other	 <e1> DRUG1 </e1> - DRUG0 containing side chains of N-methylthiotetrazole ( DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) or methylthiadiazole ( DRUG0 ) can cause vitamin K deficiency and hypoprothrombinemia . 	Cephalosporins	cefamandole
other	 In vitro displacement studies with highly protein-bound drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 showed no influence on the extent of <e2> DRUG2 </e2> protein binding . 	tolbutamide	nateglinide
other	 [Stimulation by DRUG0 --an analog of the octapeptide cholecystokinin--of <e1> DRUG1 </e1> binding after the long-term administration of DRUG0 ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of <e2> DRUG2 </e2> (0.25 mg/kg) and DRUG0 (0.25 mg/kg) resulted in the reduced interaction between DRUG0 and low affinity binding sites for DRUG0 in subcortical structures , whereas DRUG0 binding with high affinity binding sites for DRUG0 increased both in the frontal cortex and subcortical structures of the forebrain . 	3H-spiroperidol	haloperidol
other	 DRUG0 : <e1> DRUG1 </e1> blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of DRUG0 and can be used to treat <e2> DRUG2 </e2> poisoning . 	Chlorpromazine	amphetamine
other	 When DRUG0 <e1> DRUG1 </e1> is given for long periods of time , concomitant supplementation with water-miscible (or parenteral) forms of <e2> DRUG2 </e2> should be considered . 	resin	fat-soluble vitamins
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	fluoxetine	quinupristin
other	 Studies have shown that <e1> DRUG1 </e1> does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system , such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or <e2> DRUG2 </e2> in healthy subjects . 	lansoprazole	terfenadine
other	 DRUG0 may interact with DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	aspirin	corticotropin
mechanism	 For example , since <e1> DRUG1 </e1> may reduce the gastrointestinal absorption of both the oral <e2> DRUG2 </e2> and DRUG0 , the net effects are unpredictable . 	cholestyramine	anticoagulants
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	prednisolone	temazepam
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	cyclosporine	Fortovase
other	 Reported examples of this interaction include the following : DRUG0 s : DRUG0 ( <e1> DRUG1 </e1> substrate) administered in combination with oral DRUG0 has been reported to produce persistently elevated plasma concentrations of <e2> DRUG2 </e2> resulting in elevated creatinine , despite reduction in dose of DRUG0 . 	CYP3A4	cyclosporine
other	 - <e1> DRUG1 </e1> and DRUG0 DRUG0 : DRUG0 and <e2> DRUG2 </e2> DRUG0 have the potential of binding DRUG0 and reducing DRUG0 absorption from the gastrointestinal tract 	Cholestyramine	colestipol
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , <e1> DRUG1 </e1> , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	insulin	6-mercaptopurine
effect	 If <e1> DRUG1 </e1> is to be combined with other <e2> DRUG2 </e2> such as DRUG0 or DRUG0 / DRUG0 , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of DRUG0 and DRUG0 (e.g. , DRUG0 or DRUG0 ) are additive . 	desipramine hydrochloride	psychotropic agents
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chloral hydrate	ranitidine
other	 DRUG0 : Coadministration of DRUG0 (200 mg BID) , a potent CYP3A4 inducer , with DRUG0 (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both <e1> DRUG1 </e1> and its active metabolite , <e2> DRUG2 </e2> . 	aripiprazole	dehydro-aripiprazole
other	 The concomitant intake of <e1> DRUG1 </e1> and DRUG0 does not affect the pharmacokinetics of either DRUG0 or <e2> DRUG2 </e2> . 	alcohol	acamprosate
mechanism	 DRUG0 Absorption : The following agents may bind and decrease absorption of <e1> DRUG1 </e1> from the gastrointestinal tract : DRUG0 , DRUG0 resin , DRUG0 , DRUG0 , DRUG0 , soybean flour (e.g. , infant formula) , <e2> DRUG2 </e2> . 	levothyroxine sodium	sucralfate
other	 The purpose of this study was to evaluate the effect of DRUG0 ( <e1> DRUG1 </e1> ) and DRUG0 ( DRUG0 ) conjugates on the intestinal permeation of DRUG0 ( <e2> DRUG2 </e2> ) and model peptide drugs , DRUG0 and DRUG0 . 	NaCMC	NaFlu
advise	 Dosage adjustment of <e1> DRUG1 </e1> may be necessary when coadministered with CYP2D6 inhibitors , e.g. , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	STRATTERA	paroxetine
other	 For comprehensive information concerning laboratory test alterations associated with <e1> DRUG1 </e1> , physicians should refer to the complete prescribing information for <e2> DRUG2 </e2> ( DRUG0 ) . 	ritonavir	NORVIR
other	 Those for which effectiveness is reported includes DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	methdilazine	tripelennamine
mechanism	 DRUG0 : <e1> DRUG1 </e1> , including DRUG0 , decrease the clearance of <e2> DRUG2 </e2> , the less active isomer of racemic DRUG0 . 	Quinolones	R-warfarin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ethacrynic acid	fenoprofen
other	 DRUG0 / <e1> DRUG1 </e1> -containing <e2> DRUG2 </e2> : Absorption of DRUG0 is moderately reduced (approximately 25%) when coadministered with DRUG0 / DRUG0 -containing DRUG0 . 	Aluminum	Antacid Products
other	 In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUG0 should be premedicated with DRUG0 (such as <e1> DRUG1 </e1> ) , diphen-hydramine and DRUG0 (such as <e2> DRUG2 </e2> or DRUG0 ) . 	dexamethasone	cimetidine
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ); 	Voltaren	Aleve
other	 Although neither DRUG0 nor DRUG0 affected the proliferation of prostatic epithelium in RPMI1640 containing DRUG0 alone , they modify the mitogenic effect of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	EGF	insulin
effect	 Because <e1> DRUG1 </e1> may enhance the serotonergic effects of <e2> DRUG2 </e2> , caution should be exercised when DRUG0 and DRUG0 are coadministered . 	lithium	escitalopram
advise	 In simultaneous treatment with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> , the anticoagulant effect should be carefully titrated and monitored . 	imidazole drugs	coumarin drugs
int	 <e1> DRUG1 </e1> may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Etonogestrel	Tegretol
other	 Such individuals are referred to as poor metabolizers of drugs such as <e1> DRUG1 </e1> , DRUG0 , the DRUG0 , and <e2> DRUG2 </e2> . 	debrisoquin	clozapine
other	 <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> may decrease DRUG0 plasma levels , resulting in a decrease in effectiveness of a previously effective DRUG0 dose . 	Phenytoin	rifampin
advise	 This time window is different than for other oral formulations of <e1> DRUG1 </e1> , which are usually administered 2 hours before or 6 hours after <e2> DRUG2 </e2> . 	ciprofloxacin	antacids
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving <e1> DRUG1 </e1> metabolized similarly to DRUG0 or on the basis of in vitro studies with DRUG0 or other DRUG0 (caution is recommended during coadministration with DRUG0 ) : Available data from clinical studies of DRUG0 other than DRUG0 suggest a possible drug interaction with DRUG0 for the following : DRUG0 , DRUG0 , DRUG0 such as <e2> DRUG2 </e2> and DRUG0 , and grapefruit juice . 	benzodiazepines	erythromycin
other	 <e1> DRUG1 </e1> containing <e2> DRUG2 </e2> , when administered concomitantly with DRUG0 , reduce both the rate and extent of absorption . 	Antacids	magnesium trisilicate
other	 <e1> DRUG1 </e1> , DRUG0 (e.g. , DRUG0 ) , <e2> DRUG2 </e2> and DRUG0 , DRUG0 , DRUG0 , and other drugs having anticholinergic activity . 	MAO inhibitors	nitrates
other	 DRUG0 : It has been reported that <e1> DRUG1 </e1> prolongs the half-life of the <e2> DRUG2 </e2> , DRUG0 . 	allopurinol	anticoagulant
other	 When used in therapeutic doses , DRUG0 had a modest effect on the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (intravenous and oral) , DRUG0 , DRUG0 / DRUG0 or <e2> DRUG2 </e2> . 	rifabutin	zidovudine
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all <e1> DRUG1 </e1> (eg , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , other DRUG0 , general DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) may result in additive central nervous system depressant effects . 	central nervous system depressants	hypnotics
mechanism	 CONCLUSIONS : <e1> DRUG1 </e1> inhibit the metabolism of DRUG0 that are metabolized by CYP3A4 (i.e. , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) . 	Macrolide antibiotics	simvastatin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e2> DRUG2 </e2> , DRUG0 . 	protease inhibitors	verapamil
other	 Concomitant medications were grouped as DRUG0 , oral DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , inducers of CYP3A4 , substrates and inhibitors of CYP3A4 , substrates and inhibitors of P-glycoprotein , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , substrates and inhibitors of tubular organic cation transport , and QTc-prolonging drugs . 	cardiac glycosides	potassium sparing diuretics
effect	 Drugs Decreasing DRUG0 Effect : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or DRUG0 may partially counteract the anticoagulant action of <e2> DRUG2 </e2> . 	Digitalis	heparin sodium
other	 Because changes in glucose concentrations with <e1> DRUG1 </e1> coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dL , dose adjustment for <e2> DRUG2 </e2> (5 mg QD and 10 mg BID) with DRUG0 coadministration (up to 40 mg QD) is not indicated . 	valdecoxib	glyburide
other	 <e1> DRUG1 </e1> : Coadministration of a single dose of DRUG0 10 mg and multiple doses of DRUG0 ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either <e2> DRUG2 </e2> or DRUG0 . 	Venlafaxine	zaleplon
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	clindamycin	anesthetics
other	 DRUG0 (CNS) drugs including DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , blood pressure medications ( DRUG0 , DRUG0 , DRUG0 ) , motion sickness medications , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , sleeping pills and DRUG0 	antihistamines	sedatives
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Topamax	phenylbutazone
other	 DRUG0 may interact with DRUG0 (e.g. , <e1> DRUG1 </e1> ) , DRUG0 (e.g. , DRUG0 ) , local DRUG0 (e.g. , DRUG0 and DRUG0 ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , <e2> DRUG2 </e2> (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	Tylenol	procainamide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; <e1> DRUG1 </e1> ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	disulfiram	glucagon
other	 In general , these are drugs that have one or more pharmacologic activities similar to <e1> DRUG1 </e1> , including DRUG0 such as DRUG0 and DRUG0 , <e2> DRUG2 </e2> and DRUG0 . 	bepridil hydrochloride	cardiac glycosides
other	 Antiacid , DRUG0 , DRUG0 , DRUG0 , DRUG0 , Indanavir , DRUG0 , <e1> DRUG1 </e1> , Phenobarbitol , DRUG0 , DRUG0 , DRUG0 , Ritanovir , <e2> DRUG2 </e2> . 	Phenytoin	Saquinavir
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ]) or 	Mellaril	Vesprin
other	 DRUG0 , DRUG0 and DRUG0 : DRUG0 has no significant pharmacokinetic interactions with DRUG0 and DRUG0 , and <e1> DRUG1 </e1> has no significant effect on plasma levels of <e2> DRUG2 </e2> . 	losartan	bosentan
int	 <e1> DRUG1 </e1> may interact with DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	Chlorotrianisene	barbiturates
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isozyme , including DRUG0 , DRUG0 , DRUG0 , and DRUG0 (e.g. , DRUG0 , <e1> DRUG1 </e1> and DRUG0 ) , or that inhibit this enzyme (e.g. , <e2> DRUG2 </e2> ) , should be approached with caution . 	flecainide	quinidine
other	 Concomitant use of DRUG0 and drugs that inhibit CYP3A4 (eg , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increase exposure to <e2> DRUG2 </e2> and should be avoided . 	indinavir	dasatinib
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	glucocorticoids	praziquantel
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	miconazole	sulfinpyrazone
effect	 <e1> DRUG1 </e1> can interact with DRUG0 or other <e2> DRUG2 </e2> (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , DRUG0 or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and DRUG0 (concurrent use with DRUG0 may prolong and intensify the anticholinergic and CNS depressant effects of DRUG0 ) . 	Dexbrompheniramine	CNS depressants
other	 DRUG0 : In a clinical pharmacology study , coadministration of an <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , and DRUG0 ) with DRUG0 reduced serum levels and urinary excretion of DRUG0 as compared with DRUG0 administered alone , suggesting that <e2> DRUG2 </e2> may impair absorption of DRUG0 . 	antacid	antacids
other	 DRUG0 - Combined administration of racemic <e1> DRUG1 </e1> (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate <e2> DRUG2 </e2> (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either DRUG0 or DRUG0 . 	citalopram	triazolam
other	 Drugs That Should Not Be Coadministered With DRUG0 <e1> DRUG1 </e1> : DRUG0 , DRUG0 DRUG0 : DRUG0 , DRUG0 Antimigraine : DRUG0 DRUG0 : DRUG0 DRUG0 DRUG0 , <e2> DRUG2 </e2> GI motility agents : DRUG0 	Antiarrhythmics	triazolam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	aminosalicylic acid	quinine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextran	phenylbutazone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	itraconazole	zonisamide
other	 These in vitro studies suggest that concomitant administration of DRUG0 and <e1> DRUG1 </e1> in humans may result in sub-therapeutic concentrations of active phosphorylated DRUG0 , which may lead to a decreased <e2> DRUG2 </e2> effect of DRUG0 . 	lamivudine	antiretroviral
other	 In addition , under the influence of sympatholytic medicinal products such as DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> , the signs of hypoglycemia may be reduced or absent . 	clonidine	reserpine
other	 METHODS : <e1> DRUG1 </e1> (100 mg) and <e2> DRUG2 </e2> (20 mg) were administered orally to 16 healthy male and female volunteers in a four-session , placebo-controlled , within-subject , crossover design . 	Hydrocortisone	d-amphetamine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	clarithromycin	erythromycin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	thyroid drugs	triclofos sodium
advise	 However , because some DRUG0 have been reported to enhance the effects of DRUG0 or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a <e1> DRUG1 </e1> is administered with <e2> DRUG2 </e2> or its derivatives . 	quinolone antimicrobial	warfarin
other	 Cardiac effects of DRUG0 are antagonized by <e1> DRUG1 </e1> , such as <e2> DRUG2 </e2> and DRUG0 . 	beta-adrenergic blocking agents	propranolol
effect	 DRUG0 , DRUG0 and <e1> DRUG1 </e1> may enhance the effects of : other DRUG0 s , DRUG0 , general DRUG0 , DRUG0 such as <e2> DRUG2 </e2> , DRUG0 , or other DRUG0 , causing increased CNS depression . 	caffeine	chlordiazepoxide
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	thiocyanate	nitroprusside
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	amiodarone	iodine-containing compounds
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextran	prolonged narcotics
other	 The hypoglycemic action of DRUG0 may be potentiated by certain drugs including <e1> DRUG1 </e1> and other drugs that are highly protein bound , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	nonsteroidal anti-inflammatory agents	sulfonamides
effect	 Concomitant use of <e1> DRUG1 </e1> with DRUG0 , <e2> DRUG2 </e2> , DRUG0 , or other DRUG0 may have an additive effect . 	antihistamines	tricyclic antidepressants
mechanism	 The absorption of <e1> DRUG1 </e1> may be affected by the simultaneous administration of indigestion remedies , <e2> DRUG2 </e2> or DRUG0 supplements . 	lymecycline	iron
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , DRUG0 ( DRUG0 s) , DRUG0 , DRUG0 ( DRUG0 may decrease the effects of these medicines) , DRUG0 (using these medicines with <e1> DRUG1 </e1> may result in increased CNS depressant effects) , DRUG0 , <e2> DRUG2 </e2> (using these medicines with DRUG0 may change the amount of either medicine that you need to take) , and oral DRUG0 containing DRUG0 ( DRUG0 may decrease the effectiveness of these oral DRUG0 , and you may need to change to a different type of birth control) . 	barbiturates	valproic acid
other	 <e1> DRUG1 </e1> serum levels should be monitored and appropriate dose adjustments considered for patients given both DRUG0 and <e2> DRUG2 </e2> . 	Theophylline	PEGASYS
other	 The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (e.g. , <e2> DRUG2 </e2> ) , DRUG0 . 	somatostatin analog	octreotide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e1> DRUG1 </e1> (4) , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	Phenytoin	quetiapine
other	 In three separate controlled , parallel group clinical pharmacology studies , DRUG0 at the clinical dose of 5 mg has been coadministered with DRUG0 500 mg followed by 250 mg once daily for 4 days (n=18) or with <e1> DRUG1 </e1> 20 mg once daily for 7 days after a 23 day pretreatment period with DRUG0 (n=18) or with <e2> DRUG2 </e2> 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers . 	fluoxetine	cimetidine
other	 Agents with Increased Levels in the Presence of DRUG0 : DRUG0 increases the plasma levels of the following agents : DRUG0 , DRUG0 (6) , and <e1> DRUG1 </e1> Thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with <e2> DRUG2 </e2> , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary . 	primidone	EQUETROTM
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> with DRUG0 plus DRUG0 ) without receiving DRUG0 therapy . 	doxorubicin	prednisone
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> DRUG1 </e1> doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	finasteride	HMG-CoA reductase inhibitors
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> overdosage . 	miconazole	warfarin sodium
other	 DRUG0 can interact with DRUG0 or other DRUG0 (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , DRUG0 or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and <e1> DRUG1 </e1> (concurrent use with <e2> DRUG2 </e2> may prolong and intensify the anticholinergic and CNS depressant effects of DRUG0 ) . 	monoamine oxidase (MAO) inhibitors	antihistamines
other	 DRUG0 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	anticoagulants	beta blockers
other	 DRUG0 and Foods Fortified With DRUG0 Concomitant administration of DRUG0 with a therapeutic <e1> DRUG1 </e1> containing 60 mg of elemental DRUG0 (as FeSO4) or DRUG0 supplemented with 10 mg of elemental <e2> DRUG2 </e2> reduced extent of absorption by 80% and 31% , respectively . 	iron supplement	iron
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	fenoprofen
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	doxycycline	risperidone
effect	 DRUG0 : <e1> DRUG1 </e1> may counteract the anticholinesterase effect of <e2> DRUG2 </e2> , thereby potentially aggravating myasthenia gravis . 	Dipyridamole	cholinesterase inhibitors
other	 The following drugs have been coadministered with DRUG0 and have not altered its pharmacokinetics : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	chlorthalidone	hydrochlorothiazide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	monoamine oxidase inhibitors	quinine
effect	 DRUG0 : Because <e1> DRUG1 </e1> can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of <e2> DRUG2 </e2> including DRUG0 , there is a risk that an interaction will lead to deterioration . 	cyclosporine	fibrate drugs
other	 Radioligand binding experiments using the uptake inhibitor hydrogen-3 <e1> DRUG1 </e1> revealed a significant decrease by approximately 30% in <e2> DRUG2 </e2> uptake-1 carrier density in functional classes II to III and IV myocardium versus nonfailing myocardium (p < 0.05) . 	mazindol	norepinephrine
other	 <e1> DRUG1 </e1> in combination with DRUG0 enhances the manifestation of corneal lesions in rats Epidural Injection <e2> DRUG2 </e2> may potentiate the CNS-depressive effect of DRUG0 , DRUG0 or other DRUG0 . 	Amitriptyline	Clonidine
other	 Coadministration of <e1> DRUG1 </e1> with DRUG0 or any known CYP3A4 inducer should be avoided and alternative <e2> DRUG2 </e2> therapy should be considered . 	SULAR	antihypertensive
other	 When such drugs are withdrawn from patients receiving <e1> DRUG1 </e1> in combination with DRUG0 or <e2> DRUG2 </e2> , patients should be observed closely for any evidence of hypoglycemia . 	Acarbose	insulin
mechanism	 Increasing the DRUG0 dose to 1000 mg every 8 hours does not compensate for the increased <e1> DRUG1 </e1> metabolism due to <e2> DRUG2 </e2> . 	indinavir	SUSTIVA
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chymotrypsin	indomethacin
other	 Other Drugs : In healthy volunteers , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , hormone replacement therapy (a combination of conjugated <e2> DRUG2 </e2> and DRUG0 ) , DRUG0 DRUG0 and DRUG0 s) and DRUG0 did not affect the pharmacokinetics of DRUG0 . 	glyburide	estrogens
other	 Drug Interactions : DRUG0 may interact with some drugs , like DRUG0 ( <e1> DRUG1 </e1> ) : DRUG0 could theoretically affect DRUG0 pharmacodynamics - DRUG0 - Eproxindine - <e2> DRUG2 </e2> : DRUG0 and DRUG0 cause additive CNS depression - DRUG0 : DRUG0 increases the effect of DRUG0 	MAOI	Ethanol
effect	 Drugs that have been reported to diminish oral <e1> DRUG1 </e1> response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	anticoagulant	antihistamines
mechanism	 DRUG0 : Doses of DRUG0 ( <e1> DRUG1 </e1> ) 1 g/day have been reported to increase plasma concentration of <e2> DRUG2 </e2> by ~47% , possibly by inhibiting conjugation; 	vitamin C	synthetic estrogens
other	 DRUG0 / <e1> DRUG1 </e1> -containing <e2> DRUG2 </e2> : Absorption of DRUG0 is moderately reduced (approximately 25%) when coadministered with DRUG0 / DRUG0 -containing DRUG0 . 	Aluminum	Antacid Products
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cinchophen	thyroid drugs
other	 DRUG0 should be administered with caution to patients who are taking other DRUG0 or <e1> DRUG1 </e1> , including DRUG0 , <e2> DRUG2 </e2> and DRUG0 , or to those with a history of psychiatric disorder (including manic-depressive illness and schizophrenia) . 	CNS depressants	barbiturates
other	 Short-term pharmacokinetic studies have demonstrated that concomitant administration of DRUG0 and DRUG0 ( <e1> DRUG1 </e1> capsules and tablets) results in reduced protein binding of <e2> DRUG2 </e2> , but there was no change in the clearance of free DRUG0 . 	etodolac	warfarin
other	 DRUG0 is contraindicated in patients using <e1> DRUG1 </e1> or who may need to use <e2> DRUG2 </e2> , because the combination may cause a sharp fall of the blood pressure . 	long-acting nitrates	short-acting nitrates
other	 DRUG0 : Coadministration of <e1> DRUG1 </e1> with DRUG0 resulted in a 152% increase in <e2> DRUG2 </e2> plasma AUC and very little change in DRUG0 plasma A.C . 	ritonavir	nelfinavir
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Gris-PEG	rifampin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , <e1> DRUG1 </e1> , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	fluvoxamine	protease inhibitors
other	 The aim of this paper was to study the interaction between <e1> DRUG1 </e1> and both DRUG0 or its synthetic analogue <e2> DRUG2 </e2> , or DRUG0 , on the antinonciceptive effect of these peptides in mice after intracisternal injection . 	neurotensin	D-Ala2-metenkephalinamide
other	 The hypoglycemic action of DRUG0 may be potentiated by certain drugs including DRUG0 and other drugs that are highly protein bound , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	monoamine oxidase inhibitors	beta adrenergic blocking agents
effect	 Pharmacodynamic Interactions : The CNS-depressant action of the <e1> DRUG1 </e1> of drugs may be potentiated by DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , the DRUG0 , DRUG0 and DRUG0 , DRUG0 and the DRUG0 , and by other DRUG0 . 	benzodiazepine class	antianxiety agents
int	 <e1> DRUG1 </e1> may interact with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	Chlorotrianisene	tamoxifen
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> inhibit the hypotensive effect of DRUG0 . 	Veratrum alkaloids	Amphetamines
other	 The similarity of the DRUG0 -associated adverse event profile between Study 1 (without co-administered DRUG0 ) and Study 2 (with co-administered <e1> DRUG1 </e1> ) indicates that this alteration in clearance does not necessitate reduction of the <e2> DRUG2 </e2> dose to maintain safety , General) . 	AVONEX	TYSABRI
effect	 DRUG0 - There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a <e1> DRUG1 </e1> ( DRUG0 ) and <e2> DRUG2 </e2> . 	selective serotonin reuptake inhibitor	sumatriptan
other	 <e1> DRUG1 </e1> : DRUG0 toxicity has been reported in patients receiving DRUG0 concomitantly with drugs which cause elimination of sodium , including <e2> DRUG2 </e2> . 	Lithium	ACE inhibitors
mechanism	 The mechanism for this interaction probably is adsorption of <e1> DRUG1 </e1> onto the surface of <e2> DRUG2 </e2> . 	nitrofurantoin	magnesium trisilicate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	p-aminosalicylic acid	lithium
effect	 poor metabolizers of DRUG0 : Interactions of DRUG0 with strong inhibitors of CYP2D6 (such as DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of <e2> DRUG2 </e2> . 	propafenone	carvedilol
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (2) , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> Thus , if a patient has been titrated to a stable dosage on DRUG0 , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for DRUG0 may be necessary . 	methsuximide	theophylline
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (e.g. , in oral DRUG0 ) . 	niacin	progestogens
other	 <e1> DRUG1 </e1> has been used concomitantly with DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 , without evidence of clinically important adverse interactions . 	Lotensin	diuretics
other	 The concomitant use of transdermal DRUG0 with <e1> DRUG1 </e1> or other potent 3A4 inhibitors such as DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and nefazadone may result in an increase in DRUG0 plasma concentrations . 	ritonavir	troleandomycin
other	 DRUG0 : Available data suggest that there is no significant effect of DRUG0 on the clearance of <e1> DRUG1 </e1> at steady state , Therefore , the addition of <e2> DRUG2 </e2> is not expected to cause a clinically important effect on DRUG0 ( DRUG0 ) plasma concentrations . 	Felbatol	valproate
mechanism	 This decrease in bioavailability was about 5% when <e1> DRUG1 </e1> was administered 2 hours after <e2> DRUG2 </e2> . 	gabapentin	Maalox
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	nalidixic acid	phenytoin
other	 Additionally , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> did not show potential for altering CYP1A2-mediated metabolism in vitro . 	aripiprazole	dehydroaripiprazole
other	 Tell your doctor if you are taking any of the following drugs : <e1> DRUG1 </e1> s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 DRUG0 ( DRUG0 ) DRUG0 ( DRUG0 ) <e2> DRUG2 </e2> DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	blood thinner	estrogens
other	 These drugs include the DRUG0 and other DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	phenytoin	isoniazid
effect	 Additive CNS depression may occur when <e1> DRUG1 </e1> are administered concomitantly with other <e2> DRUG2 </e2> including DRUG0 , DRUG0 , and DRUG0 . 	antihistamines	CNS depressants
other	 Caution should be used when administering or taking DRUG0 with DRUG0 and other strong CYP3A4 inhibitors such as , but not limited to , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> . 	itraconazole	voriconazole
other	 The gonadotropin levels may be transiently elevated by <e1> DRUG1 </e1> , minimally elevated by DRUG0 , and suppressed by oral DRUG0 and <e2> DRUG2 </e2> . 	spironolactone	digoxin
other	 Serial plasma and urine samples for measurement of DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> and their DRUG0 , were measured by high-performance liquid chromatography . 	rifabutin	rifampin
mechanism	 DRUG0 : DRUG0 , as well as other <e1> DRUG1 </e1> , probably reduces the tubular secretion of <e2> DRUG2 </e2> based on in vitro studies in rabbit kidney slices . 	nonsteroidal anti-inflammatory drugs	methotrexate
mechanism	 <e1> DRUG1 </e1> , DRUG0 , and DRUG0 decrease the half-life of <e2> DRUG2 </e2> . 	Barbiturates	doxycycline
other	 <e1> DRUG1 </e1> / DRUG0 , <e2> DRUG2 </e2> / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , and DRUG0 / DRUG0 . 	acetaminophen	lidocaine
advise	 The use of DRUG0 should be considered in place of DRUG0 or <e1> DRUG1 </e1> in patients receiving <e2> DRUG2 </e2> therapy . 	proton pump inhibitors	SPRYCEL
other	 <e1> DRUG1 </e1> such as DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 ) : Using these medicines with DRUG0 may increase the chance of side effects . 	Monoamine oxidase (MAO) inhibitors	Nardil
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	diazepam	lovastatin
other	 Other concomitant therapy Although specific interaction studies were not performed , DRUG0 doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (also referred to as DRUG0 ) , and <e2> DRUG2 </e2> without evidence of clinically significant adverse interactions . 	prostaglandin synthetase inhibitors	quinolone anti-infectives
other	 The effectiveness of DRUG0 -only pills is reduced by hepatic enzyme-inducing drugs such as the DRUG0 DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> , and the DRUG0 DRUG0 . 	carbamazepine	barbiturates
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ranitidine	trimethoprim
advise	 Because there is a theoretical basis that these effects may be additive , use of <e1> DRUG1 </e1> -containing or DRUG0 (like DRUG0 or DRUG0 ) and <e2> DRUG2 </e2> within 24 hours is contraindicated . 	ergotamine	naratriptan
other	 In order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with DRUG0 should be premedicated with <e1> DRUG1 </e1> (such as DRUG0 ) , diphen-hydramine and DRUG0 (such as DRUG0 or <e2> DRUG2 </e2> ) . 	corticosteroids	ranitidine
other	 DRUG0 ( <e1> DRUG1 </e1> ) (e.g. , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 . 	SSRIs	sertraline
effect	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as <e1> DRUG1 </e1> include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	NIMBEX	sodium colistemethate
other	 DRUG0 and <e1> DRUG1 </e1> (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving DRUG0 25 to 50 mg also received <e2> DRUG2 </e2> or DRUG0 ( DRUG0 / DRUG0 ) . 	Angiotensin II Receptor Antagonists	ACE inhibitors
other	 The pharmacokinetics and protein binding of <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> were not altered when DRUG0 and DRUG0 were concurrently administered in single submaximal doses . 	fosphenytoin	diazepam
other	 The effects of concomitant administration of <e1> DRUG1 </e1> on the pharmacokinetics of <e2> DRUG2 </e2> and its active metabolites were studied in 24 healthy young male volunteers . 	cimetidine	bupropion
advise	 Patients who are applying <e1> DRUG1 </e1> gel should not concurrently use products that contain <e2> DRUG2 </e2> (N , DRUG0 ) , a common component of insect repellent products . 	Panretin	DEET
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral <e2> DRUG2 </e2> ) . 	phenothiazine derivatives	contraceptives
other	 May interact with wthionamide ( <e1> DRUG1 </e1> ) and <e2> DRUG2 </e2> ( DRUG0 ) . 	Trecator-SC	isoniazid
other	 In clinical studies , coadministration of <e1> DRUG1 </e1> with DRUG0 , <e2> DRUG2 </e2> , or DRUG0 did not interfere with the lipid-lowering activity of the DRUG0 . 	WelChol	lovastatin
other	 Garlic Capsules Garlic capsules should not be used while taking DRUG0 ( <e1> DRUG1 </e1> ) as the sole <e2> DRUG2 </e2> due to the risk of decreased DRUG0 plasma concentrations . 	FORTOVASE	protease inhibitor
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (5) , DRUG0 , and DRUG0 . 	doxycycline	valproate
other	 DRUG0 , DRUG0 and DRUG0 : <e1> DRUG1 </e1> has no significant pharmacokinetic interactions with <e2> DRUG2 </e2> and DRUG0 , and DRUG0 has no significant effect on plasma levels of DRUG0 . 	Bosentan	digoxin
other	 DRUG0 may interact with the following medications : DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Tylenol	clofibrate
other	 The following agents may increase certain actions or side effects of DRUG0 . DRUG0 DRUG0 of class (e.g . DRUG0 ) , DRUG0 <e1> DRUG1 </e1> (e.g . DRUG0 ) , <e2> DRUG2 </e2> . 	antipsychotic agents	benzodiazepines
other	 <e1> DRUG1 </e1> and <e2> DRUG2 </e2> each may be associated with increased serum potassium levels . 	INDOCIN	potassium-sparing diuretics
other	 <e1> DRUG1 </e1> , DRUG0 , and DRUG0 : Drugs such as DRUG0 , <e2> DRUG2 </e2> , and DRUG0 may increase the risk of developing peripheral neuropathy or other DRUG0 -associated adverse events by interfering with the renal clearance of DRUG0 (thereby raising systemic exposure) . 	Amphotericin	foscarnet
effect	 These results suggest that both DRUG0 and DRUG0 , and possibly other DRUG0 and <e1> DRUG1 </e1> , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of <e2> DRUG2 </e2> and DRUG0 . 	retinoids	insulin
other	 In addition , <e1> DRUG1 </e1> neither influenced the pharmacodynamics of DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> , nor the pharmacokinetics of DRUG0 at steady state . 	Fondaparinux	digoxin
other	 Studies have shown that <e1> DRUG1 </e1> does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system , such as DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or DRUG0 in healthy subjects . 	lansoprazole	ibuprofen
other	 Drug-Drug Interactions DRUG0 - DRUG0 should be administered with caution to patients being treated with systemically-administered (oral or intravenous) DRUG0 (or other <e1> DRUG1 </e1> ) because the action of <e2> DRUG2 </e2> on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure . 	beta2 agonists	albuterol
mechanism	 DRUG0 : In normal volunteers , concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> resulted in significantly increased plasma levels of DRUG0 . 	diflunisal	hydrochlorothiazide
mechanism	 The absorption of oral <e1> DRUG1 </e1> is significantly reduced by the concomitant administration of an DRUG0 containing <e2> DRUG2 </e2> and DRUG0 . 	gemifloxacin	aluminum
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cinchophen	methylphenidate
other	 The behavioral effects of the stereoisomers of DRUG0 ( <e1> DRUG1 </e1> ) were compared with those of DRUG0 ( <e2> DRUG2 </e2> ) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation . 	NANM	PCP
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	phenylbutazone	tolbutamide
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> may delay intestinal absorption of DRUG0 . 	Ethosuximide	Amphetamines
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anabolic steroids	oxyphenbutazone
other	 The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 ) , <e2> DRUG2 </e2> . 	fibrates	sulfonamide antibiotics
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	prednisolone	temazepam
other	 When used in therapeutic doses , DRUG0 had a modest effect on the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (intravenous and oral) , DRUG0 , DRUG0 / <e2> DRUG2 </e2> or DRUG0 . 	fluconazole	sulfamethoxazole
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 ); 	Nuprin	Anaprox
other	 These drugs include the DRUG0 and other DRUG0 , DRUG0 , phe-nothiazines , DRUG0 , DRUG0 , oral DRUG0 , <e1> DRUG1 </e1> , DRUG0 , sympathomimet-ics , <e2> DRUG2 </e2> , and DRUG0 . 	phenytoin	calcium channel blocking drugs
other	 DRUG0 (CNS) drugs including DRUG0 , DRUG0 , DRUG0 , DRUG0 , blood pressure medications ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , motion sickness medications , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , sleeping pills and DRUG0 	methyldopa	muscle relaxants
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	sulindac
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	buspirone	Phenytoin
other	 Hormonal DRUG0 Co-administration of DRUG0 with an oral <e1> DRUG1 </e1> has been shown to influence the plasma concentrations of the two hormonal components , <e2> DRUG2 </e2> (EE) and DRUG0 (LNG) . 	contraceptive	ethinylestradiol
other	 Oral <e1> DRUG1 </e1> : In one study , DRUG0 was given to adult diabetics who were already receiving DRUG0 (n=4) , DRUG0 (n=2) DRUG0 with DRUG0 (n= 3) or <e2> DRUG2 </e2> with DRUG0 (n=6) . 	Hypoglycemic Agents	glyburide
other	 Endothelium-intact aortic rings from high- <e1> DRUG1 </e1> rats were supersensitive to DRUG0 when compared to vehicle- , <e2> DRUG2 </e2> - and DRUG0 + high- DRUG0 -treated rats (pD2 values = 7.77+/-0.12 , 7.21+/-0.13 , 6.93+/-0.04 and 7.22+/-0.18 , respectively) . 	estradiol	progesterone
other	 In patients taking DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and various chemotherapy agents , no effect was shown on the clearance of <e2> DRUG2 </e2> . 	diltiazem	hydrodolasetron
other	 Certain DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> . 	diuretic	vaccines
advise	 Caution is advised when <e1> DRUG1 </e1> is coadministered with other medications that can prolong the QT interval (e.g . certain DRUG0 or <e2> DRUG2 </e2> ) or lead to electrolyte abnormalities (such as DRUG0 or DRUG0 ) . 	TRISENOX	thioridazine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	metronidazole	thyroid drugs
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , <e2> DRUG2 </e2> , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	felodipine	oxcarbazepine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Prolixin	Sparine
other	 May interact with thyroid medication (e.g. , DRUG0 ) , <e1> DRUG1 </e1> -containing products , DRUG0 , DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) . 	iodine	ranitidine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	monoamine oxidase inhibitors	quinine
other	 <e1> DRUG1 </e1> : Estimates of steady-state pharmacokinetic parameters for DRUG0 or <e2> DRUG2 </e2> (300 mg TID; 	Phenobarbital	gabapentin
other	 Among the <e1> DRUG1 </e1> , many , like <e2> DRUG2 </e2> , cannot be used clinically because they are toxic; 	polyene antibiotics	filipin
other	 - DRUG0 and <e1> DRUG1 </e1> DRUG0 : DRUG0 and DRUG0 <e2> DRUG2 </e2> have the potential of binding DRUG0 and reducing DRUG0 absorption from the gastrointestinal tract 	colestipol	resins
other	 Some <e1> DRUG1 </e1> /substances are known to accelerate the metabolism of DRUG0 by stimulating the synthesis of <e2> DRUG2 </e2> (enzyme induction) . 	drugs	CYP3A4
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	pyrazolones	trimethoprim
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , <e2> DRUG2 </e2> , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	cyclosporin	oxcarbazepine
mechanism	 Co-administration of <e1> DRUG1 </e1> decreased the plasma concentrations of <e2> DRUG2 </e2> by approximately 40% . 	bosentan	glyburide
other	 Before taking DRUG0 , tell your doctor if you are taking any of the following medicines : - DRUG0 or another DRUG0 such as DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 , others) , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	Trilisate	choline salicylate
other	 DRUG0 : Based on reports of profound hypotension and loss of consciousness when DRUG0 was administered with DRUG0 , the concomitant use of DRUG0 with drugs of the DRUG0 (including , for example , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> ) is contraindicated . 	ondansetron	alosetron
other	 The homodimeric disintegrin DRUG0 was compared directly to the monomeric disintegrins <e1> DRUG1 </e1> and <e2> DRUG2 </e2> for the ability to affect protein tyrosine phosphorylation in tumor cells . 	echistatin	flavoridin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	salicylates	sulfinpyrazone
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Prolixin	Trilafon
other	 DRUG0 ( <e1> DRUG1 </e1> ) : DRUG0 plasma concentrations were not affected by co-administration of <e2> DRUG2 </e2> . 	Magnesium-Aluminum Hydroxide	antacid
effect	 The concomitant use of DRUG0 s , vasoconstricting agents (such as <e1> DRUG1 </e1> ) and some <e2> DRUG2 </e2> may result in severe hypertension . 	ergonovine	oxytocic drugs
effect	 Interactions attributed to the combined use of <e1> DRUG1 </e1> injection and epidural <e2> DRUG2 </e2> include hypotension and dyspnea . 	baclofen	morphine
other	 The principal drugs given (number of patients in parentheses) were : <e1> DRUG1 </e1> (115) , DRUG0 and DRUG0 (103) , DRUG0 (52) , oral DRUG0 (45) , cough and cold preparations (45) , DRUG0 (38) , DRUG0 (29) , DRUG0 (24) , oral DRUG0 (18) , DRUG0 (13) , <e2> DRUG2 </e2> (10) , and DRUG0 (10) . 	cardiac glycosides	insulin
other	 The bioavailability of the capsule formulation of <e1> DRUG1 </e1> was not affected when administered 5 minutes following an <e2> DRUG2 </e2> . 	cefprozil	antacid
other	 <e1> DRUG1 </e1> : The AUC of DRUG0 was increased about 4-fold when DRUG0 at 300 mg/day was coadministered with a single 200-mg dose of <e2> DRUG2 </e2> to two patients with renal impairment (CLcr=15 and 18 mL/min) . 	Allopurinol	VIDEX
other	 DRUG0 such as <e1> DRUG1 </e1> (e.g. , DRUG0 ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 ) : Using these medicines with DRUG0 may increase the chance of side effects . 	isocarboxazid	Nardil
other	 DRUG0 also should be used cautiously with other drugs (e.g. , DRUG0 , <e1> DRUG1 </e1> ) that sensitize the myocardium to the actions of <e2> DRUG2 </e2> . 	glycosides	sympathomimetic drugs
other	 DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / <e1> DRUG1 </e1> , DRUG0 / DRUG0 , DRUG0 / <e2> DRUG2 </e2> , DRUG0 / DRUG0 , and DRUG0 / DRUG0 . 	acetaminophen	lidocaine
other	 <e1> DRUG1 </e1> has been administered with DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , and high-frequency ventilation . 	INOmax	dopamine
other	 - Drugs whose efficacy is impaired by DRUG0 include : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 . 	anticoagulants	rifampin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diazoxide	oxyphenbutazone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	methadone	protease inhibitors
other	 DRUG0 - DRUG0 containing side chains of N-methylthiotetrazole ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) or methylthiadiazole ( <e2> DRUG2 </e2> ) can cause vitamin K deficiency and hypoprothrombinemia . 	latamoxef	cefazolin
other	 DRUG0 may reduce the antihypertensive effects of <e1> DRUG1 </e1> , DRUG0 , DRUG0 and <e2> DRUG2 </e2> . 	reserpine	mecamylamine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	cimetidine	nefazodone
other	 The effect of <e1> DRUG1 </e1> on <e2> DRUG2 </e2> clearance has not been studied . 	TORADOL	methotrexate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	allopurinol	salicylates
other	 DRUG0 and Foods Fortified With DRUG0 Concomitant administration of <e1> DRUG1 </e1> with a therapeutic DRUG0 containing 60 mg of elemental DRUG0 (as FeSO4) or <e2> DRUG2 </e2> supplemented with 10 mg of elemental DRUG0 reduced extent of absorption by 80% and 31% , respectively . 	cefdinir	vitamins
other	 It may increase excretion of DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> and may also increase the toxicity of DRUG0 . 	lithium	ASA
other	 Since there have been isolated reports of patients with elevated <e1> DRUG1 </e1> levels , it is recommended that DRUG0 levels be monitored when initiating , adjusting , and discontinuing <e2> DRUG2 </e2> to avoid possible over- or under-digitalization . 	digoxin	nifedipine
other	 DRUG0 : If <e1> DRUG1 </e1> is given concurrently with DRUG0 , the protein binding of <e2> DRUG2 </e2> may be reduced . 	acitretin	phenytoin
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all DRUG0 (eg , DRUG0 , DRUG0 , DRUG0 , other <e1> DRUG1 </e1> , general DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) may result in additive central nervous system depressant effects . 	opioids	barbiturates
other	 DRUG0 : Since DRUG0 is a <e1> DRUG1 </e1> , it is possible that DRUG0 , such as the DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) or DRUG0 , may diminish the effectiveness of DRUG0 . 	dopamine agonist	thioxanthenes
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ibuprofen	prolonged narcotics
mechanism	 DRUG0 increase the rate of absorption of <e1> DRUG1 </e1> , while <e2> DRUG2 </e2> decreases it . 	pseudoephedrine	kaolin
other	 <e1> DRUG1 </e1> : It appears that DRUG0 may reduce plasma <e2> DRUG2 </e2> concentrations . 	Phenobarbital	felbamate
other	 Tacrolimus <e1> DRUG1 </e1> may increase the blood concentration of <e2> DRUG2 </e2> . 	Felodipine	tacrolimus
other	 Although there is no documentation of such , a similar interaction between <e1> DRUG1 </e1> and the <e2> DRUG2 </e2> may occur . 	ethotoin	coumarin anticoagulants
other	 Compounds tested in man include DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and <e2> DRUG2 </e2> . 	phenytoin	antipyrine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Neoral	Kadian
mechanism	 DRUG0 : Combination <e1> DRUG1 </e1> may decrease the clearance of some <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , DRUG0 , DRUG0 ) . 	hormonal contraceptives	benzodiazepines
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methylphenidate	miconazole
other	 <e1> DRUG1 </e1> : Although the results of a clinical study did not indicate a safe problem associated with the administration of DRUG0 ( <e2> DRUG2 </e2> ) Injection , USP to subjects already receiving DRUG0 , there have been reports that DRUG0 may potentiate the vasoconstrictive action of DRUG0 by blocking the vasodilating property of epinephrine . 	Beta Blockers	dihydroergotamine mesylate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chlorpropamide	methylphenidate
other	 In vivo interaction studies in humans have demonstrated that DRUG0 and <e1> DRUG1 </e1> do not affect the PK properties of <e2> DRUG2 </e2> , nor does DRUG0 affect the PK properties of DRUG0 or DRUG0 . 	warfarin	anagrelide
other	 The concurrent use of two or more drugs with anticholinergic activity--such as an DRUG0 (eg , DRUG0 ) , an DRUG0 (eg , DRUG0 ) , and/or a <e1> DRUG1 </e1> (eg , <e2> DRUG2 </e2> )--commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia . 	tricyclic antidepressant	amitriptyline
other	 The gastrointestinal absorption of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> is accelerated when they are coadministered with DRUG0 . 	cimetidine	ranitidine
mechanism	 In addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or DRUG0 ) with <e2> DRUG2 </e2> may result in clinically meaningful reductions in DRUG0 concentrations . 	nevirapine	CANCIDAS
mechanism	 DRUG0 : In normal volunteers , concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> resulted in significantly increased plasma levels of DRUG0 . 	diflunisal	hydrochlorothiazide
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (1) , DRUG0 , DRUG0 . 	diltiazem	valproate
other	 Example inhibitors include DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> . 	protease inhibitors	verapamil
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Serentil	Mellaril
mechanism	 These alterations in <e1> DRUG1 </e1> pharmacokinetics produced by <e2> DRUG2 </e2> explain the increase in serum DRUG0 level that has been observed when this drug combination has been used clinically . 	digoxin	amiodarone
advise	 Avoid the concomitant use of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> ( DRUG0 ) . 	chlorprothixene	tramadol
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	alcohol	rifampin
other	 DRUG0 can reduce the antihypertensive effects of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	captopril	losartan
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain <e1> DRUG1 </e1> (e . g. , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	antibiotics	aminoglycosides
effect	 <e1> DRUG1 </e1> may increase slightly the effect of DRUG0 , e.g. , <e2> DRUG2 </e2> , DRUG0 , DRUG0 . 	Fenfluramine	guanethidine
effect	 DRUG0 including coumarin derivatives , indandione derivatives , and DRUG0 such as DRUG0 ( <e1> DRUG1 </e1> ) , and DRUG0 may increase the risk of bleeding when administered concomitantly with <e2> DRUG2 </e2> . 	NSAIDs	ardeparin
mechanism	 DRUG0 : Combination <e1> DRUG1 </e1> may decrease the clearance of some DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , DRUG0 , DRUG0 ) . 	hormonal contraceptives	alprazolam
mechanism	 If <e1> DRUG1 </e1> or other hepatic enzyme inducers are taken concurrently with DRUG0 or <e2> DRUG2 </e2> , lower plasma levels of DRUG0 may occur . 	phenytoin	Norpace CR
other	 Administration of DRUG0 with DRUG0 containing DRUG0 , DRUG0 , or <e1> DRUG1 </e1> , with <e2> DRUG2 </e2> , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	calcium	sucralfate
other	 In a study with concomitant administration of DRUG0 and <e1> DRUG1 </e1> , the bioavailability of unbound <e2> DRUG2 </e2> was not altered . 	fosinopril sodium	fosinoprilat
other	 <e1> DRUG1 </e1> : A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on DRUG0 (1 gm/day) 11 days after the addition of <e2> DRUG2 </e2> (75 mg/day) . 	Tolazamide	doxepin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cimetidine	quinidine
other	 DRUG0 ) and many that are substrates for P450 2D6 (many other DRUG0 , <e1> DRUG1 </e1> , and the <e2> DRUG2 </e2> DRUG0 and DRUG0 ) . 	phenothiazines	Type 1C antiarrhythmics
other	 DRUG0 : Concomitant administration of <e1> DRUG1 </e1> ORAL and DRUG0 resulted in decreased clearance of DRUG0 and significant increases in <e2> DRUG2 </e2> plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours . 	TORADOL	ketorolac
other	 The purpose of this study was to evaluate the effect of DRUG0 ( DRUG0 ) and DRUG0 ( <e1> DRUG1 </e1> ) conjugates on the intestinal permeation of <e2> DRUG2 </e2> ( DRUG0 ) and model peptide drugs , DRUG0 and DRUG0 . 	CMC-Cys	sodium fluorescein
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e1> DRUG1 </e1> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diflunisal	glucagon
other	 A clinical study in healthy male volunteers (n=24) demonstrated that mixing <e1> DRUG1 </e1> with <e2> DRUG2 </e2> immediately before injection produced some attenuation in the peak concentration of DRUG0 , but that the time to peak and the total bioavailability of DRUG0 were not significantly affected . 	NovoLog	NPH human insulin
other	 The risk of using <e1> DRUG1 </e1> in combination with other drugs has not been systematically evaluated , but <e2> DRUG2 </e2> may potentiate the side effects of DRUG0 . 	bromocriptine mesylate	alcohol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; <e1> DRUG1 </e1> ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	disulfiram	quinidine
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	chlordiazepoxide	ethchlorvynol
other	 <e1> DRUG1 </e1> : Combination DRUG0 may decrease the clearance of some DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) and increase the clearance of others ( DRUG0 , DRUG0 , DRUG0 ) . 	Benzodiazepines	chlordiazepoxide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	indomethacin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clonazepam	tramadol
other	 <e1> DRUG1 </e1> : Elevated serum levels of DRUG0 have been reported with concomitant use of DRUG0 with other members of the <e2> DRUG2 </e2> . 	Cyclosporine	quinolone class
other	 In vitro studies have shown no binding displacement between <e1> DRUG1 </e1> and other highly bound drugs , such as DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	entacapone	diazepam
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	danazol	niacinamide
other	 Coadministration of DRUG0 with 40 mg <e1> DRUG1 </e1> tablets in epileptic patients lowered the <e2> DRUG2 </e2> plasma concentrations to undetectable levels . 	SULAR	nisoldipine
mechanism	 If <e1> DRUG1 </e1> or other hepatic enzyme inducers are taken concurrently with <e2> DRUG2 </e2> or DRUG0 , lower plasma levels of DRUG0 may occur . 	phenytoin	Norpace
effect	 DRUG0 : Drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving <e2> DRUG2 </e2> . 	dipyridamole	heparin sodium
effect	 <e1> DRUG1 </e1> potentiates other <e2> DRUG2 </e2> such as DRUG0 or DRUG0 and DRUG0 s . 	Phospholine Iodide	cholinesterase inhibitors
other	 - a sulfa-based drug such as <e1> DRUG1 </e1> - DRUG0 ( DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	sulfamethoxazole	Septra
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isozyme , including DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> (e.g. , DRUG0 , DRUG0 and DRUG0 ) , or that inhibit this enzyme (e.g. , DRUG0 ) , should be approached with caution . 	carbamazepine	Type 1C antiarrhythmics
other	 DRUG0 - <e1> DRUG1 </e1> containing side chains of N-methylthiotetrazole ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) or methylthiadiazole ( DRUG0 ) can cause vitamin K deficiency and hypoprothrombinemia . 	Cephalosporins	cefoperazone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	pentoxifylline	salicylates
effect	 DRUG0 : In cases of <e1> DRUG1 </e1> overdosage , <e2> DRUG2 </e2> CNS stimulation is potentiated and fatal convulsions can occur . 	propoxyphene	amphetamine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (1) , DRUG0 , <e2> DRUG2 </e2> . 	quinupristin	zileuton
other	 <e1> DRUG1 </e1> : Combination <e2> DRUG2 </e2> may decrease the clearance of some DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , DRUG0 , DRUG0 ) . 	Benzodiazepines	hormonal contraceptives
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	b-adrenergic blocking agents	heparin
other	 <e1> DRUG1 </e1> (such as DRUG0 , DRUG0 , or DRUG0 ) : concurrent use with <e2> DRUG2 </e2> may have a proarrhythmic effect . 	Antiarrhythmic agents, class I	arbutamine
other	 DRUG0 <e1> DRUG1 </e1> DRUG0 , like other DRUG0 , may inhibit the metabolism of <e2> DRUG2 </e2> and DRUG0 . 	Theobromine	caffeine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	perphenazine	promazine
advise	 Dose adjustment of <e1> DRUG1 </e1> may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ; 	Sensipar	erythromycin
effect	 DRUG0 - There have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a <e1> DRUG1 </e1> ( DRUG0 ) and <e2> DRUG2 </e2> . 	selective serotonin reuptake inhibitor	sumatriptan
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : <e1> DRUG1 </e1> and related DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	androgens	perphenazine
mechanism	 The concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with DRUG0 alone . 	uricosuric agents	allopurinol
other	 <e1> DRUG1 </e1> : Studies of concomitant administration of <e2> DRUG2 </e2> and DRUG0 to healthy men (n= 14) did not show a change in the steady state serum levels of either drug . 	Digoxin	flurbiprofen
other	 Because there is a theoretical basis that these effects may be additive , use of <e1> DRUG1 </e1> -containing or <e2> DRUG2 </e2> (like DRUG0 or DRUG0 ) and DRUG0 within 24 hours of each other should be avoided . 	ergotamine	ergot-type medications
other	 <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> may increase anticholinergic effect of DRUG0 . 	Amantadine	MAOIs
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain <e1> DRUG1 </e1> (e . g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	antibiotics	tetracyclines
other	 Co-administration of DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and <e2> DRUG2 </e2> did not result in clinically significant increases in DRUG0 exposure . 	warfarin	amlodipine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	perchlorate	heparin
other	 Other Cardiovascular Agents : <e1> DRUG1 </e1> and DRUG0 IV have been used concomitantly with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> and DRUG0 without evidence of clinically significant adverse interactions . 	Enalapril	prazosin
other	 The co-administration of DRUG0 with IV DRUG0 such as DRUG0 , <e1> DRUG1 </e1> , DRUG0 , or IV <e2> DRUG2 </e2> has not been evaluated (these drugs were not co-administered with DRUG0 in clinical trials) . 	nitroprusside	ACE inhibitors
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	Motrin	Indocin
other	 <e1> DRUG1 </e1> in combination with DRUG0 enhances the manifestation of corneal lesions in rats Epidural Injection DRUG0 may potentiate the CNS-depressive effect of DRUG0 , <e2> DRUG2 </e2> or other DRUG0 . 	Amitriptyline	barbiturates
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	sulfinpyrazone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	miconazole
other	 <e1> DRUG1 </e1> 150 mg twice daily did not interact significantly with <e2> DRUG2 </e2> (AUC was decreased by 15-20 %) . 	Ranitidine	nisoldipine
effect	 Although this effect was noted even when <e1> DRUG1 </e1> was given 4 hours prior to <e2> DRUG2 </e2> , this regimen did not result in diminished efficacy . 	cholestyramine	fluvastatin
other	 <e1> DRUG1 </e1> : DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 have been shown to decrease plasma levels of DRUG0 ; 	Protease inhibitors	nelfinavir
other	 Based on adult data , lower doses of DRUG0 may be needed following coadministration of drugs which are reported to decrease DRUG0 elimination (e.g. , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> ) and higher DRUG0 doses may be needed following coadministration of drugs that increase DRUG0 elimination (e.g. , DRUG0 and DRUG0 ) . 	cimetidine	ketoconazole
other	 In addition , studies in healthy volunteers have shown that <e1> DRUG1 </e1> does not affect the pharmacokinetics or pharmacodynamics of DRUG0 , or the pharmacokinetics of DRUG0 (40 mg twice daily) , DRUG0 , <e2> DRUG2 </e2> , or oral DRUG0 . 	TIKOSYN	theophylline
other	 <e1> DRUG1 </e1> - prior ingestion of DRUG0 may decrease the <e2> DRUG2 </e2> response to DRUG0 in the treatment of poisoning . 	apomorphine	emetic
other	 Since DRUG0 ( DRUG0 ) may interact with concurrently administered <e1> DRUG1 </e1> , periodic serum level determinations of these drugs may be necessary (eg , DRUG0 may elevate <e2> DRUG2 </e2> serum levels and DRUG0 has been reported to both increase and decrease DRUG0 levels) . 	antiepileptic drugs	phenytoin
other	 In addition , studies in healthy volunteers have shown that <e1> DRUG1 </e1> does not affect the pharmacokinetics or pharmacodynamics of <e2> DRUG2 </e2> , or the pharmacokinetics of DRUG0 (40 mg twice daily) , DRUG0 , DRUG0 , or oral DRUG0 . 	TIKOSYN	warfarin
other	 Therefore , interactions could occur following concomitant administration of <e1> DRUG1 </e1> (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) . 	psychotropic drugs	analgesics
effect	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as <e1> DRUG1 </e1> include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	NIMBEX	lincomycin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	antibiotics	ethacrynic acid
int	 <e1> DRUG1 </e1> may interact with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 . 	Chlorotrianisene	nicotine
other	 The growth of Pseudomonas aeruginosa , particularly serotype O11 , in <e1> DRUG1 </e1> and <e2> DRUG2 </e2> 	pentazocine	tripelennamine
other	 When the <e1> DRUG1 </e1> was administered 30 minutes after the DRUG0 nasal spray , the AUC of <e2> DRUG2 </e2> increased 11% and Cmax decreased 18% . 	STADOL NS	butorphanol
int	 <e1> DRUG1 </e1> may interact with DRUG0 , DRUG0 s , DRUG0 (allergy , cold , and sinus medicines) , diabetic drugs , <e2> DRUG2 </e2> , DRUG0 , DRUG0 like DRUG0 or DRUG0 , and high blood pressure medications . 	Benzthiazide	lithium
other	 <e1> DRUG1 </e1> had no effect on <e2> DRUG2 </e2> response . 	Nimodipine	ginsenosides
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute DRUG0 intake , <e1> DRUG1 </e1> , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 	amiodarone	succinimides
other	 Effects of DRUG0 on DRUG0 The coadministration of <e1> DRUG1 </e1> (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax , Cmin , AUC , CI/kg or tmax at <e2> DRUG2 </e2> daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy . 	erythromycin	felbamate
other	 The hypoglycemic action of DRUG0 may be potentiated by certain drugs including <e1> DRUG1 </e1> and other drugs that are highly protein bound , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	nonsteroidal anti-inflammatory agents	chloramphenicol
other	 The following agents may increase certain actions or side effects of DRUG0 . DRUG0 DRUG0 of class (e.g . DRUG0 ) , DRUG0 <e1> DRUG1 </e1> (e.g . DRUG0 ) , <e2> DRUG2 </e2> . 	antipsychotic agents	benzodiazepines
effect	 Drugs that reportedly may increase oral <e1> DRUG1 </e1> response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anticoagulant	methyldopa
advise	 Nucleoside Analogues DRUG0 Co-administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> is not recommended . 	COPEGUS	didanosine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxyphenbutazone	sulfonamides
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	delavirdine	risperidone
other	 Agents with Increased Levels in the Presence of <e1> DRUG1 </e1> : DRUG0 increases the plasma levels of the following agents : DRUG0 , <e2> DRUG2 </e2> (6) , and DRUG0 Thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with DRUG0 , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary . 	Carbamazepine	Phenytoin
other	 In another drug interaction study , co-administration of orally inhaled DRUG0 and oral DRUG0 , a potent inhibitor of cytochrome P450 3A4 , increased the exposure (AUC) of <e1> DRUG1 </e1> by approximately 3.6-fold at steady state , while levels of <e2> DRUG2 </e2> remained unchanged . 	des-ciclesonide	ciclesonide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	nalidixic acid	sulindac
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 , long acting; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	sulfinpyrazone	thyroid drugs
mechanism	 <e1> DRUG1 </e1> has the potential to decrease plasma concentrations of <e2> DRUG2 </e2> and DRUG0 . 	SUSTIVA	itraconazole
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	cholestyramine	contraceptives
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , DRUG0 , DRUG0 ) , myelotoxic (e.g. , DRUG0 chemotherapy) , cardiotoxic (e.g. , <e1> DRUG1 </e1> ) or hepatotoxic (e.g. , <e2> DRUG2 </e2> , DRUG0 ) effects with DRUG0 may increase toxicity in these organ systems . 	doxorubicin	methotrexate
advise	 Exert particular caution in combining <e1> DRUG1 </e1> with other DRUG0 ( DRUG0 and <e2> DRUG2 </e2> ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma . 	chlorprothixene	antiparkinsonian agents
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	niacin	thyroid hormones
other	 Compounds tested in man include DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	aminopyrine	antipyrine
other	 DRUG0 , <e1> DRUG1 </e1> -pectin , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , certain anticancer drugs , and DRUG0 may interfere with intestinal DRUG0 absorption , resulting in unexpectedly low serum concentrations . 	kaolin	cholestyramine
other	 Increases in plasma levels of <e1> DRUG1 </e1> , and in the frequency and severity of side effects , particularly <e2> DRUG2 </e2> , have been reported when DRUG0 was added to the DRUG0 regimen . 	tricyclic antidepressants	anticholinergic
effect	 A direct causal relationship has not been established , but physicians should consider the possibility that <e1> DRUG1 </e1> may alter a diabetic patient s response to DRUG0 or oral <e2> DRUG2 </e2> . 	diclofenac	hypoglycemic agents
other	 Since the pharmacokinetics of DRUG0 were studied in patients treated with DRUG0 , the clearance of <e1> DRUG1 </e1> at the recommended dose may be lower and exposure (AUC) higher in patients not treated with <e2> DRUG2 </e2> . 	BUSULFEX	phenytoin
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of DRUG0 : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral <e2> DRUG2 </e2> ) . 	sympathomimetic agents	contraceptives
advise	 DRUG0 plasma concentrations should be monitored when <e1> DRUG1 </e1> and <e2> DRUG2 </e2> are coadministered . 	Itraconazole	isoniazid
other	 - a <e1> DRUG1 </e1> ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( <e2> DRUG2 </e2> ); 	monoamine oxidase inhibitor	Nardil
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and related anabolic hormones , complex anions ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	androgens	perchlorate
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , <e1> DRUG1 </e1> ) , local DRUG0 (e.g. , DRUG0 and DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	Chloromycetin	para-aminobenzoic acid
other	 <e1> DRUG1 </e1> ) and many that are substrates for P450 2D6 (many other DRUG0 , <e2> DRUG2 </e2> , and the DRUG0 DRUG0 and DRUG0 ) . 	cimetidine	phenothiazines
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	cholestyramine	primidone
other	 Co-administration of <e1> DRUG1 </e1> did not significantly affect the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 or DRUG0 . 	aliskiren	celecoxib
other	 DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , etc.) : in vitro and animal studies with the combination of DRUG0 and DRUG0 suggest that DRUG0 may induce fungal resistance to <e2> DRUG2 </e2> . 	fluconazole	amphotericin B
effect	 <e1> DRUG1 </e1> and DRUG0 ( DRUG0 ) : may potentiate <e2> DRUG2 </e2> - induced hypokalemia which may predispose the patient to cardiac dysfunction . 	Corticosteroids	amphotericin B
other	 <e1> DRUG1 </e1> - Combined administration of racemic DRUG0 (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate DRUG0 (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either <e2> DRUG2 </e2> or DRUG0 . 	Triazolam	citalopram
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	chlordiazepoxide	rifampin
other	 While all the DRUG0 ( DRUG0 ) , e . g. , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> , inhibit P450 2D6 , they may vary in the extent of inhibition . 	sertraline	paroxetine
other	 Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose DRUG0 and <e1> DRUG1 </e1> , specifically , DRUG0 , DRUG0 , <e2> DRUG2 </e2> and DRUG0 . 	antineoplastic agents	tamoxifen
other	 Ventricular tachycardia induced by DRUG0 was generally converted to sinus rhythm following administration of DRUG0 , <e1> DRUG1 </e1> , or DRUG0 but not after administration of <e2> DRUG2 </e2> alone or after DRUG0 . 	ketamine	fentayl
other	 Potential drug interactions between DRUG0 and other DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) were also assessed by evaluating the serum concentrations of <e2> DRUG2 </e2> and these DRUG0 during placebo-controlled clinical studies . 	carbamazepine	levetiracetam
other	 DRUG0 : Immediate Release Capsules : There have been rare reports of an interaction between DRUG0 and <e1> DRUG1 </e1> (with a decreased plasma level of <e2> DRUG2 </e2> ) . 	nifedipine	quinidine
other	 <e1> DRUG1 </e1> - and/or DRUG0 -containing DRUG0 , products containing DRUG0 ( DRUG0 ) , DRUG0 containing DRUG0 or other metal cations , or DRUG0 ( <e2> DRUG2 </e2> ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	Magnesium	didanosine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	mesoridazine	Phenergan
other	 The in vitro anti-cryptosporidial activity of DRUG0 alone and in combination with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> was investigated . 	azithromycin	minocycline
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	monoamine oxidase inhibitors	trimethoprim
other	 The plasma maximum concentration and area under the plasma concentration-time curve of DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> were unchanged after coadministration of DRUG0 , and no potentiation of the effects of DRUG0 on diastolic or systolic blood pressure or on the electrocardiographic parameters was seen . 	desacetyldiltiazem	desmethyldiltiazem
other	 Because <e1> DRUG1 </e1> is a serotonin releaser and reuptake inhibitor , DRUG0 should not be used concomitantly with a <e2> DRUG2 </e2> . 	dexfenfluramine	MAO inhibitor
mechanism	 DRUG0 : Since the excretion of DRUG0 is similar to that of urate , <e1> DRUG1 </e1> , which increase the excretion of urate , are also likely to increase the excretion of <e2> DRUG2 </e2> and thus lower the degree of inhibition of xanthine oxidase . 	uricosuric agents	oxipurinol
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 . 	MS Contin	Theo-Dur
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	antibiotics	metronidazole
other	 DRUG0 including <e1> DRUG1 </e1> , DRUG0 , and DRUG0 HC1 : Concomitant use of DRUG0 and non-selective <e2> DRUG2 </e2> may cause hypertension . 	tranylcypromine sulfate	MAO inhibitors
other	 The co-administration of <e1> DRUG1 </e1> with IV DRUG0 such as <e2> DRUG2 </e2> , DRUG0 , DRUG0 , or IV DRUG0 has not been evaluated (these drugs were not co-administered with DRUG0 in clinical trials) . 	Natrecor	nitroglycerin
advise	 <e1> DRUG1 </e1> should be administered with caution to patients who are taking other DRUG0 or DRUG0 , including DRUG0 , <e2> DRUG2 </e2> and DRUG0 , or to those with a history of psychiatric disorder (including manic-depressive illness and schizophrenia) . 	Nabilone	barbiturates
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	barbiturates	cholestyramine
other	 Effects of other Antiepilepsy Drugs ( <e1> DRUG1 </e1> ) on <e2> DRUG2 </e2> : DRUG0 : Population pharmacokinetic analyses indicate that DRUG0 clearance is 60% greater in patients taking DRUG0 with or without other enzyme- inducing DRUG0 . 	AEDs	GABITRIL
other	 Before taking DRUG0 , tell your doctor if you are taking any of the following medicines : - DRUG0 or another <e1> DRUG1 </e1> such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , others) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( <e2> DRUG2 </e2> ); 	salicylate	Pepto-Bismol
other	 DRUG0 ( <e1> DRUG1 </e1> ) : Concomitant use of <e2> DRUG2 </e2> (or other DRUG0 ) and DRUG0 increases the risk of gastrointestinal side effects . 	NSAIDS	aspirin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	antifungals	Kadian
other	 DRUG0 : DRUG0 , <e1> DRUG1 </e1> (systemic) and <e2> DRUG2 </e2> 	lidocaine	quinidine
other	 <e1> DRUG1 </e1> : Although the results of a clinical study did not indicate a safe problem associated with the administration of <e2> DRUG2 </e2> ( DRUG0 ) Injection , USP to subjects already receiving DRUG0 , there have been reports that DRUG0 may potentiate the vasoconstrictive action of DRUG0 by blocking the vasodilating property of epinephrine . 	Beta Blockers	D.H.E. 45
other	 Drugs That Should Not Be Coadministered With DRUG0 DRUG0 : <e1> DRUG1 </e1> , DRUG0 DRUG0 : DRUG0 , DRUG0 Antimigraine : DRUG0 DRUG0 : <e2> DRUG2 </e2> DRUG0 DRUG0 , DRUG0 GI motility agents : DRUG0 	amiodarone	rifampin
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , DRUG0 ( DRUG0 s) , DRUG0 , DRUG0 ( DRUG0 may decrease the effects of these medicines) , DRUG0 (using these medicines with <e1> DRUG1 </e1> may result in increased CNS depressant effects) , DRUG0 , DRUG0 (using these medicines with DRUG0 may change the amount of either medicine that you need to take) , and oral DRUG0 containing <e2> DRUG2 </e2> ( DRUG0 may decrease the effectiveness of these oral DRUG0 , and you may need to change to a different type of birth control) . 	barbiturates	estrogens
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; <e2> DRUG2 </e2> under-dosage . 	haloperidol	warfarin sodium
advise	 Consequently , it is recommended not to exceed a single 2.5 mg <e1> DRUG1 </e1> dose in a 72-hour period when used in combination with <e2> DRUG2 </e2> . 	Vardenafil	ritonavir
advise	 Avoid the use of preparations such as DRUG0 and local DRUG0 which contain any DRUG0 (e.g. , <e1> DRUG1 </e1> , DRUG0 ) , since it has been reported that <e2> DRUG2 </e2> can potentiate the effects of catecholamines . 	epinephrine	tricyclic antidepressants
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (5) , DRUG0 , and <e2> DRUG2 </e2> . 	warfarin	zonisamide
other	 Administration of DRUG0 with DRUG0 containing <e1> DRUG1 </e1> , DRUG0 , or DRUG0 , with DRUG0 , with metal cations such as <e2> DRUG2 </e2> , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	aluminum	iron
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	trimethoprim
advise	 Other <e1> DRUG1 </e1> should be used with caution in patients taking <e2> DRUG2 </e2> , since the effects may be additive . 	CNS depressant drugs	fenfluramine
other	 Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when <e1> DRUG1 </e1> was given concomitantly with <e2> DRUG2 </e2> or DRUG0 . 	felodipine	indomethacin
other	 DRUG0 : <e1> DRUG1 </e1> is known to slow the metabolism of DRUG0 and increase its serum levels DRUG0 levels should be determined prior to concurrent administration with DRUG0 , signs and symptoms of DRUG0 toxicity should be monitored closely , and appropriate dosage adjustment of the <e2> DRUG2 </e2> should be made . 	Isoniazid	anticonvulsant
other	 No dose adjustment is necessary when DRUG0 is added to triple-immunosuppression regimens including DRUG0 , <e1> DRUG1 </e1> , and either DRUG0 or <e2> DRUG2 </e2> . 	corticosteroids	mycophenolate mofetil
mechanism	 DRUG0 : In a pharmacokinetic study , maximum plasma concentrations of <e1> DRUG1 </e1> were considerably lower in epileptic patients on long-term DRUG0 therapy (eg , DRUG0 , DRUG0 , or <e2> DRUG2 </e2> ) than in healthy volunteers . 	felodipine	phenobarbital
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	buspirone	topiramate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	citalopram	Phenytoin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (1) , DRUG0 , DRUG0 . 	azole antifungals	troleandomycin
other	 DRUG0 : Potentiation of DRUG0 -type ( <e1> DRUG1 </e1> and DRUG0 substrate) DRUG0 response is almost always seen in patients receiving <e2> DRUG2 </e2> and can result in serious or fatal bleeding . 	CYP2C9	amiodarone
mechanism	 DRUG0 : Coadministration of <e1> DRUG1 </e1> (using an experimental soft-gelatin capsule formulation of DRUG0 1200mg) with <e2> DRUG2 </e2> resulted in an 18% increase in DRUG0 plasma AUC and a 4-fold increase in DRUG0 plasma A.C . 	saquinavir	VIRACEPT
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	sulfonamides
other	 The absorption of DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> was significantly decreased when given simultaneously with DRUG0 ; 	furosemide	gemfibrozil
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving DRUG0 metabolized similarly to DRUG0 or on the basis of in vitro studies with DRUG0 or other <e1> DRUG1 </e1> (caution is recommended during coadministration with DRUG0 ) : Available data from clinical studies of DRUG0 other than <e2> DRUG2 </e2> suggest a possible drug interaction with DRUG0 for the following : DRUG0 , DRUG0 , DRUG0 such as DRUG0 and DRUG0 , and grapefruit juice . 	benzodiazepines	alprazolam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methyldopa	naproxen
other	 <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> decrease the ED50 of DRUG0 by 30% to 45% . 	Isoflurane	halothane
effect	 <e1> DRUG1 </e1> may enhance the effects of DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and other DRUG0 . 	Antihistamines	alcohol
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , and DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ); 	Daypro	Naprosyn
effect	 Spontaneous reports of serotonin syndrome associated with co-administration of <e1> DRUG1 </e1> and DRUG0 , including DRUG0 such as DRUG0 ( <e2> DRUG2 </e2> ) , have been reported . 	ZYVOX	SSRIs
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	antidepressants	risperidone
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	Topamax	temazepam
other	 This drug may interact with DRUG0 or other <e1> DRUG1 </e1> (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , <e2> DRUG2 </e2> or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and DRUG0 (concurrent use with DRUG0 may prolong and intensify the anticholinergic and CNS depressant effects of DRUG0 ) . 	CNS depressants	anticholinergics
effect	 Concomitant use of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> increases the risk of cardiac arrhythmias . 	digoxin	sympathomimetics
other	 However , the antagonism of the DRUG0 -induced anxiogenic effects by DRUG0 was only observed in the time spent in the light zone , and DRUG0 -induced anxiogenic effects were neither reversed by <e1> DRUG1 </e1> nor by <e2> DRUG2 </e2> . 	CGS 21680	CPA
other	 Interactions for DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) : DRUG0 : <e2> DRUG2 </e2> has been reported to reduce intestinal absorption of DRUG0 ; 	Calcitriol	Cholestyramine
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a <e1> DRUG1 </e1> , including DRUG0 , with multivalent cation-containing products such as DRUG0 or DRUG0 DRUG0 , DRUG0 , DRUG0 chewable/buffered tablets or pediatric powder , or products containing DRUG0 , DRUG0 , or <e2> DRUG2 </e2> may substantially decrease the absorption of DRUG0 , resulting in serum and urine levels considerably lower than desired . 	quinolone	zinc
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; <e1> DRUG1 </e1> ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	disulfiram	influenza virus vaccine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	sulindac
other	 Patients receiving other DRUG0 s , general DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 or other <e1> DRUG1 </e1> (including <e2> DRUG2 </e2> ) concomitantly with DRUG0 may exhibit an additive CNS depression . 	CNS depressants	alcohol
other	 Coadministration of DRUG0 and DRUG0 1/35  increased the exposure of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> by 20% and 34% , respectively . 	norethindrone	ethinyl estradiol
advise	 If concomitant treatment with <e1> DRUG1 </e1> and an <e2> DRUG2 </e2> is clinically warranted , appropriate observation of the patient is advised . 	AXERT	SSRI
other	 <e1> DRUG1 </e1> (200 mg once daily) produced a 10-fold increase in DRUG0 AUC and a 4-fold increase in Cmax when co-administered with <e2> DRUG2 </e2> (5 mg) in healthy volunteers . 	Ketoconazole	Vardenafil
other	 No significant difference was found between the mean values of the volume of distribution of <e1> DRUG1 </e1> with and without <e2> DRUG2 </e2> (13.0 and 12.6 liters , respectively) . 	cloxacillin	probenecid
other	 DRUG0 : No clinically significant changes occurred in heart rate or corrected QT intervals , or in DRUG0 metabolite or DRUG0 pharmacokinetics , during concurrent administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> at steady-state in 28 healthy males . 	lomefloxacin	terfenadine
mechanism	 DRUG0 : <e1> DRUG1 </e1> may increase serum levels of <e2> DRUG2 </e2> . 	Isoniazid	phenytoin
effect	 <e1> DRUG1 </e1> also significantly decreased the incidence of lymphatic invasion of adenocarcinomas , which was enhanced by <e2> DRUG2 </e2> . 	Verapamil	bombesin
other	 - DRUG0 ( DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Tindal	Serentil
int	 <e1> DRUG1 </e1> may interact with <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	Chlorotrianisene	antidepressants
other	 Other Drugs : In small groups of patients (7-10/interaction study) , the concomitant administration of DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , or DRUG0 did not significantly affect the peak levels and AUC values of <e2> DRUG2 </e2> . 	prednisolone	diclofenac
other	 DRUG0 should not be used concomitantly with other drugs known to prolong the QT interval : certain DRUG0 , including those of Class IA (such as <e1> DRUG1 </e1> and DRUG0 ) and Class III (such as <e2> DRUG2 </e2> ); 	quinidine	sotalol
other	 In monkeys , the effects of <e1> DRUG1 </e1> , but not <e2> DRUG2 </e2> or DRUG0 , were antagonized by DRUG0 ; 	(-)-NANM	(+)-NANM
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	paraldehyde	rifampin
other	 In clinical trials , DRUG0 was used with DRUG0 , DRUG0 , DRUG0 , oral DRUG0 , and supplemental DRUG0 .In a pharmacokinetic substudy in patients with congestive heart failure receiving DRUG0 or DRUG0 in whom therapy with <e1> DRUG1 </e1> was initiated , apparent oral clearance values for DRUG0 (n = 23) and <e2> DRUG2 </e2> (n = 30) were decreased by 13% and 15% , respectively , on the second day of therapy and had returned to baseline values by day 87 . 	FLOLAN	digoxin
other	 <e1> DRUG1 </e1> ( DRUG0 ) (e.g. , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-HTv agonists . 	Selective serotonin reuptake inhibitors	fluoxetine
other	 Concomitant <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> chemotherapy plus DRUG0 therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma . 	cyclophosphamide	prednisone
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> DRUG1 </e1> doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	finasteride	prostaglandin synthetase inhibitors
other	 In a drug interaction study , co-administration of orally inhaled <e1> DRUG1 </e1> and oral DRUG0 , an inhibitor of cytochrome P450 3A4 , had no effect on the pharmacokinetics of either DRUG0 or <e2> DRUG2 </e2> . 	ciclesonide	erythromycin
other	 <e1> DRUG1 </e1> (CNS) drugs including DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , blood pressure medications ( DRUG0 , DRUG0 , DRUG0 ) , motion sickness medications , DRUG0 , DRUG0 , DRUG0 , sleeping pills and DRUG0 	Central nervous system depressant	antidepressants
effect	 Spontaneous reports of serotonin syndrome associated with co-administration of <e1> DRUG1 </e1> and DRUG0 , including <e2> DRUG2 </e2> such as DRUG0 ( DRUG0 ) , have been reported . 	ZYVOX	antidepressants
other	 While additional research is needed , the initial clinical data in kidney recipients suggest that DRUG0 , in combination with DRUG0 or <e1> DRUG1 </e1> , might have the potential to reduce the frequency of rejection episodes , permit reductions in <e2> DRUG2 </e2> or DRUG0 dosage , and permit steroid withdrawal (Kelly , 1999) . 	tacrolimus	cyclosporine
other	 DRUG0 , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , certain DRUG0 , DRUG0 , <e2> DRUG2 </e2> and DRUG0 , thereby delaying elimination and increasing blood levels of these drugs . 	phenytoin	theophylline
other	 <e1> DRUG1 </e1> : Altered serum levels of DRUG0 (increased and decreased) have been reported in patients receiving concomitant <e2> DRUG2 </e2> . 	Phenytoin	ciprofloxacin
other	 Serum <e1> DRUG1 </e1> concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including DRUG0 , DRUG0 ( DRUG0 or <e2> DRUG2 </e2> ) and aminosalicylates . 	infliximab	ciprofloxacin
advise	 However , because some DRUG0 have been reported to enhance the anticoagulant effects of DRUG0 or its derivatives in patients , the prothrombin time or other suitable coagulation test should be closely monitored if a <e1> DRUG1 </e1> is administered concomitantly with <e2> DRUG2 </e2> or its derivatives . 	quinolone antimicrobial	warfarin
other	 DRUG0 may interact with DRUG0 , DRUG0 s , <e1> DRUG1 </e1> (allergy , cold , and sinus medicines) , diabetic drugs , <e2> DRUG2 </e2> , DRUG0 , DRUG0 like DRUG0 or DRUG0 , and high blood pressure medications . 	decongestant drugs	lithium
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , <e2> DRUG2 </e2> , local DRUG0 , DRUG0 , and DRUG0 . 	aminoglycosides	lithium
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	barbiturates	carbamazepine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Compazine	thioridazine
other	 The concomitant administration of <e1> DRUG1 </e1> and DRUG0 -containing <e2> DRUG2 </e2> has not been formally studied . 	Exjade	antacid preparations
other	 DRUG0 did not affect the conversion of <e1> DRUG1 </e1> to the active metabolite after intravenous administration of DRUG0 , and <e2> DRUG2 </e2> had no clinically significant effect after oral administration . 	losartan	erythromycin
other	 Coadministration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> had no clinically significant effects on blood pressure or heart rate . 	LEXAPRO	metoprolol
other	 <e1> DRUG1 </e1> : DRUG0 may enhance the effects of the oral <e2> DRUG2 </e2> , DRUG0 , or its derivatives . 	Warfarin	anticoagulant
other	 Rarely <e1> DRUG1 </e1> toxicity may occur in patients who discontinue DRUG0 after concurrent high-dose <e2> DRUG2 </e2> therapy . 	salicylate	aspirin
other	 DRUG0 may interact with <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	antidepressants	corticotropin
effect	 The antihypertensive effects of <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and DRUG0 may be reduced by <e2> DRUG2 </e2> . 	methyldopa	sympathomimetics
effect	 Patients who begin taking DRUG0 or who increase their DRUG0 dose or any other <e1> DRUG1 </e1> while taking DRUG0 , <e2> DRUG2 </e2> , or DRUG0 may develop toxicity characteristics for these drugs . 	NSAID	methotrexate
mechanism	 <e1> DRUG1 </e1> may interfere with the absorption of <e2> DRUG2 </e2> . 	Antacids	LEVSIN
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isoenzyme , including other DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> (eg , DRUG0 , DRUG0 , and DRUG0 ) , or that inhibit this enzyme (eg , DRUG0 ) , should be approached with caution . 	carbamazepine	Type 1C antiarrhythmics
other	 DRUG0 : Combination DRUG0 may decrease the clearance of some <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) . 	benzodiazepines	oxazepam
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	Kaletra	temazepam
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isozyme , including DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 (e.g. , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) , or that inhibit this enzyme (e.g. , DRUG0 ) , should be approached with caution . 	carbamazepine	encainide
other	 The absorption of oral DRUG0 is significantly reduced by the concomitant administration of an DRUG0 containing <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	aluminum	magnesium
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , DRUG0 , DRUG0 ) , myelotoxic (e.g. , <e1> DRUG1 </e1> chemotherapy) , cardiotoxic (e.g. , DRUG0 ) or hepatotoxic (e.g. , DRUG0 , <e2> DRUG2 </e2> ) effects with DRUG0 may increase toxicity in these organ systems . 	cytotoxic	asparaginase
other	 DRUG0 / DRUG0 -containing DRUG0 : Absorption of DRUG0 is moderately reduced (approximately 25%) when coadministered with DRUG0 / <e1> DRUG1 </e1> -containing <e2> DRUG2 </e2> . 	aluminum	antacid products
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cinchophen	thyroid drugs
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ); 	Indocin	Aleve
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all DRUG0 (eg , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , other DRUG0 , general DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) may result in additive central nervous system depressant effects . 	sedatives	antihistamines
other	 The <e1> DRUG1 </e1> metabolite of <e2> DRUG2 </e2> does not appear to be produced by the cytochrome P450 isoenzymes . 	threohydrobupropion	bupropion
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	salicylates	sulfinpyrazone
advise	 Drugs that may alter DRUG0 plasma concentrations Drugs that may increase DRUG0 plasma concentrations : Caution is recommended when administering <e1> DRUG1 </e1> with inhibitors of the CYP3A4 family (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) . 	Gleevec	erythromycin
other	 When <e1> DRUG1 </e1> DRUG0 is given for long periods of time , concomitant supplementation with water-miscible (or parenteral) forms of <e2> DRUG2 </e2> should be considered . 	cholestyramine	fat-soluble vitamins
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chymotrypsin	ranitidine
other	 <e1> DRUG1 </e1> - and/or DRUG0 -containing DRUG0 , products containing DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> containing DRUG0 or other metal cations , or DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	Magnesium	multivitamin preparations
mechanism	 <e1> DRUG1 </e1> , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , certain DRUG0 , <e2> DRUG2 </e2> , DRUG0 and DRUG0 , thereby delaying elimination and increasing blood levels of these drugs . 	Tagamet	lidocaine
mechanism	 DRUG0 : <e1> DRUG1 </e1> may delay intestinal absorption of <e2> DRUG2 </e2> ; 	Amphetamines	phenytoin
mechanism	 <e1> DRUG1 </e1> modifies DRUG0 metabolism with increased serum levels of <e2> DRUG2 </e2> . 	DIAMOX	phenytoin
other	 DRUG0 : Administration of DRUG0 to volunteers under fasting conditions , or with <e1> DRUG1 </e1> suspension yielded similar serum <e2> DRUG2 </e2> time profiles in young subjects (n=12) . 	antacid	flurbiprofen
other	 A similar association , though less marked , has been suggested with <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and possibly with DRUG0 and <e2> DRUG2 </e2> 72 . 	barbiturates	tetracyclines
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	carbamazepine	diuretics
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (1) , DRUG0 , DRUG0 . 	fluoxetine	valproate
other	 Administration of DRUG0 with other CYP3A4 inhibitors (e.g. , <e1> DRUG1 </e1> 500 mg BID , DRUG0 240 mg QD , DRUG0 1200 mg TID , DRUG0 200 mg QD) resulted in increases in Cmax of <e2> DRUG2 </e2> ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold . 	erythromycin	eplerenone
other	 In the present study , evoked potentials were recorded at 5 , 20 , and 40 min following IP injections of saline , <e1> DRUG1 </e1> (2.0 g/kg) , DRUG0 (0.6 mg/kg) or <e2> DRUG2 </e2> (15.0 mg/kg) on separate days . 	ethanol	atropine
effect	 Both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when <e1> DRUG1 </e1> is administered in combination with other <e2> DRUG2 </e2> such as DRUG0 , DRUG0 , DRUG0 , or inhalation general DRUG0 . 	ALFENTA	CNS depressants
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	colistin	procainamide
other	 DRUG0 / DRUG0 , DRUG0 / <e1> DRUG1 </e1> , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , and DRUG0 / <e2> DRUG2 </e2> . 	quinidine	phenobarbital
other	 On the basis of the metabolism of <e1> DRUG1 </e1> by cytochrome P450 3A4 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , grapefruit juice , and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma DRUG0 concentrations . 	bexarotene	gemfibrozil
advise	 Based on adult data , lower doses of <e1> DRUG1 </e1> may be needed following coadministration of drugs which are reported to decrease DRUG0 elimination (e.g. , <e2> DRUG2 </e2> and DRUG0 ) and higher DRUG0 doses may be needed following coadministration of drugs that increase DRUG0 elimination (e.g. , DRUG0 and DRUG0 ) . 	caffeine	cimetidine
other	 After 14 days of co-administration , mean trough concentrations of <e1> DRUG1 </e1> and its metabolites , DRUG0 and DRUG0 , were elevated with <e2> DRUG2 </e2> by about three-fold compared to baseline concentrations . 	clozapine	fluvoxamine
other	 Comparison of DRUG0 pharmacokinetics in patients treated with 202.5 mg/m2 plus DRUG0 to those in patients treated with 100 mg/m2 without <e1> DRUG1 </e1> indicated that there were no changes in the elimination rate constant , volume of distribution , or total body clearance of <e2> DRUG2 </e2> . 	thiosulfate	cisplatin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	methadone	contraceptives
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	monoamine oxidase inhibitors	ranitidine
other	 Therefore , when <e1> DRUG1 </e1> and DRUG0 are used concomitantly , the patient should be observed closely to determine if the desired effect of the <e2> DRUG2 </e2> is obtained.) 	hydroflumethiazide	diuretic
other	 When DRUG0 was coadministered with <e1> DRUG1 </e1> , DRUG0 , or H2antagonists , reduced plasma concentrations of <e2> DRUG2 </e2> were reported . 	phenytoin	itraconazole
other	 DRUG0 may interact with the following medications : <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	acetaminophen	Kadian
other	 [Dose-time effects of competitive displacement of DRUG0 by DRUG0 following oral and intravenous administration] The effect of various doses of <e1> DRUG1 </e1> in several dose fractions on the extent and the time scale of displacement of <e2> DRUG2 </e2> , in dependence on application mode , was studied . 	sodium perchlorate	radiopertechnetate
other	 <e1> DRUG1 </e1> to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , AUC and Cmax , differences were  20% between <e2> DRUG2 </e2> given singly and in combination with DRUG0 , and between DRUG0 given singly and in combination with DRUG0 . 	propranolol	isradipine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	allopurinol	chloral hydrate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clonazepam	Phenytoin
effect	 Drug Interactions : The central DRUG0 syndrome can occur when DRUG0 agents such as <e1> DRUG1 </e1> are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain DRUG0 such as DRUG0 , the DRUG0 and other DRUG0 , DRUG0 , certain DRUG0 such as the <e2> DRUG2 </e2> salts , and DRUG0 . 	AKINETON	quinidine
other	 THE POTENTIATING ACTION OF DRUG0 MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH DRUG0 SUCH AS DRUG0 , <e1> DRUG1 </e1> AND <e2> DRUG2 </e2> . 	NON-NARCOTIC ANALGESICS	BARBITURATES
other	 Concomitant medications were grouped as <e1> DRUG1 </e1> , oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , inducers of CYP3A4 , substrates and inhibitors of CYP3A4 , substrates and inhibitors of P-glycoprotein , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , substrates and inhibitors of tubular organic cation transport , and QTc-prolonging drugs . 	ACE inhibitors	sulphonylureas
other	 <e1> DRUG1 </e1> s : After repeated co-administration of <e2> DRUG2 </e2> , the AUC of DRUG0 was lowered by 28% [90% CI : 20-33] . 	Calcium Antagonist	Trileptal
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> , long acting; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	sulfonamides	sulindac
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	chlorpromazine	promazine
mechanism	 DRUG0 : In vitro and/or in vivo data show that <e1> DRUG1 </e1> , DRUG0 , and DRUG0 markedly inhibit the metabolism of <e2> DRUG2 </e2> , which can result in an increase in plasma DRUG0 levels and prolongation of the QT interval on the ECG . 	clarithromycin	cisapride
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clobazam	protease inhibitors
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chymotrypsin	pyrazolones
other	 <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	astemizole	terodiline
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	dopamine	lovastatin
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain <e1> DRUG1 </e1> (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	antibiotics	quinidine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anesthetics	naproxen
other	 <e1> DRUG1 </e1> : DRUG0 , DRUG0 , DRUG0 , or DRUG0 may interfere with the bactericidal effect of <e2> DRUG2 </e2> . 	Bacteriostatic Antibiotics	penicillins
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	griseofulvin	haloperidol
mechanism	 In vitro studies have shown that the metabolism of <e1> DRUG1 </e1> may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome P450 3A4 , such as <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	docetaxel	cyclosporine
other	 DRUG0 to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , AUC and Cmax , differences were  20% between DRUG0 given singly and in combination with DRUG0 , and between <e1> DRUG1 </e1> given singly and in combination with <e2> DRUG2 </e2> . 	propranolol	isradipine
other	 DRUG0 : In a single (400 mg) and multiple dose (400 mg TID) study of DRUG0 in epileptic patients (N=8) maintained on <e1> DRUG1 </e1> monotherapy for at least 2 months , DRUG0 had no effect on the steady-state trough plasma concentrations of DRUG0 and DRUG0 had no effect on <e2> DRUG2 </e2> pharmacokinetics . 	phenytoin	gabapentin
other	 May interact <e1> DRUG1 </e1> (altered hypo-prothrombinemic effect) , DRUG0 , <e2> DRUG2 </e2> and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of DRUG0 ) , DRUG0 (increased effect of DRUG0 ) . 	anticoagulants	rifampin
other	 <e1> DRUG1 </e1> concentration <e2> DRUG2 </e2> concentration 	indinavir	rifabutin
effect	 <e1> DRUG1 </e1> decrease the hypotensive effect of <e2> DRUG2 </e2> . 	TCAs	guanfacine
other	 Other concomitant therapy Although specific interaction studies were not performed , DRUG0 doses of 1 mg or more were concomitantly used in clinical studies with <e1> DRUG1 </e1> , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	acetaminophen	diuretics
other	 <e1> DRUG1 </e1> doses of up to 300 mg b.i.d . have been safely used concomitantly with sustained-release DRUG0 (sustained-release <e2> DRUG2 </e2> ) with no clinically significant adverse interactions . 	Eprosartan	nifedipine
mechanism	 <e1> DRUG1 </e1> tablets may alter the metabolism of <e2> DRUG2 </e2> , DRUG0 , and DRUG0 , resulting in elevated plasma concentrations of the latter drugs . 	Ketoconazole	cyclosporine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ]) or 	oxymetholone	Winstrol
effect	 Nephrotoxicity has been reported following concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	aminoglycoside antibiotics	cephalosporin antibiotics
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 DRUG0 ( DRUG0 ) DRUG0 ( <e1> DRUG1 </e1> ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( <e2> DRUG2 </e2> ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	Tagamet	Nizoral
other	 Clinical trials have indicated that DRUG0 can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral DRUG0 , DRUG0 , enzyme supplements , DRUG0 , oral or inhaled <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	corticosteroids	analgesics
other	 These drugs include the <e1> DRUG1 </e1> and other DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 . 	thiazides	nicotinic acid
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e2> DRUG2 </e2> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anabolic steroids	diflunisal
other	 A similar association , though less marked , has been suggested with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and possibly with DRUG0 and <e2> DRUG2 </e2> 72 . 	topiramate	tetracyclines
other	 <e1> DRUG1 </e1> , DRUG0 , and DRUG0 : Drugs such as DRUG0 , DRUG0 , and DRUG0 may increase the risk of developing peripheral neuropathy or other DRUG0 -associated adverse events by interfering with the renal clearance of <e2> DRUG2 </e2> (thereby raising systemic exposure) . 	Amphotericin	zalcitabine
other	 Such individuals are referred to as poor metabolizers of drugs such as DRUG0 , DRUG0 , the <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	tricyclic antidepressants	clozapine
other	 <e1> DRUG1 </e1> : Co-administration of DRUG0 with DRUG0 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50% decrease in <e2> DRUG2 </e2> plasma concentrations . 	Rifampin	rofecoxib
effect	 In patients receiving nonselective DRUG0 ( DRUG0 ) (e.g. , <e1> DRUG1 </e1> ) in combination with DRUG0 (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , there have been reports of serious , sometimes fatal , reactions . 	selegiline hydrochloride	paroxetine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	mefenamic acid	methyldopa
effect	 DRUG0 Anesthesia : Severe hypotension has been reported during <e1> DRUG1 </e1> anesthesia with concomitant use of a DRUG0 and a <e2> DRUG2 </e2> . 	fentanyl	calcium channel blocker
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	levothyroxine	risperidone
other	 <e1> DRUG1 </e1> -related adverse effects have occurred in patients when DRUG0 and <e2> DRUG2 </e2> were coadministered . 	Theophylline	enoxacin
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isozyme , including DRUG0 , DRUG0 , DRUG0 , and DRUG0 (e.g. , <e1> DRUG1 </e1> , DRUG0 and DRUG0 ) , or that inhibit this enzyme (e.g. , <e2> DRUG2 </e2> ) , should be approached with caution . 	propafenone	quinidine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> . 	anticonvulsants	vitamin C
other	 Administration of DRUG0 with <e1> DRUG1 </e1> containing <e2> DRUG2 </e2> , DRUG0 , or DRUG0 , with DRUG0 , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	antacids	aluminum
other	 Interactions with <e1> DRUG1 </e1> : DRUG0 (eg , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and DRUG0 ) should NOT be administered to a patient who has received or is receiving a course of therapy with a DRUG0 such as DRUG0 . 	Mixed Agonist/Antagonist Opioid Analgesics	nalbuphine
other	 Although these results do not indicate a significant interaction between DRUG0 and DRUG0 or <e1> DRUG1 </e1> , the administration of DRUG0 to patients taking <e2> DRUG2 </e2> should be done extremely cautiously , and patients should be closely monitored . 	heparin	anticoagulants
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the DRUG0 , DRUG0 , DRUG0 , and DRUG0 (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 with DRUG0 plus DRUG0 ) without receiving <e2> DRUG2 </e2> therapy . 	doxorubicin	antiretroviral
mechanism	 DRUG0 : <e1> DRUG1 </e1> may raise serum <e2> DRUG2 </e2> levels in some individuals . 	Enoxacin	digoxin
other	 <e1> DRUG1 </e1> may affect DRUG0 bioavailabillty and may require dose adjustment of <e2> DRUG2 </e2> by 16% (90% confidence interval : 8-23%) , decrease mean C max DRUG0 by 26% (90% confidence interval : 16-34%) and decrease mean trough concentrations of DRUG0 by 9% (90% confidence limit : 19% decrease to 2% increase) . 	Acarbose	digoxin
other	 <e1> DRUG1 </e1> and <e2> DRUG2 </e2> : Upon concomitant administration of 5 mg of DRUG0 with 600 mg BID DRUG0 , the Cmax and AUC of DRUG0 were reduced by approximately 20% . 	Ritonavir	indinavir
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ibuprofen	indomethacin
other	 <e1> DRUG1 </e1> : Other <e2> DRUG2 </e2> drugs , such as DRUG0 , DRUG0 , DRUG0 , and DRUG0 , have been used concurrently with DRUG0 . 	Antiarrhythmics	antiarrhythmic
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methylphenidate	sulfinpyrazone
effect	 DRUG0 : The concomitant use of <e1> DRUG1 </e1> ( DRUG0 transdermal system) with other DRUG0 , including but not limited to other DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (e.g. , DRUG0 ) , general DRUG0 , DRUG0 , DRUG0 , and DRUG0 , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death . 	DURAGESIC	sedatives
other	 <e1> DRUG1 </e1> : Coadministration of DRUG0 (200 mg/day for 14 days) with a 15-mg single dose of DRUG0 increased the AUC of <e2> DRUG2 </e2> and its active metabolite by 63% and 77% , respectively . 	Ketoconazole	aripiprazole
other	 There have been reports of QTc prolongation , with or without TdP , in patients taking <e1> DRUG1 </e1> when <e2> DRUG2 </e2> , DRUG0 , or azoles were administered concomitantly . 	amiodarone	fluoroquinolones
other	 Single dose bioavailability studies in normal volunteers have failed to wshow an effect of <e1> DRUG1 </e1> on <e2> DRUG2 </e2> blood levels . 	aspirin	ibuprofen
other	 DRUG0 may interact with <e1> DRUG1 </e1> (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , local DRUG0 (e.g. , DRUG0 and <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	acetaminophen	lidocaine
other	 [The effect of <e1> DRUG1 </e1> on the renal excretion of DRUG0 and <e2> DRUG2 </e2> in dogs] The intravenous injection of DRUG0 in a dose of 20 mg/kg enhanced DRUG0 and DRUG0 excretion in chronic canine experiments . 	cimetidine	iodamide
other	 Oral DRUG0 : Based on AUC and half-life , multiple-dose pharmacokinetic profiles of DRUG0 and <e1> DRUG1 </e1> following administration of tablets containing 2.5 mg of DRUG0 and 50 mcg of DRUG0 were similar with and without coadministration of <e2> DRUG2 </e2> (400 mg TID; 	ethinyl estradiol	gabapentin
other	 Caution should also be taken in concurrent or serial use of other DRUG0 and <e1> DRUG1 </e1> because they may enhance neomycin s nephrotoxicity and/or ototoxicity and potentiate <e2> DRUG2 </e2> neuromuscular blocking effects . 	polymyxins	neomycin sulfate
other	 - <e1> DRUG1 </e1> (e.g. , <e2> DRUG2 </e2> ) or 	Procainamide	Pronestyl
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isozyme , including <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and DRUG0 (e.g. , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) , or that inhibit this enzyme (e.g. , DRUG0 ) , should be approached with caution . 	antidepressants	encainide
other	 there was no significant change in prothrombin test results during the trials of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	chloral hydrate	methaqualone
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	antihistamines	glutethimide
other	 - a DRUG0 ( <e1> DRUG1 </e1> ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	NSAID	Cataflam
other	 A study in eight healthy volunteers has shown a 50% increase in mean peak <e1> DRUG1 </e1> plasma concentrations and a 90% increase in mean area under the curve , after a one week course of <e2> DRUG2 </e2> at 1,000 mg/day and DRUG0 at 90 mg/day . 	nimodipine	cimetidine
other	 DRUG0 (CNS) drugs including <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , blood pressure medications ( DRUG0 , DRUG0 , DRUG0 ) , motion sickness medications , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , sleeping pills and DRUG0 	alcohol	sedatives
other	 <e1> DRUG1 </e1> : Concurrent administration of certain DRUG0 , such as DRUG0 and <e2> DRUG2 </e2> , would be expected to compromise the beneficial effects of DRUG0 . 	Anticholinergics	dicyclomine
other	 <e1> DRUG1 </e1> ) and many that are substrates for P450 2D6 (many other DRUG0 , DRUG0 , and the DRUG0 DRUG0 and <e2> DRUG2 </e2> ) . 	cimetidine	flecainide
effect	 Drug Interactions : The central <e1> DRUG1 </e1> syndrome can occur when DRUG0 agents such as DRUG0 are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain DRUG0 such as DRUG0 , the DRUG0 and other DRUG0 , DRUG0 , certain DRUG0 such as the <e2> DRUG2 </e2> salts , and DRUG0 . 	anticholinergic	quinidine
other	 However , co-administration of DRUG0 with DRUG0 - and DRUG0 -containing <e1> DRUG1 </e1> (51 mEq) or DRUG0 with <e2> DRUG2 </e2> , had no significant effect on the rate or extent of DRUG0 absorption after administration of a 40-mg oral dose . 	antacids	famotidine
other	 DRUG0 may have additive effects with DRUG0 and other <e1> DRUG1 </e1> , e.g. , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> . 	CNS depressants	antianxiety agents
other	 Reported examples of this interaction include the following : <e1> DRUG1 </e1> s : DRUG0 ( DRUG0 substrate) administered in combination with oral DRUG0 has been reported to produce persistently elevated plasma concentrations of <e2> DRUG2 </e2> resulting in elevated creatinine , despite reduction in dose of DRUG0 . 	Immunosuppressive	cyclosporine
other	 <e1> DRUG1 </e1> : Coadministration of DRUG0 (200 mg BID) , a potent CYP3A4 inducer , with <e2> DRUG2 </e2> (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both DRUG0 and its active metabolite , DRUG0 . 	Carbamazepine	aripiprazole
mechanism	 DRUG0 : When <e1> DRUG1 </e1> and <e2> DRUG2 </e2> suspension were coadministered , plasma concentrations of DRUG0 decreased approximately 35% . 	atorvastatin	Maalox TC
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (5) , DRUG0 , and DRUG0 . 	Acetaminophen	valproate
int	 The extent to which <e1> DRUG1 </e1> - <e2> DRUG2 </e2> interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the DRUG0 involved . 	SSRI	TCA
other	 On the basis of the estimated number of regular users of intravenous <e1> DRUG1 </e1> in Ontario , the mortality rate in such users is at least four times as high as in the general population of the same age , and is comparable to that in alcoholics and <e2> DRUG2 </e2> addicts . 	amphetamine	heroin
other	 DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / <e1> DRUG1 </e1> , DRUG0 / DRUG0 , and DRUG0 / <e2> DRUG2 </e2> . 	lidocaine	phenobarbital
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of DRUG0 : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	danazol	albuterol
other	 Rat kidney homogenates supplemented with coenzyme A , ATP , oxaloacetate , and Mg2+ converted <e1> DRUG1 </e1> to <e2> DRUG2 </e2> in vitro . 	1,3-difluoroacetone	(-)-erythro-fluorocitrate
mechanism	 In addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , or DRUG0 ) with <e2> DRUG2 </e2> may result in clinically meaningful reductions in DRUG0 concentrations . 	efavirenz	CANCIDAS
other	 A study of interaction between DRUG0 and <e1> DRUG1 </e1> showed that concomitant administration of <e2> DRUG2 </e2> and DRUG0 does not alter DRUG0 plasma levels . 	warfarin	BREVIBLOC
advise	 Therefore , co-administration of <e1> DRUG1 </e1> with other drugs that are metabolized by this isoenzyme , including other DRUG0 , DRUG0 , DRUG0 , and DRUG0 (eg , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 ) , or that inhibit this enzyme (eg , DRUG0 ) , should be approached with caution . 	tricyclic antidepressants	flecainide
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> is not recommended for use in patients who have received DRUG0 within 14 days because severe and unpredictable potentiation by DRUG0 has been reported with DRUG0 	MAO Inhibitors	DURAGESIC
effect	 DRUG0 ( DRUG0 ) (e.g. , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> DRUG2 </e2> . 	fluoxetine	5-HT1 agonists
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	quinidine	tolbutamide
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	azole antifungals	delavirdine
other	 DRUG0 / <e1> DRUG1 </e1> : The coadministration of DRUG0 or DRUG0 will not affect plasma concentrations of DRUG0 , but may reduce endogenous plasma levels of <e2> DRUG2 </e2> /ergocalcitriol by accelerating metabolism . 	Phenobarbital	calcitriol
other	 The hypoglycemic action of DRUG0 may be potentiated by certain drugs including <e1> DRUG1 </e1> and other drugs that are highly protein bound , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	nonsteroidal anti-inflammatory agents	chloramphenicol
advise	 Nephrotoxic agents : Concomitant administration of <e1> DRUG1 </e1> and agents with nephrotoxic potential [e.g. , intravenous DRUG0 (e.g. , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 , <e2> DRUG2 </e2> , intravenous DRUG0 , DRUG0 , and DRUG0 ] is contraindicated . 	VISTIDE	foscarnet
effect	 <e1> DRUG1 </e1> may decrease the effectiveness of oral DRUG0 , certain <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	Barbiturates	antibiotics
mechanism	 DRUG0 containing <e1> DRUG1 </e1> and DRUG0 reduce the oral absorption of <e2> DRUG2 </e2> by 75% . 	aluminum hydroxide	enoxacin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	clofibrate	pentoxifylline
other	 Therefore , when DRUG0 and <e1> DRUG1 </e1> are used concomitantly , the patient should be observed closely to determine if the desired effect of the <e2> DRUG2 </e2> is obtained . 	non- steroidal anti- inflammatory agents	diuretic
mechanism	 DRUG0 - Administration of 20 mg/day <e1> DRUG1 </e1> for 21 days in healthy volunteers resulted in a 50% increase in Cmax and 82% increase in AUC of the DRUG0 <e2> DRUG2 </e2> (given in a single dose of 100 mg) . 	LEXAPRO	metoprolol
other	 <e1> DRUG1 </e1> : Several short-term controlled studies failed to wshow that <e2> DRUG2 </e2> significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on DRUG0 . 	Coumarin-Type Anticoagulants	ibuprofen
other	 Therefore , co-administration of DRUG0 with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain DRUG0 ( DRUG0 [ DRUG0 ] , such as DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) , DRUG0 and DRUG0 (e.g. , <e2> DRUG2 </e2> , DRUG0 ) , should be approached with caution . 	amitriptyline	propafenone
other	 In controlled clinical trials , however , <e1> DRUG1 </e1> including <e2> DRUG2 </e2> were concurrently administered with DRUG0 and were well tolerated . 	beta blockers	metoprolol
effect	 DRUG0 and <e1> DRUG1 </e1> could exaggerate the prolongation of the QT interval observed with <e2> DRUG2 </e2> . 	tricyclic anti-depressants	bepridil hydrochloride
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	nortriptyline	zonisamide
other	 Animals dosed with <e1> DRUG1 </e1> did not display the 2-3 hour lag phase in either <e2> DRUG2 </e2> synthesis or in citrate and fluoride accumulation characteristic of animals dosed with DRUG0 . 	1,3-difluoroacetone	(-)-erythro-fluorocitrate
other	 In vitro studies evaluating the minimum inhibitory concentration (MIC) of DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> /flucoxacillin , DRUG0 , DRUG0 , and DRUG0 demonstrated no evidence of incompatibility of these <e2> DRUG2 </e2> with DRUG0 . 	ampicillin	antibiotics
int	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and DRUG0 ) DRUG0 (sometimes prescribed to control blood sugar in type 2 diabetes) DRUG0 (used to control inflammation associated with Crohns disease and ulcerative colitis) DRUG0 (a DRUG0 ) DRUG0 There has been concern about the interaction between <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	vitamin B12	folic acid
other	 <e1> DRUG1 </e1> : Use of <e2> DRUG2 </e2> with DRUG0 and other DRUG0 may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed . 	Tricyclic Antidepressants	thyroid products
mechanism	 Products containing DRUG0 and other multivalent cations (such as <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) are likely to interfere with absorption of <e2> DRUG2 </e2> . 	aluminum	Ibandronate
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , <e2> DRUG2 </e2> ]) or 	stanozolol	Winstrol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chymotrypsin	diazoxide
other	 Interactions between treatments with DRUG0 , <e1> DRUG1 </e1> (an <e2> DRUG2 </e2> ) , DRUG0 (an DRUG0 ) , and DRUG0 (an inducer of microsomal enzymes) were investigated in sheep . 	bishydroxycoumarin	anticoagulant
other	 The principal drugs given (number of patients in parentheses) were : <e1> DRUG1 </e1> (115) , <e2> DRUG2 </e2> and DRUG0 (103) , DRUG0 (52) , oral DRUG0 (45) , cough and cold preparations (45) , DRUG0 (38) , DRUG0 (29) , DRUG0 (24) , oral DRUG0 (18) , DRUG0 (13) , DRUG0 (10) , and DRUG0 (10) . 	cardiac glycosides	sedatives
other	 The pharmacokinetics of <e1> DRUG1 </e1> and its major metabolite <e2> DRUG2 </e2> were unaffected following co-administration with DRUG0 . 	naltrexone	6-beta-naltrexol
advise	 The daily dose of <e1> DRUG1 </e1> should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and nefazadone) . 	ENABLEX	ritonavir
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	delavirdine	nicotinamide
effect	 Oral DRUG0 : In some normal volunteers , the concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> , DRUG0 , or DRUG0 resulted in prolongation of prothrombin time . 	diflunisal	warfarin
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	barbiturates	ranitidine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , <e2> DRUG2 </e2> , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	thiocyanate	insulin
other	 There was no evidence of drug interactions in clinical studies in which <e1> DRUG1 </e1> was administered concurrently with other drugs , including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	dobutamine	potassium chloride
effect	 <e1> DRUG1 </e1> may antagonize the hypotensive effects of <e2> DRUG2 </e2> . 	Tricyclic antidepressants	clonidine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anesthetics	pentoxifylline
other	 In addition , <e1> DRUG1 </e1> neither influenced the pharmacodynamics of DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 , nor the pharmacokinetics of DRUG0 at steady state . 	Fondaparinux	piroxicam
advise	 Additionally , <e1> DRUG1 </e1> should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as DRUG0 , <e2> DRUG2 </e2> , and DRUG0 because of the danger of blocking cardiac contractility when systemic vascular resistance is high . 	BREVIBLOC	epinephrine
mechanism	 - Drugs that may decrease plasma <e1> DRUG1 </e1> concentrations include : DRUG0 , chronic <e2> DRUG2 </e2> abuse , DRUG0 	phenytoin	alcohol
other	 DRUG0 may decrease the effectiveness of oral <e1> DRUG1 </e1> , certain DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	contraceptives	anticoagulants
other	 When used in therapeutic doses , DRUG0 had a modest effect on the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (intravenous and oral) , DRUG0 , <e1> DRUG1 </e1> / DRUG0 or <e2> DRUG2 </e2> . 	trimethoprim	zidovudine
mechanism	 Concomitant administration of <e1> DRUG1 </e1> and DRUG0 , DRUG0 , <e2> DRUG2 </e2> , or an DRUG0 / DRUG0 oral DRUG0 produced minor changes in the pharmacokinetics of DRUG0 , which were considered to be without clinical significance . 	FACTIVE	omeprazole
other	 - DRUG0 ( DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Tindal	Compazine
other	 DRUG0 : It has not been established if there is a pharmacokinetic interaction between <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	acitretin	combined oral contraceptives
mechanism	 Coadministration of <e1> DRUG1 </e1> with oral <e2> DRUG2 </e2> or DRUG0 has resulted in elevated plasma concentrations of the latter two drugs . 	Itraconazole	midazolam
mechanism	 <e1> DRUG1 </e1> may decrease the amount of DRUG0 ( <e2> DRUG2 </e2> , DRUG0 ) that gets absorbed into your body . 	Aminosalicylic acid	Lanoxin
other	 <e1> DRUG1 </e1> : Because <e2> DRUG2 </e2> does not affect the pharmacokinetics of DRUG0 , interactions with other DRUG0 metabolized via the same cytochrome isozymes are not expected . 	Antipyrine	atorvastatin
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	chlordiazepoxide	griseofulvin
effect	 DRUG0 , DRUG0 and <e1> DRUG1 </e1> may enhance the effects of : other DRUG0 s , DRUG0 , general DRUG0 , DRUG0 such as <e2> DRUG2 </e2> , DRUG0 , or other DRUG0 , causing increased CNS depression . 	caffeine	chlordiazepoxide
other	 Since blood level of <e1> DRUG1 </e1> /ergocalcitriol will be reduced , higher doses of <e2> DRUG2 </e2> may be necessary if these drugs are administered simultaneously . 	calcitriol	Rocaltrol
other	 <e1> DRUG1 </e1> taken concomitantly with DRUG0 increases <e2> DRUG2 </e2> serum concentration by 33% after two days . 	Amiodarone	quinidine
other	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and DRUG0 ) <e1> DRUG1 </e1> (sometimes prescribed to control blood sugar in type 2 diabetes) DRUG0 (used to control inflammation associated with Crohns disease and ulcerative colitis) DRUG0 (a DRUG0 ) DRUG0 There has been concern about the interaction between <e2> DRUG2 </e2> and DRUG0 . 	metformin	vitamin B12
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	levothyroxine	contraceptives
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	danazol	quinine
other	 DRUG0 may interact with the following medications : DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Tylenol	morphine
other	 The effects of <e1> DRUG1 </e1> may be potentiated by DRUG0 which inhibits the metabolism of <e2> DRUG2 </e2> . 	ERGOMAR	ergotamine
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	clindamycin	procainamide
other	 Pharmacodynamic Interactions : The CNS-depressant action of the DRUG0 of drugs may be potentiated by <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , the DRUG0 , DRUG0 and DRUG0 , DRUG0 and the <e2> DRUG2 </e2> , and by other DRUG0 . 	alcohol	tricyclic antidepressants
effect	 DRUG0 : <e1> DRUG1 </e1> may potentiate the toxic effects of <e2> DRUG2 </e2> . 	Thyroid preparations	digitalis
other	 Among <e1> DRUG1 </e1> or DRUG0 users , the incidence of upper gastrointestinal adverse events in patients treated with <e2> DRUG2 </e2> 2.5 mg daily (28.9%) was similar to that in placebo-treated patients (30.7%) . 	aspirin	ibandronate
other	 DRUG0 : In patients with mild to moderate hypertension , administration of DRUG0 once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with <e1> DRUG1 </e1> 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of <e2> DRUG2 </e2> AUC and a simultaneous 1.7-fold increase of DRUG0 AUC . 	diltiazem	aprepitant
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; <e2> DRUG2 </e2> under-dosage . 	paraldehyde	warfarin sodium
other	 Interactions between treatments with DRUG0 , <e1> DRUG1 </e1> (an DRUG0 ) , DRUG0 (an DRUG0 ) , and <e2> DRUG2 </e2> (an inducer of microsomal enzymes) were investigated in sheep . 	bishydroxycoumarin	phenobarbital sodium
other	 METHOD : This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive <e1> DRUG1 </e1> tablets at doses of 0.5 mg , 1 mg , or 2 mg twice daily with DRUG0 and <e2> DRUG2 </e2> . 	everolimus	prednisone
other	 DRUG0 may interact with the following medications : <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	acetaminophen	Gris-PEG
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or <e1> DRUG1 </e1> (basic) , as well as <e2> DRUG2 </e2> DRUG0 , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and DRUG0 , and DRUG0 . 	propranolol	tetracycline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	theophylline	zonisamide
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	cimetidine	nefazodone
effect	 Drugs Decreasing DRUG0 Effect : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , or DRUG0 may partially counteract the anticoagulant action of <e2> DRUG2 </e2> . 	nicotine	heparin sodium
mechanism	 Oral <e1> DRUG1 </e1> may potentiate the hypoglycemic action of DRUG0 , eg , DRUG0 and <e2> DRUG2 </e2> , by inhibiting their metabolism in the liver . 	anticoagulants	chlorpropamide
other	 <e1> DRUG1 </e1> : Clinical studies , as well as post-marketing observations , have shown that DRUG0 can reduce the natriuretic effect of DRUG0 and <e2> DRUG2 </e2> in some patients . 	Furosemide	thiazides
other	 <e1> DRUG1 </e1> : Administration of DRUG0 with <e2> DRUG2 </e2> resulted in the appearance of unchanged DRUG0 in plasma; 	Terfenadine	VIRACEPT
effect	 Both the sedative and anticholinergic effects of the <e1> DRUG1 </e1> are also additive to those of <e2> DRUG2 </e2> . 	major tranquilizers	desipramine
other	 DRUG0 : In a clinical pharmacology study , coadministration of an DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) with DRUG0 reduced serum levels and urinary excretion of <e2> DRUG2 </e2> as compared with DRUG0 administered alone , suggesting that DRUG0 may impair absorption of DRUG0 . 	magnesium hydroxide	fosinoprilat
other	 Based on known metabolic profiles , clinically significant drug interactions are not expected between DRUG0 and DRUG0 , <e1> DRUG1 </e1> / DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 or DRUG0 . 	trimethoprim	clarithromycin
other	 Interactions may also occur with the following : DRUG0 / <e1> DRUG1 </e1> , drugs used to treat an overactive thyroid , <e2> DRUG2 </e2> (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 pain medication (e.g. , DRUG0 ) , drugs used to aid sleep , drowsiness-causing DRUG0 (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	anti-anxiety drugs	beta-blockers
effect	 <e1> DRUG1 </e1> decrease the hypotensive effect of <e2> DRUG2 </e2> . 	TCAs	guanfacine
other	 - <e1> DRUG1 </e1> and DRUG0 DRUG0 : DRUG0 and DRUG0 DRUG0 have the potential of binding DRUG0 and reducing <e2> DRUG2 </e2> absorption from the gastrointestinal tract 	Cholestyramine	diuretic
other	 DRUG0 or DRUG0 excess may decrease the effect of <e1> DRUG1 </e1> , and an <e2> DRUG2 </e2> deficiency can increase the effect of DRUG0 . 	Carbimazole	iodine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (1) , DRUG0 , DRUG0 . 	cimetidine	valproate
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; <e2> DRUG2 </e2> under-dosage . 	carbamazepine	warfarin sodium
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , <e1> DRUG1 </e1> salts , DRUG0 , local DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	magnesium	procainamide
mechanism	 The effect may be mediated by <e1> DRUG1 </e1> s known inhibition of hepatic cytochrome P-450 , the enzyme system responsible for the first-pass metabolism of <e2> DRUG2 </e2> . 	cimetidine	diltiazem
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute DRUG0 intake , <e1> DRUG1 </e1> , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 	amiodarone	estrogens
mechanism	 DRUG0 : The addition of DRUG0 to patients taking DRUG0 chronically had no effect on DRUG0 pharmacokinetics , but <e1> DRUG1 </e1> significantly decreased <e2> DRUG2 </e2> binding in vitro from 96.3 to 94.8% , which resulted in an increase of approximately 40% in the free DRUG0 concentration . 	valproate	tiagabine
other	 Other Drugs : In healthy volunteers , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , hormone replacement therapy (a combination of conjugated DRUG0 and DRUG0 ) , DRUG0 DRUG0 and DRUG0 s) and DRUG0 did not affect the pharmacokinetics of <e2> DRUG2 </e2> . 	ranitidine	TIKOSYN
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	clofibrate	Invirase
effect	 The antihypertensive effects of DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> may be reduced by <e2> DRUG2 </e2> . 	veratrum alkaloids	sympathomimetics
advise	 Although the interaction between DRUG0 and other potent CYP3A4 inhibitors (e.g. , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) has not been studied , increased exposures to DRUG0 may be expected when <e2> DRUG2 </e2> is used concomitantly with these medications . 	ritonavir	almotriptan
other	 If DRUG0 is to be combined with other DRUG0 such as DRUG0 or <e1> DRUG1 </e1> / DRUG0 , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of <e2> DRUG2 </e2> and DRUG0 (e.g. , DRUG0 or DRUG0 ) are additive . 	sedative	desipramine
other	 In this study we investigated the effect of <e1> DRUG1 </e1> on high threshold voltage-dependent Ca(2+) channel subtypes using their DRUG0 DRUG0 (L-type) , <e2> DRUG2 </e2> (N-type) , or DRUG0 (P-type) in bovine chromaffin cells . 	ginsenosides	omega-conotoxin GVIA
other	 <e1> DRUG1 </e1> therapy should be monitored , particularly during the first few weeks , after initiating therapy with <e2> DRUG2 </e2> in patients receiving DRUG0 or similar agents . 	Anticoagulant	BEXTRA
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	oxyphenbutazone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e1> DRUG1 </e1> (3) , DRUG0 , DRUG0 (4) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	contraceptives	praziquantel
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> . 	antifungals	vitamin C
other	 The intensity , uniformity and time course of DRUG0 interference by DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and <e2> DRUG2 </e2> were systematically investigated in 16 patients receiving DRUG0 therapy . 	secobarbital	methaqualone
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; <e2> DRUG2 </e2> under-dosage . 	antihistamines	warfarin sodium
other	 Although DRUG0 has a lower affinity for DRUG0 than for <e1> DRUG1 </e1> , DRUG0 should not be taken with <e2> DRUG2 </e2> -containing DRUG0 . 	iron	aluminum
effect	 Organic DRUG0 - <e1> DRUG1 </e1> supplements theoretically may potentiate the effects of organic <e2> DRUG2 </e2> if taken concomitantly . 	L-arginine	nitrates
other	 DRUG0 : <e1> DRUG1 </e1> coadministration leads to an increased peak plasma concentration and AUC of DRUG0 , there is no effect on DRUG0 absorption when it is coadministered with <e2> DRUG2 </e2> . 	Cimetidine	ranitidine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	clofibrate	Kaletra
other	 Drug Interactions : DRUG0 may interact with some drugs , like <e1> DRUG1 </e1> ( DRUG0 ) : DRUG0 could theoretically affect DRUG0 pharmacodynamics - DRUG0 - Eproxindine - DRUG0 : DRUG0 and DRUG0 cause additive CNS depression - DRUG0 : DRUG0 increases the effect of <e2> DRUG2 </e2> 	Monoamine oxidase inhibitors	Tricyclic antidepressants
other	 DRUG0 : Coadministration of DRUG0 with <e1> DRUG1 </e1> resulted in a 152% increase in DRUG0 plasma AUC and very little change in <e2> DRUG2 </e2> plasma A.C . 	VIRACEPT	ritonavir
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or DRUG0 (basic) , as well as DRUG0 DRUG0 , DRUG0 , thyroid and <e1> DRUG1 </e1> preparations , DRUG0 and DRUG0 , and <e2> DRUG2 </e2> . 	thyroxine	digitalis
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (5) , DRUG0 , and DRUG0 . 	cyclosporin	valproate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 . 	thiocyanate	somatostatin analogs
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	cyclosporin	praziquantel
effect	 Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using <e1> DRUG1 </e1> or DRUG0 concomitantly with <e2> DRUG2 </e2> . 	beta-blockers	Tiazac
other	 <e1> DRUG1 </e1> : DRUG0 coadministration leads to an increased peak plasma concentration and AUC of DRUG0 , there is no effect on DRUG0 absorption when it is coadministered with <e2> DRUG2 </e2> . 	H2 Receptor Antagonists	ranitidine
effect	 The actions of the <e1> DRUG1 </e1> may be potentiated by <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 or other DRUG0 . 	benzodiazepines	barbiturates
other	 DRUG0 reduced or eliminated the increases in FI responding produced by intermediate doses of either DRUG0 or <e1> DRUG1 </e1> in pigeons , but did not antagonize the decreases in FI or FR responding produced by high doses of DRUG0 or either stereoisomer of <e2> DRUG2 </e2> . 	PCP	NANM
other	 Unmodified DRUG0 (1% m/v) significantly improved the transport ratio (R= P(app) polymer/ P(app) control) of <e1> DRUG1 </e1> to 1.3 and 1% (m/v) DRUG0 conjugated with <e2> DRUG2 </e2> further enhanced the permeation . 	NaFlu	cysteine
other	 Both <e1> DRUG1 </e1> and its major metabolite , <e2> DRUG2 </e2> , are inhibitors of the cytochrome P450 3A4 enzyme system . 	itraconazole	hydroxyitraconazole
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	Advil	Relafen
other	 poor metabolizers of <e1> DRUG1 </e1> : Interactions of DRUG0 with strong inhibitors of CYP2D6 (such as DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of DRUG0 . 	debrisoquin	propafenone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clozapine	contraceptives
other	 Concomitant medications were grouped as DRUG0 , oral <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , inducers of CYP3A4 , substrates and inhibitors of CYP3A4 , substrates and inhibitors of P-glycoprotein , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , substrates and inhibitors of tubular organic cation transport , and QTc-prolonging drugs . 	anticoagulants	nitrates
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Dilantin	Kaletra
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (e.g. , in oral <e2> DRUG2 </e2> ) . 	estrogens	contraceptives
other	 Concurrent administration of <e1> DRUG1 </e1> (another TNF -blocking agent) and DRUG0 (an <e2> DRUG2 </e2> ) has been associated with an increased risk of serious infections , and increased risk of neutropenia and no additional benefit compared to these medicinal products alone . 	etanercept	interleukin-1 antagonist
effect	 Co-administration of <e1> DRUG1 </e1> at steady-state with a single dose of <e2> DRUG2 </e2> (2 x 600 mg tablets) results in increased DRUG0 serum concentrations . 	nelfinavir	azithromycin
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	corticosteroids	thyroid hormones
mechanism	 The effect may be mediated by <e1> DRUG1 </e1> s known inhibition of hepatic cytochrome P-450 , the enzyme system responsible for the first-pass metabolism of <e2> DRUG2 </e2> . 	cimetidine	diltiazem
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	desipramine	Phenytoin
other	 In vitro , DRUG0 does not displace tightly bound drugs like <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> from serum proteins . 	phenytoin	warfarin
effect	 Preliminary data which suggest that <e1> DRUG1 </e1> may inhibit the anti-inflammatory activity of <e2> DRUG2 </e2> have not been confirmed . 	dapsone	Lamprene
other	 In vitro studies indicate that , at therapeutic concentrations of <e1> DRUG1 </e1> (300 m g/mL) , the binding of DRUG0 was reduced from approximately 99.2% to 97.5% , representing a potential twofold increase in unbound <e2> DRUG2 </e2> plasma levels . 	salicylate	ketorolac
other	 In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of <e1> DRUG1 </e1> alone were compared to DRUG0 given concomitantly with DRUG0 , the use of <e2> DRUG2 </e2> was associated with a reduced antihypertensive effect , although the difference between the two regimens was not significant . 	PRINIVIL	indomethacin
other	 It may increase excretion of DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> and may also increase the toxicity of DRUG0 . 	lithium	ASA
other	 <e1> DRUG1 </e1> in combination with DRUG0 enhances the manifestation of corneal lesions in rats Epidural Injection <e2> DRUG2 </e2> may potentiate the CNS-depressive effect of DRUG0 , DRUG0 or other DRUG0 . 	Amitriptyline	Clonidine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chloral hydrate	miconazole
mechanism	 <e1> DRUG1 </e1> DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or <e2> DRUG2 </e2> (basic) , as well as DRUG0 DRUG0 , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and DRUG0 , and DRUG0 . 	Cholestyramine	propranolol
other	 A dose increase of <e1> DRUG1 </e1> / <e2> DRUG2 </e2> to 533/133 mg twice daily with food isrecommended in combination with DRUG0 . 	lopinavir	ritonavir
other	 Based on adult data , lower doses of <e1> DRUG1 </e1> may be needed following coadministration of drugs which are reported to decrease DRUG0 elimination (e.g. , DRUG0 and DRUG0 ) and higher DRUG0 doses may be needed following coadministration of drugs that increase DRUG0 elimination (e.g. , <e2> DRUG2 </e2> and DRUG0 ) . 	caffeine	phenobarbital
advise	 A dose adjustment is not needed when <e1> DRUG1 </e1> is administered with <e2> DRUG2 </e2> . 	zidovudine	VIRACEPT
other	 THE POTENTIATING ACTION OF DRUG0 MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH <e1> DRUG1 </e1> SUCH AS DRUG0 , <e2> DRUG2 </e2> AND DRUG0 . 	CENTRAL NERVOUS SYSTEM DEPRESSANTS	NON-NARCOTIC ANALGESICS
other	 Drugs that reduce the number of blood platelets by causing bone marrow depression (such as <e1> DRUG1 </e1> ) or drugs which inhibit platelet function (eg , DRUG0 and other DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) may increase the bleeding tendency produced by DRUG0 without altering prothrombin time determinations . 	antineoplastic agents	hydrochloroquine
other	 In addition , DRUG0 is not associated with a risk of agranulocytosis as seen with <e1> DRUG1 </e1> or clinically significant hyperprolactinaemia as seen with <e2> DRUG2 </e2> or prolongation of the QT interval . 	clozapine	risperidone
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	adrenocortical steroids	meprobamate
other	 Drugs That Should Not Be Coadministered With DRUG0 DRUG0 : DRUG0 , <e1> DRUG1 </e1> DRUG0 : DRUG0 , DRUG0 Antimigraine : DRUG0 DRUG0 : DRUG0 <e2> DRUG2 </e2> DRUG0 , DRUG0 GI motility agents : DRUG0 	quinidine	Benzodiazepines
other	 <e1> DRUG1 </e1> / DRUG0 : Excessive concurrent use of <e2> DRUG2 </e2> may accelerate epiphyseal closure . 	Somatrem	thyroid hormone
other	 <e1> DRUG1 </e1> or DRUG0 ( DRUG0 and related drugs , <e2> DRUG2 </e2> and DRUG0 ) enhanced hypokalemia . 	Amphotericin B	ethacrynic acid
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 drugs (e.g. , <e2> DRUG2 </e2> ) , DRUG0 , DRUG0 . 	aminoglycosides	ibuprofen
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	Trileptal	temazepam
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (2) , DRUG0 , DRUG0 , and DRUG0 Thus , if a patient has been titrated to a stable dosage on <e2> DRUG2 </e2> , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for DRUG0 may be necessary . 	phenobarbital	EQUETROTM
other	 <e1> DRUG1 </e1> , Including Oral , Injectable , Transdermal , and Implantable DRUG0 : An interaction study demonstrated that co-administration of <e2> DRUG2 </e2> and the oral DRUG0 DRUG0 produced average decreases of DRUG0 and DRUG0 levels of 14% and 31% , respectively . 	Hormonal Contraceptives	bosentan
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e1> DRUG1 </e1> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diflunisal	influenza virus vaccine
other	 DRUG0 may interact with DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	barbiturates	cyclosporine
other	 In the DIAMOND trials , 1252 patients were treated with <e1> DRUG1 </e1> and DRUG0 concomitantly of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and <e2> DRUG2 </e2> . 	TIKOSYN	diuretics
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	amiodarone	perchlorate
other	 - a DRUG0 such as DRUG0 ( DRUG0 , DRUG0 , others) , <e1> DRUG1 </e1> ( DRUG0 , others) , <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , others) , and others; 	methylprednisolone	prednisolone
effect	 Serious cardiac dysrhythmias , some resulting in death , have occurred in patients receiving <e1> DRUG1 </e1> concomitantly with other <e2> DRUG2 </e2> . 	terfenadine	macrolide antibiotics
other	 Interactions with DRUG0 : <e1> DRUG1 </e1> (eg , DRUG0 , DRUG0 , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) should NOT be administered to a patient who has received or is receiving a course of therapy with a DRUG0 such as DRUG0 . 	Agonist/antagonist analgesics	buprenorphine
other	 <e1> DRUG1 </e1> has demonstrated superiority over <e2> DRUG2 </e2> in nucleoside-experienced patients , although combining these 2 agents may represent the best approach in these circumstances . 	Efavirenz	nelfinavir
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	naproxen
other	 In separate single or multiple dose pharmacokinetic interaction studies with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 , the bioavailability of <e2> DRUG2 </e2> was not altered by coadministration of DRUG0 with any one of these drugs . 	propantheline	fosinoprilat
mechanism	 Previous studies have demonstrated a significant reduction in the oral bioavailability of <e1> DRUG1 </e1> and DRUG0 when administered concomitantly with an intravenous DRUG0 such as <e2> DRUG2 </e2> . 	trovafloxacin	morphine
other	 Coadministration of <e1> DRUG1 </e1> and drugs that induce CYP3A may decrease <e2> DRUG2 </e2> plasma concentrations and reduce its therapeutic effect . 	VIRACEPT	nelfinavir
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (2) , DRUG0 , DRUG0 , and DRUG0 Thus , if a patient has been titrated to a stable dosage on <e2> DRUG2 </e2> , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for DRUG0 may be necessary . 	Phenytoin	EQUETROTM
other	 Tell your doctor if you are taking any of the following drugs : <e1> DRUG1 </e1> s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 DRUG0 ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 <e2> DRUG2 </e2> ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	blood thinner	fluoxetine
other	 Effects of Other DRUG0 on DRUG0 <e1> DRUG1 </e1> : DRUG0 causes an approximate doubling of the clearance of DRUG0 ( DRUG0 ) at steady state and , therefore , the addition of DRUG0 causes an approximate 45% decrease in the steady-state trough concentrations of <e2> DRUG2 </e2> as compared to the same dose of DRUG0 given as monotherapy . 	Phenytoin	Felbatol
other	 DRUG0 : Coadministration of DRUG0 and <e1> DRUG1 </e1> resulted in a 32% decrease in <e2> DRUG2 </e2> plasma AUC and a 207% increase in DRUG0 plasma A.C . 	VIRACEPT	nelfinavir
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	phenyramidol	trimethoprim
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	allopurinol	oxolinic acid
other	 Repeated oral administration of DRUG0 in sheep : interactions of DRUG0 with <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> . 	bishydroxycoumarin	phenobarbital sodium
other	 Coadministration of <e1> DRUG1 </e1> (10 mg BID for 7 days) with DRUG0 (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of <e2> DRUG2 </e2> . 	valdecoxib	glyburide
other	 The purpose of this study was to evaluate the effect of DRUG0 ( DRUG0 ) and DRUG0 ( DRUG0 ) conjugates on the intestinal permeation of <e1> DRUG1 </e1> ( DRUG0 ) and model peptide drugs , DRUG0 and <e2> DRUG2 </e2> . 	sodium fluorescein	insulin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , <e2> DRUG2 </e2> ( DRUG0 ) , and DRUG0 . 	Topamax	theophylline
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methyldopa	prolonged narcotics
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 . 	morphine	Theo-Dur
advise	 Nephrotoxic agents : Concomitant administration of <e1> DRUG1 </e1> and agents with nephrotoxic potential [e.g. , intravenous DRUG0 (e.g. , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 , DRUG0 , intravenous DRUG0 , DRUG0 , and <e2> DRUG2 </e2> ] is contraindicated . 	VISTIDE	non-steroidal anti-inflammatory agents
other	 DRUG0 can interact with <e1> DRUG1 </e1> or other <e2> DRUG2 </e2> (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , DRUG0 or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and DRUG0 (concurrent use with DRUG0 may prolong and intensify the anticholinergic and CNS depressant effects of DRUG0 ) . 	alcohol	CNS depressants
other	 <e1> DRUG1 </e1> : Hallucinations have been reported when <e2> DRUG2 </e2> was used in patients taking DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) . 	Psychoactive Drugs	TORADOL
other	 <e1> DRUG1 </e1> : DRUG0 is known to slow the metabolism of DRUG0 and increase its serum levels DRUG0 levels should be determined prior to concurrent administration with <e2> DRUG2 </e2> , signs and symptoms of DRUG0 toxicity should be monitored closely , and appropriate dosage adjustment of the DRUG0 should be made . 	Carbamazepine	isoniazid
other	 Caution should also be applied for other DRUG0 , and for DRUG0 and <e1> DRUG1 </e1> and <e2> DRUG2 </e2> , which may also precipitate arrhythmias . 	theophylline	tricyclic antidepressants
effect	 Drugs that reportedly may increase oral <e1> DRUG1 </e1> response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; <e2> DRUG2 </e2> ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anticoagulant	disulfiram
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	phenylbutazone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	tolbutamide
other	 DRUG0 , <e1> DRUG1 </e1> and other <e2> DRUG2 </e2> have been reported to reduce the tubular secretion of DRUG0 in an animal model , possibly increasing the toxicity of DRUG0 . 	naproxen sodium	NSAIDs
other	 Other Drugs : Based on the results of drug interaction studies , no dosage adjustment is recommended when DRUG0 ( DRUG0 ) is given with the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> . 	nelfinavir	zidovudine
other	 <e1> DRUG1 </e1> : When a single 125-mg dose of <e2> DRUG2 </e2> was administered on Day5 of a 10-day regimen of 400 mg/day of DRUG0 , a strong CYP3A4 inhibitor , the AUC of DRUG0 increased approximately 5-fold and the mean terminal half-life of DRUG0 increased approximately 3-fold . 	Ketoconazole	Aprepitant
other	 <e1> DRUG1 </e1> : Since DRUG0 may bind other drugs given concurrently , patients should take DRUG0 at least 1 hour before or 4-6 hours after a <e2> DRUG2 </e2> to avoid impeding its absorption . 	Resins	bile acid binding resin
other	 Potential interactions between DRUG0 , a substrate of CYP3A4 , and DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> ) , which are substrates and/or inhibitors of CYP3A4 , have not been evaluated in clinical trials . 	indinavir	nelfinavir
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute DRUG0 intake , <e1> DRUG1 </e1> , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 	amiodarone	halothane
other	 substrates , in vitro data suggest similar effects of <e1> DRUG1 </e1> in CYP3A4 mediated metabolism and <e2> DRUG2 </e2> metabolism . 	grepafloxacin	theophylline
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute <e1> DRUG1 </e1> intake , DRUG0 , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 	alcohol	H2-antagonists
other	 There are rare reports , however , from marketing experiences , of changes in effects of <e1> DRUG1 </e1> or oral <e2> DRUG2 </e2> in the presence of DRUG0 that necessitated changes in the doses of such agents . 	insulin	hypoglycemic agents
other	 Other Drugs : Based on the results of drug interaction studies , no dosage adjustment is recommended when DRUG0 ( <e1> DRUG1 </e1> ) is given with the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	efavirenz	paroxetine
other	 Although additional drug interaction studies have not been conducted , the most common medications used concomitantly with DRUG0 in clinical trials were <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	aspirin	allopurinol
effect	 Injection : DRUG0 injection , like other injectable DRUG0 , produces depression of the central nervous system when administered with DRUG0 , DRUG0 , DRUG0 , DRUG0 , and other DRUG0 .When <e1> DRUG1 </e1> is used concomitantly with injectable <e2> DRUG2 </e2> , an increased incidence of sedation , hallucinations , and irrational behavior has been observed . 	scopolamine	lorazepam
other	 Because there are no data on the compatibility of DRUG0 and crystalline <e1> DRUG1 </e1> preparations , <e2> DRUG2 </e2> should not be mixed with these preparations . 	zinc insulin	NovoLog
effect	 Drugs that reportedly may increase oral <e1> DRUG1 </e1> response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anticoagulant	dextrothyroxine
mechanism	 DRUG0 : Steady-state trough concentrations of DRUG0 were about 56% higher when 8 mg <e1> DRUG1 </e1> was coadministered with each dose of <e2> DRUG2 </e2> (15 mg/kg/day) in eight neurocysticercosis patients . 	dexamethasone	albendazole
other	 DRUG0 and DRUG0 DRUG0 can antagonize the in vitro antiviral activity of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> against HIV . 	stavudine	zidovudine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as <e1> DRUG1 </e1> and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	ampicillin	Kadian
other	 These data suggest that <e1> DRUG1 </e1> are negatively coupled to three types of calcium channels in bovine chromaffin cell , including an <e2> DRUG2 </e2> -sensitive (N-type) channel , an DRUG0 -sensitive (P-type) channel and DRUG0 / DRUG0 / DRUG0 -resistant (presumptive Q-type) channel . 	ginsenosides	omega-conotoxin GVIA
other	 <e1> DRUG1 </e1> : Following concomitant administration of a single dose of <e2> DRUG2 </e2> to subjects receiving multiple doses of DRUG0 , M1 peak levels were increased (~40%) over those seen when DRUG0 was given alone . 	Rifampin	ARAVA
other	 Additionally , DRUG0 , such as <e1> DRUG1 </e1> and <e2> DRUG2 </e2> , may antagonize the activity of DRUG0 . 	chloroquine	mefloquine
other	 <e1> DRUG1 </e1> did not inhibit the antitumor activity of four DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) in four murine models . 	Dolasetron mesylate	cyclophosphamide
other	 Because of the increased risk of adverse reactions in patients who have been taking <e1> DRUG1 </e1> on a regular basis , it is particularly important that physicians query patients or their guardians carefully about DRUG0 , <e2> DRUG2 </e2> and DRUG0 use as part of the history prior to any procedure in which the use of DRUG0 is planned . 	benzodiazepines	alcohol
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , <e2> DRUG2 </e2> , local DRUG0 , DRUG0 , and DRUG0 . 	polymyxins	lithium
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , <e1> DRUG1 </e1> , DRUG0 ) , myelotoxic (e.g. , DRUG0 chemotherapy) , cardiotoxic (e.g. , <e2> DRUG2 </e2> ) or hepatotoxic (e.g. , DRUG0 , DRUG0 ) effects with DRUG0 may increase toxicity in these organ systems . 	aminoglycosides	doxorubicin
other	 Because there are no data on the compatibility of DRUG0 and crystalline <e1> DRUG1 </e1> preparations , <e2> DRUG2 </e2> should not be mixed with these preparations . 	zinc insulin	NovoLog
mechanism	 Coadministration with compounds that are potent inducers of CYP3A4 (eg , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) may result in decreased plasma levels of <e2> DRUG2 </e2> . 	carbamazepine	saquinavir
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chymotrypsin	ibuprofen
other	 DRUG0 / <e1> DRUG1 </e1> : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between DRUG0 and concomitantly administered DRUG0 (162.5 mg orally given 26 and 2 hours prior to initiation of <e2> DRUG2 </e2> 1  g/kg/min . over 4 hours) or DRUG0 (1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of DRUG0 1.5  g/kg/min . over 18 hours) . 	Acetaminophen	Argatroban
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( DRUG0 ) other <e1> DRUG1 </e1> DRUG0 DRUG0 DRUG0 ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) <e2> DRUG2 </e2> ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	antidepressants	ketoconazole
other	 No interaction was noted with the <e1> DRUG1 </e1> DRUG0 in two multiple-dose interaction studies when DRUG0 was coadministered with a DRUG0 / <e2> DRUG2 </e2> (n=29) . 	MAO-B inhibitor	dopa decarboxylase inhibitor
other	 Particular caution should be observed with DRUG0 since there are conflicting results for the effect of DRUG0 on the availability of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	digoxin	digitoxin
other	 DRUG0 , including DRUG0 , may enhance the effects of oral <e1> DRUG1 </e1> , including <e2> DRUG2 </e2> or its derivatives or similar agents . 	anticoagulants	warfarin
other	 No significant drug interactions have been reported in studies of DRUG0 given with other drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and oral <e2> DRUG2 </e2> in healthy volunteers , or given with DRUG0 to patients with heart failure (NYHA class II and III) . 	hydrochlorothiazide	contraceptives
other	 When therapeutic concentrations of DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or DRUG0 were added to human plasma (in vitro) , the plasma protein binding of <e2> DRUG2 </e2> was not altered . 	dipyridamole	nicardipine HCl
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> DRUG1 </e1> due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	EQUETROTM	Phenytoin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	salicylates	triclofos sodium
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , DRUG0 ( DRUG0 s) , DRUG0 , DRUG0 ( DRUG0 may decrease the effects of these medicines) , <e1> DRUG1 </e1> (using these medicines with DRUG0 may result in increased CNS depressant effects) , DRUG0 , DRUG0 (using these medicines with <e2> DRUG2 </e2> may change the amount of either medicine that you need to take) , and oral DRUG0 containing DRUG0 ( DRUG0 may decrease the effectiveness of these oral DRUG0 , and you may need to change to a different type of birth control) . 	central nervous system (CNS) depressants	barbiturates
mechanism	 DRUG0 : When a single 375-mg dose of <e1> DRUG1 </e1> was administered on Day9 of a 14-day regimen of 600 mg/day of <e2> DRUG2 </e2> , a strong CYP3A4 inducer , the AUC of DRUG0 decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold . 	Aprepitant	rifampin
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> ; DRUG0 under-dosage . 	adrenocortical steroids	vitamin C
other	 <e1> DRUG1 </e1> : In a single (400 mg) and multiple dose (400 mg TID) study of DRUG0 in epileptic patients (N=8) maintained on DRUG0 monotherapy for at least 2 months , DRUG0 had no effect on the steady-state trough plasma concentrations of DRUG0 and DRUG0 had no effect on <e2> DRUG2 </e2> pharmacokinetics . 	Phenytoin	gabapentin
other	 - <e1> DRUG1 </e1> (e.g. , <e2> DRUG2 </e2> ) Use of DRUG0 with DRUG0 may increase the chance of side effects affecting the liver and/or the blood 	Methyldopa	Aldomet
other	 However , since <e1> DRUG1 </e1> , DRUG0 , and DRUG0 are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUG0 or DRUG0 with <e2> DRUG2 </e2> . 	aspirin	Ibandronate
other	 DRUG0 : Since <e1> DRUG1 </e1> is a DRUG0 , it is possible that <e2> DRUG2 </e2> , such as the DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 . 	apomorphine	dopamine antagonists
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ); 	Relafen	Aleve
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , <e1> DRUG1 </e1> salts , <e2> DRUG2 </e2> , local DRUG0 , DRUG0 , and DRUG0 . 	magnesium	lithium
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	chlorpromazine	thioridazine
other	 Although it has not been established that there is an interaction between DRUG0 and DRUG0 or other <e1> DRUG1 </e1> , caution is advised when DRUG0 is initiated in patients taking a <e2> DRUG2 </e2> or any other DRUG0 . 	psychotropics	benzodiazepine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cinchophen	mefenamic acid
effect	 Injection : DRUG0 injection , like other injectable <e1> DRUG1 </e1> , produces depression of the central nervous system when administered with DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and other DRUG0 .When DRUG0 is used concomitantly with injectable DRUG0 , an increased incidence of sedation , hallucinations , and irrational behavior has been observed . 	benzodiazepines	MAO inhibitors
effect	 Drugs that reportedly may increase oral <e1> DRUG1 </e1> response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anticoagulant	oxolinic acid
other	 DRUG0 Reversible increases in serum DRUG0 concentrations and toxicity have been reported during concomitant administration of DRUG0 with <e1> DRUG1 </e1> , and with some <e2> DRUG2 </e2> . 	ACE inhibitors	angiotensin II receptor antagonists
effect	 In a Phase I trial using escalating doses of DRUG0 (110-200 mg/m2) and DRUG0 (50 or 75 mg/m2) given as sequential infusions , myelosuppression was more profound when <e1> DRUG1 </e1> was given after <e2> DRUG2 </e2> than with the alternate sequence (ie , DRUG0 before DRUG0 ) . 	TAXOL	cisplatin
other	 Twelve strains of Staphylococcus aureus (a frequent cause of infection in <e1> DRUG1 </e1> , but not in DRUG0 and <e2> DRUG2 </e2> , addicts) were completely inhibited by the drug combination . 	heroin	tripelennamine
other	 There has been too little experience with the coadministration of <e1> DRUG1 </e1> with DRUG0 or <e2> DRUG2 </e2> to recommend concomitant use . 	TAMBOCOR	diltiazem
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 <e1> DRUG1 </e1> ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( <e2> DRUG2 </e2> ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	carbamazepine	Sporanox
other	 Patients receiving other <e1> DRUG1 </e1> s , general DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> or other DRUG0 (including DRUG0 ) concomitantly with DRUG0 may exhibit an additive CNS depression . 	narcotic analgesic	tricyclic antidepressants
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	sulindac	trimethoprim
effect	 Other depressasnts such as DRUG0 , DRUG0 , and <e1> DRUG1 </e1> may enhance CNS depression when administered with <e2> DRUG2 </e2> . 	MAOIs	ethchlorvynol
other	 Other Drugs : In small groups of patients (7-10/interaction study) , the concomitant administration of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or <e1> DRUG1 </e1> did not significantly affect the peak levels and AUC values of <e2> DRUG2 </e2> . 	digitoxin	diclofenac
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 overdosage . 	glucagon	sulfamethoxazole
int	 A pharmacokinetic interaction between <e1> DRUG1 </e1> and <e2> DRUG2 </e2> has been observed during studies involving renal and cardiac transplant patients . 	diltiazem	cyclosporine
other	 In patients receiving nonselective DRUG0 ( <e1> DRUG1 </e1> ) (e.g. , <e2> DRUG2 </e2> ) in combination with DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , there have been reports of serious , sometimes fatal , reactions . 	MAOIs	selegiline hydrochloride
other	 Interactions for DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> ) : DRUG0 : DRUG0 has been reported to reduce intestinal absorption of DRUG0 ; 	Vitamin D2	Calcidiol
advise	 Therefore , <e1> DRUG1 </e1> should be taken at least 30 minutes prior to <e2> DRUG2 </e2> . 	proton pump inhibitors	sucralfate
other	 Administration of DRUG0 with DRUG0 containing DRUG0 , <e1> DRUG1 </e1> , or DRUG0 , with DRUG0 , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or <e2> DRUG2 </e2> , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	magnesium	zinc
other	 - DRUG0 ( DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Anabolin	oxymetholone
other	 <e1> DRUG1 </e1> works differently from the DRUG0 currently available , and except for increased lipid levels , the adverse reaction profile of DRUG0 does not appear to overlap to any great extent with that associated with DRUG0 or <e2> DRUG2 </e2> . 	Sirolimus	tacrolimus
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	adrenocortical steroids	carbamazepine
other	 DRUG0 and Foods Fortified With DRUG0 Concomitant administration of DRUG0 with a therapeutic <e1> DRUG1 </e1> containing 60 mg of elemental DRUG0 (as FeSO4) or <e2> DRUG2 </e2> supplemented with 10 mg of elemental DRUG0 reduced extent of absorption by 80% and 31% , respectively . 	iron supplement	vitamins
other	 <e1> DRUG1 </e1> : Coadministration of DRUG0 and <e2> DRUG2 </e2> resulted in a 32% decrease in DRUG0 plasma AUC and a 207% increase in DRUG0 plasma A.C . 	Rifabutin	VIRACEPT
other	 The gonadotropin levels may be transiently elevated by <e1> DRUG1 </e1> , minimally elevated by DRUG0 , and suppressed by oral <e2> DRUG2 </e2> and DRUG0 . 	spironolactone	contraceptives
other	 DRUG0 <e1> DRUG1 </e1> may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or <e2> DRUG2 </e2> (basic) , as well as DRUG0 DRUG0 , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and DRUG0 , and DRUG0 . 	resin	propranolol
other	 Effects of Other <e1> DRUG1 </e1> on DRUG0 DRUG0 : DRUG0 causes an approximate doubling of the clearance of DRUG0 ( <e2> DRUG2 </e2> ) at steady state and , therefore , the addition of DRUG0 causes an approximate 45% decrease in the steady-state trough concentrations of DRUG0 as compared to the same dose of DRUG0 given as monotherapy . 	Antiepileptic Drugs	felbamate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	amiodarone	nalidixic acid
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , <e2> DRUG2 </e2> , and DRUG0 . 	tiagabine	ziprasidone
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	amiodarone	6-mercaptopurine
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving DRUG0 metabolized similarly to DRUG0 or on the basis of in vitro studies with DRUG0 or other DRUG0 (caution is recommended during coadministration with DRUG0 ) : Available data from clinical studies of <e1> DRUG1 </e1> other than DRUG0 suggest a possible drug interaction with DRUG0 for the following : DRUG0 , <e2> DRUG2 </e2> , DRUG0 such as DRUG0 and DRUG0 , and grapefruit juice . 	benzodiazepines	isoniazid
other	 However , neither <e1> DRUG1 </e1> nor <e2> DRUG2 </e2> appears to affect DRUG0 metabolism . 	phenobarbital	diazepam
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , <e1> DRUG1 </e1> (e.g. , DRUG0 ) , local DRUG0 (e.g. , DRUG0 and <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	chloramphenicol	lidocaine
other	 The serum androgen concentrations of <e1> DRUG1 </e1> + DRUG0 -treated rats did not change significantly , while those of <e2> DRUG2 </e2> -treated rats dropped to 30-40% 	estradiol	endotoxin
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , <e2> DRUG2 </e2> salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	aminoglycosides	magnesium
other	 DRUG0 may interact with the following medications : <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	acetaminophen	protease inhibitors
other	 Several drug interaction studies have been completed with both <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	INVIRASE	FORTOVASE
other	 A 21 (17)% decrease in the steady-state AUC of <e1> DRUG1 </e1> was observed when <e2> DRUG2 </e2> was administered 2 hours prior to DRUG0 , but not when the two drugs were administered simultaneously (n = 12) . 	ganciclovir	VIDEX
other	 <e1> DRUG1 </e1> : Since DRUG0 may bind other drugs given concurrently , patients should take <e2> DRUG2 </e2> at least 1 hour before or 4-6 hours after a DRUG0 to avoid impeding its absorption . 	Resins	TRICOR
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	allopurinol	pyrazolones
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	adrenocortical steroids	chlordiazepoxide
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	barbiturates	griseofulvin
other	 In three separate controlled , parallel group clinical pharmacology studies , DRUG0 at the clinical dose of 5 mg has been coadministered with <e1> DRUG1 </e1> 500 mg followed by 250 mg once daily for 4 days (n=18) or with DRUG0 20 mg once daily for 7 days after a 23 day pretreatment period with DRUG0 (n=18) or with <e2> DRUG2 </e2> 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers . 	azithromycin	cimetidine
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and DRUG0 ) , <e2> DRUG2 </e2> salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	lincomycin	magnesium
other	 DRUG0 may interact with the following medications : <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	acetaminophen	anticonvulsants
advise	 <e1> DRUG1 </e1> generally should not be given with <e2> DRUG2 </e2> because they reduce its renal clearance and add a high risk of lithium toxicity . 	Lithium	diuretics
other	 In in vivo studies , 10- to 30-mg/day doses of DRUG0 had no significant effect on metabolism by CYP2D6 ( DRUG0 ) , CYP2C9 ( <e1> DRUG1 </e1> ) , CYP2C19 ( DRUG0 , DRUG0 ) , and CYP3A4 ( <e2> DRUG2 </e2> ) substrates . 	warfarin	dextromethorphan
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	b-adrenergic blocking agents	heparin
advise	 If concomitant treatment with <e1> DRUG1 </e1> and an <e2> DRUG2 </e2> is clinically warranted , appropriate observation of the patient is advised . 	naratriptan	SSRI
mechanism	 DRUG0 : In vitro data indicate that <e1> DRUG1 </e1> inhibits the metabolism of <e2> DRUG2 </e2> , which can result in an increase in plasma DRUG0 levels and prolongation of the QT interval on the ECG . 	nefazodone	cisapride
other	 In clinical studies performed with DRUG0 , the concomitant use of oral DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , and <e2> DRUG2 </e2> did not significantly affect the pharmacokinetics/pharmacodynamics of DRUG0 . 	piroxicam	digoxin
other	 Population pharmacokinetic analyses revealed that DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> did not influence <e2> DRUG2 </e2> clearance . 	TNF blocking agents	abatacept
other	 Other drugs which may enhance the neuromuscular blocking action of DRUG0 such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) , DRUG0 salts , DRUG0 , local <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	colistin	anesthetics
other	 The principal drugs given (number of patients in parentheses) were : DRUG0 (115) , DRUG0 and DRUG0 (103) , DRUG0 (52) , oral DRUG0 (45) , cough and cold preparations (45) , DRUG0 (38) , <e1> DRUG1 </e1> (29) , DRUG0 (24) , oral DRUG0 (18) , DRUG0 (13) , DRUG0 (10) , and <e2> DRUG2 </e2> (10) . 	antihyperlipidemics	beta blockers
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> causes an increase in steady-state DRUG0 concentrations . 	Valproate	Felbatol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	fenoprofen	indomethacin
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	trifluoperazine	triflupromazine
other	 The effect of DRUG0 on the <e1> DRUG1 </e1> requirement of our patient appeared to be maximal 5 to 7 days after the initiation of <e2> DRUG2 </e2> and extended a similar length of time after DRUG0 withdrawal . 	warfarin	rifampin
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> DRUG1 </e1> : DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	ORENCIA	TNF blocking agents
int	 In addition to bleeding associated with DRUG0 and DRUG0 , drugs that alter platelet function (such as <e1> DRUG1 </e1> , DRUG0 and DRUG0 ) may increase the risk of bleeding if administered prior to , during , or after <e2> DRUG2 </e2> therapy . 	acetylsalicylic acid	Activase
other	 Potential drug interactions between <e1> DRUG1 </e1> and other DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) were also assessed by evaluating the serum concentrations of <e2> DRUG2 </e2> and these DRUG0 during placebo-controlled clinical studies . 	Keppra	levetiracetam
other	 Persons taking most DRUG0 , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> invalidate DRUG0 and DRUG0 diagnostic blood assays . 	methotrexate	pyrimethamine
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain <e1> DRUG1 </e1> (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , <e2> DRUG2 </e2> , local DRUG0 , DRUG0 , and DRUG0 . 	antibiotics	lithium
other	 DRUG0 and DRUG0 - DRUG0 may decrease hepatic toxicity in those with <e1> DRUG1 </e1> overdosage or in those taking <e2> DRUG2 </e2> . 	acetaminophen	methotrexate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	pyrazolones	triclofos sodium
other	 The amount of <e1> DRUG1 </e1> absorbed while taking <e2> DRUG2 </e2> was bioequivalent to the amount absorbed when taking placebo , as indicated by the plasma AUC values . 	metformin	Acarbose
advise	 <e1> DRUG1 </e1> , DRUG0 and DRUG0 concentrations should be monitored at the initiation of <e2> DRUG2 </e2> therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately . 	Cyclosporine	Itraconazole
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxolinic acid	thyroid drugs
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Gris-PEG	Norvir
other	 It is , however , possible that concomitant use of other known <e1> DRUG1 </e1> such as DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 and DRUG0 might increase the photosensitivity reaction of actinic keratoses treated with the DRUG0 for Topical Solution . 	photosensitizing agents	thiazide diuretics
other	 BACKGROUND : The effects of combined administration of DRUG0 and DRUG0 ( <e1> DRUG1 </e1> ) , a DRUG0 , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by <e2> DRUG2 </e2> ( DRUG0 ) and the labeling index of intestinal cancers were investigated in male Wistar rats . 	verapamil	azoxymethane
other	 Interactions may also occur with the following : DRUG0 / DRUG0 , drugs used to treat an overactive thyroid , <e1> DRUG1 </e1> (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 pain medication (e.g. , DRUG0 ) , drugs used to aid sleep , drowsiness-causing <e2> DRUG2 </e2> (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	beta-blockers	antihistamines
other	 DRUG0 (e . g. , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , etc.) : in vitro and animal studies with the combination of DRUG0 and DRUG0 suggest that <e2> DRUG2 </e2> may induce fungal resistance to DRUG0 . 	ketoconazole	imidazoles
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 . 	diazepam	sulfonamides
other	 Since the concomitant administration of <e1> DRUG1 </e1> with DRUG0 increases the prothrombin time by 100% after 3 to 4 days , the dose of the <e2> DRUG2 </e2> should be reduced by one-third to one-half , and prothrombin times should be monitored closely . 	warfarin	anticoagulant
other	 If signs and symptoms suggestive of DRUG0 toxicity occur when <e1> DRUG1 </e1> and DRUG0 are given concomitantly , physicians are advised to obtain serum DRUG0 levels and adjust <e2> DRUG2 </e2> doses appropriately . 	enoxacin	digoxin
mechanism	 DRUG0 and DRUG0 : Upon concomitant administration of 5 mg of <e1> DRUG1 </e1> with 600 mg BID <e2> DRUG2 </e2> , the Cmax and AUC of DRUG0 were reduced by approximately 20% . 	Vardenafil	ritonavir
advise	 Therefore , co-administration of <e1> DRUG1 </e1> with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	bupropion	imipramine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Lipitor	rifampin
other	 There have been reports of interactions of DRUG0 with DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	cyclosporine	astemizole
other	 The actions of the DRUG0 may be potentiated by DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 or other <e2> DRUG2 </e2> . 	narcotics	antidepressants
mechanism	 DRUG0 : Doses of <e1> DRUG1 </e1> ( DRUG0 ) 1 g/day have been reported to increase plasma concentration of <e2> DRUG2 </e2> by ~47% , possibly by inhibiting conjugation; 	ascorbic acid	synthetic estrogens
other	 Administration of DRUG0 with DRUG0 containing DRUG0 , DRUG0 , or <e1> DRUG1 </e1> , with DRUG0 , with metal cations such as <e2> DRUG2 </e2> , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	calcium	iron
other	 - a <e1> DRUG1 </e1> ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	nonsteroidal anti-inflammatory drug	Orudis
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , <e1> DRUG1 </e1> , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e2> DRUG2 </e2> , DRUG0 . 	fluvoxamine	verapamil
other	 [Stimulation by DRUG0 --an analog of the octapeptide cholecystokinin--of <e1> DRUG1 </e1> binding after the long-term administration of DRUG0 ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of DRUG0 (0.25 mg/kg) and DRUG0 (0.25 mg/kg) resulted in the reduced interaction between DRUG0 and low affinity binding sites for <e2> DRUG2 </e2> in subcortical structures , whereas DRUG0 binding with high affinity binding sites for DRUG0 increased both in the frontal cortex and subcortical structures of the forebrain . 	3H-spiroperidol	apomorphine
other	 - <e1> DRUG1 </e1> ( DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Phenothiazines	Tindal
mechanism	 The absorption of oral <e1> DRUG1 </e1> is significantly reduced by the concomitant administration of an DRUG0 containing <e2> DRUG2 </e2> and DRUG0 . 	gemifloxacin	aluminum
other	 DRUG0 / DRUG0 : <e1> DRUG1 </e1> did not have any clinically important effect on the pharmacokinetics of DRUG0 or <e2> DRUG2 </e2> . 	Rofecoxib	prednisone
other	 All subjects received <e1> DRUG1 </e1> (1,200 mg twice a day) for 4 days , followed by a 7-day washout period , followed by either DRUG0 (300 mg once a day [QD]) (cohort 1) or <e2> DRUG2 </e2> (600 mg QD) (cohort 2) for 14 days . 	amprenavir	rifampin
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ); 	Cataflam	Naprosyn
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	sulfinpyrazone
other	 Oral DRUG0 : DRUG0 , when given once daily for 14 days as a 100-mg capsule with an oral DRUG0 containing 35 mcg of <e1> DRUG1 </e1> and 1 mg of <e2> DRUG2 </e2> , decreased the AUC of DRUG0 by 43% , and decreased the AUC of DRUG0 by 8%; 	ethinyl estradiol	norethindrone
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	fluoxetine	nicotinamide
other	 Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving <e1> DRUG1 </e1> (caution is recommended during coadministration with DRUG0 ) : Coadministration of <e2> DRUG2 </e2> with DRUG0 increased the maximum plasma concentration of DRUG0 by 46% , decreased clearance by 21% , increased half-life by 17% , and decreased measured psychomotor performance . 	Alprazolam	fluoxetine
other	 In general , most patients treated with <e1> DRUG1 </e1> who are receiving concomitant DRUG0 therapy may not require empiric adjustment of <e2> DRUG2 </e2> dosage or monitoring of DRUG0 plasma concentrations . 	dirithromycin	theophylline
other	 Since DRUG0 is a substrate for <e1> DRUG1 </e1> , there is the potential that the use of St . John s Wort in patients receiving DRUG0 could result in reduced <e2> DRUG2 </e2> levels . 	CYP3A4	amiodarone
other	 Although it has not been established that there is an interaction between DRUG0 and <e1> DRUG1 </e1> or other DRUG0 , caution is advised when DRUG0 is initiated in patients taking a DRUG0 or any other <e2> DRUG2 </e2> . 	benzodiazepines	psychotropic drug
other	 In vitro displacement studies with highly protein-bound drugs such as DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> showed no influence on the extent of DRUG0 protein binding . 	nicardipine	metformin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anesthetics	phenytoin
effect	 DRUG0 or DRUG0 administered with <e1> DRUG1 </e1> / DRUG0 to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of DRUG0 and decrease the required infusion rate of <e2> DRUG2 </e2> . 	nitrous oxide	NIMBEX
other	 Interactions may also occur with the following : <e1> DRUG1 </e1> / DRUG0 , drugs used to treat an overactive thyroid , <e2> DRUG2 </e2> (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 pain medication (e.g. , DRUG0 ) , drugs used to aid sleep , drowsiness-causing DRUG0 (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	anti-depressants	beta-blockers
other	 The administration of local <e1> DRUG1 </e1> containing DRUG0 or <e2> DRUG2 </e2> to patients receiving DRUG0 or DRUG0 may produce severe , prolonged hypertension . 	anesthetic solutions	norepinephrine
other	 <e1> DRUG1 </e1> did not influence the plasma pharmacokinetics or renal elimination of a single oral dose of <e2> DRUG2 </e2> . 	Rofecoxib	digoxin
other	 Drugs Metabolized by Cytochrome P450IID6 (CYP2D6) : Many drugs , including most DRUG0 (SSRIs , many <e1> DRUG1 </e1> ) , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> are metabolized by the CYP2D6 isoenzyme . 	tricyclics	antipsychotics
other	 Multivalent Cation-Containing Products : Concurrent administration of a DRUG0 , including DRUG0 , with multivalent cation-containing products such as DRUG0 or DRUG0 <e1> DRUG1 </e1> , DRUG0 , DRUG0 chewable/buffered tablets or pediatric powder , or products containing DRUG0 , DRUG0 , or DRUG0 may substantially decrease the absorption of <e2> DRUG2 </e2> , resulting in serum and urine levels considerably lower than desired . 	antacids	ciprofloxacin
mechanism	 DRUG0 : It has been reported that <e1> DRUG1 </e1> prolongs the half-life of the DRUG0 , <e2> DRUG2 </e2> . 	allopurinol	dicumarol
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> may counteract the sedative effect of DRUG0 . 	Antihistamines	Amphetamines
effect	 Other drugs which may enhance the neuromuscular blocking action of <e1> DRUG1 </e1> such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and DRUG0 . 	nondepolarizing agents	polymyxins
mechanism	 In a ten-subject study , coadministration of <e1> DRUG1 </e1> (120 mg bid) with <e2> DRUG2 </e2> resulted in a 3-4 times increase in mean DRUG0 AUC and Cmax vs . DRUG0 alone; 	diltiazem	lovastatin
effect	 - DRUG0 (e.g. , DRUG0 ) Use of <e1> DRUG1 </e1> with <e2> DRUG2 </e2> may increase the chance of side effects affecting the liver and/or the side effects of DRUG0 	phenytoin	sulfapyridine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	sulfinpyrazone
other	 <e1> DRUG1 </e1> or Oral DRUG0 : <e2> DRUG2 </e2> may enhance the blood-sugar-reducing effect of DRUG0 and oral DRUG0 . 	Insulin	Agents with b-blocking properties
effect	 The blood pressure effect of <e1> DRUG1 </e1> tended to be greater in patients on <e2> DRUG2 </e2> than in patients on no other DRUG0 therapy . 	SULAR	atenolol
other	 For comprehensive information concerning laboratory test alterations associated with <e1> DRUG1 </e1> , physicians should refer to the complete prescribing information for <e2> DRUG2 </e2> ( DRUG0 ) . 	ritonavir	NORVIR
other	 Drugs that reduce the number of blood platelets by causing bone marrow depression (such as DRUG0 ) or drugs which inhibit platelet function (eg , <e1> DRUG1 </e1> and other DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) may increase the bleeding tendency produced by DRUG0 without altering prothrombin time determinations . 	aspirin	dextran
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	amitriptyline	triazolam
mechanism	 The following are examples of drugs known to inhibit the metabolism of other related <e1> DRUG1 </e1> , presumably through inhibition of CYP3A : <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and some DRUG0 . 	benzodiazepines	nefazodone
other	 While all the selective <e1> DRUG1 </e1> ( DRUG0 ) , e.g. , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 , inhibit P450 2D6 , they may vary in the extent of inhibition . 	serotonin reuptake inhibitors	fluoxetine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	atorvastatin	protease inhibitors
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	carbamazepine	phenytoin
mechanism	 <e1> DRUG1 </e1> may also decrease the absorption of <e2> DRUG2 </e2> , which can lead to a deficiency . 	Aminosalicylic acid	vitamin B12
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diazoxide	miconazole
other	 Caution should be used when administering or taking DRUG0 with <e1> DRUG1 </e1> and other strong CYP3A4 inhibitors such as , but not limited to , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	ketoconazole	atazanavir
other	 Other Drugs : In healthy volunteers , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , hormone replacement therapy (a combination of conjugated <e2> DRUG2 </e2> and DRUG0 ) , DRUG0 DRUG0 and DRUG0 s) and DRUG0 did not affect the pharmacokinetics of DRUG0 . 	phenytoin	estrogens
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> DRUG1 </e1> are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (1) , DRUG0 , DRUG0 . 	EQUETROTM	valproate
other	 When <e1> DRUG1 </e1> is added to DRUG0 therapy , plasma <e2> DRUG2 </e2> levels may increase two-fold or more in some patients , if DRUG0 dosage is not reduced . 	amiodarone	flecainide
other	 Administration of <e1> DRUG1 </e1> with <e2> DRUG2 </e2> containing DRUG0 , DRUG0 , or DRUG0 , with DRUG0 , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	quinolones	antacids
effect	 As with some other <e1> DRUG1 </e1> , the time of onset of neuromuscular block induced by DRUG0 is lengthened and the duration of block is shortened in patients receiving <e2> DRUG2 </e2> or DRUG0 . 	nondepolarizing neuromuscular blocking agents	phenytoin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	antifungals	Kaletra
effect	 In patients receiving nonselective DRUG0 ( <e1> DRUG1 </e1> ) (e.g. , DRUG0 ) in combination with DRUG0 (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , there have been reports of serious , sometimes fatal , reactions . 	MAOIs	paroxetine
other	 Oral <e1> DRUG1 </e1> : In pharmacokinetic studies of DRUG0 in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with DRUG0 or with <e2> DRUG2 </e2> 	Hypoglycemic Agents	chlorpropamide
other	 DRUG0 (such as DRUG0 , DRUG0 , or <e1> DRUG1 </e1> ) : concurrent use with <e2> DRUG2 </e2> may have a proarrhythmic effect . 	quinidine	arbutamine
mechanism	 DRUG0 enhance the renal toxicity of DRUG0 in animals . 7 <e1> DRUG1 </e1> interferes with the action of <e2> DRUG2 </e2> preparations by chelating the DRUG0 . 7 	Edetate calcium disodium	zinc insulin
other	 In patients receiving DRUG0 ( DRUG0 ) or DRUG0 ( <e1> DRUG1 </e1> ) , the concomitant administration of 300-600 mg of DRUG0 per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of <e2> DRUG2 </e2> or DRUG0 . 	Imuran	mercaptopurine
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of <e1> DRUG1 </e1> : DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	insulin	diuretics
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	indomethacin	oxyphenbutazone
other	 include <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	terfenadine	triazolam
mechanism	 <e1> DRUG1 </e1> has been reported to increase the <e2> DRUG2 </e2> requirements in human subjects ingesting these agents simultaneously . 	Rifampin	warfarin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diazoxide	oxolinic acid
other	 <e1> DRUG1 </e1> and <e2> DRUG2 </e2> : DRUG0 should be administered with extreme caution in patients being treated with DRUG0 or DRUG0 because the action of DRUG0 on the cardiovascular system may be potentiated by these agents . 	Monoamine Oxidase Inhibitors	Tricyclic Antidepressants
other	 DRUG0 may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> . 	corticosteroids	beta blockers
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all DRUG0 (eg , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , other DRUG0 , general DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and DRUG0 ) may result in additive central nervous system depressant effects . 	alcohol	phenothiazines
advise	 DRUG0 : Based on reports of profound hypotension and loss of consciousness when DRUG0 was administered with DRUG0 , the concomitant use of <e1> DRUG1 </e1> with drugs of the DRUG0 (including , for example , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) is contraindicated . 	apomorphine	ondansetron
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	aminosalicylic acid	phenylbutazone
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e2> DRUG2 </e2> , DRUG0 . 	niacinamide	verapamil
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 ) , HIV drugs classified as <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Neoral	protease inhibitors
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	estrogens	meclofenamic acid
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	amiodarone	phenytoin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , <e2> DRUG2 </e2> , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	lamotrigine	oxcarbazepine
int	 <e1> DRUG1 </e1> may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Etonogestrel	rifampin
mechanism	 Concomitant administration of <e1> DRUG1 </e1> (equivalent to 145mg DRUG0 ) with <e2> DRUG2 </e2> (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for DRUG0 by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase) , respectively , and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase) , respectively in 23 healthy adults . 	fenofibrate	pravastatin
advise	 The use of <e1> DRUG1 </e1> FOR INJECTION in combination with <e2> DRUG2 </e2> is not recommended due to the risk of severe pulmonary toxicity . 	FLUDARA	pentostatin
advise	 Before taking <e1> DRUG1 </e1> , tell your doctor if you are taking any of the following medicines : - DRUG0 or another DRUG0 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , others) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or <e2> DRUG2 </e2> ( DRUG0 ); 	glimepiride	bismuth subsalicylate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	p-aminosalicylic acid	6-mercaptopurine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	quinidine
other	 In a parallel group drug interaction study comparing the intravenous prodrug form of <e1> DRUG1 </e1> at 40 mg BID (n=10) vs placebo (n=9) , DRUG0 had no effect on in vitro <e2> DRUG2 </e2> -mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation . 	valdecoxib	aspirin
int	 <e1> DRUG1 </e1> may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Etonogestrel	Topamax
effect	 The administration of local DRUG0 containing <e1> DRUG1 </e1> or DRUG0 to patients receiving <e2> DRUG2 </e2> or DRUG0 may produce severe , prolonged hypertension . 	epinephrine	monoamine oxidase inhibitors
int	 Data from in vitro studies of DRUG0 suggest a possible drug interaction with <e1> DRUG1 </e1> for the following : <e2> DRUG2 </e2> and DRUG0 . 	alprazolam	sertraline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (5) , DRUG0 , and DRUG0 . 	nortriptyline	valproate
other	 Short-term pharmacokinetic studies have demonstrated that concomitant administration of DRUG0 and DRUG0 ( <e1> DRUG1 </e1> capsules and tablets) results in reduced protein binding of <e2> DRUG2 </e2> , but there was no change in the clearance of free DRUG0 . 	etodolac	warfarin
other	 - When <e1> DRUG1 </e1> or DRUG0 is used concurrently with DRUG0 (e.g . DRUG0 ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of DRUG0 or <e2> DRUG2 </e2> is impaired 	Bezalip	Bezalip retard
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 <e1> DRUG1 </e1> ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( <e2> DRUG2 </e2> ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	carbamazepine	Nizoral
other	 DRUG0 / <e1> DRUG1 </e1> -containing DRUG0 : Absorption of DRUG0 is moderately reduced (approximately 25%) when coadministered with DRUG0 / DRUG0 -containing <e2> DRUG2 </e2> . 	Aluminum	antacid products
other	 DRUG0 can interact with DRUG0 or other DRUG0 (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , DRUG0 or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and <e1> DRUG1 </e1> (concurrent use with <e2> DRUG2 </e2> may prolong and intensify the anticholinergic and CNS depressant effects of DRUG0 ) . 	monoamine oxidase (MAO) inhibitors	antihistamines
effect	 DRUG0 ( DRUG0 ) : <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> DRUG2 </e2> . 	SSRIs	5-HT1 agonists
mechanism	 Reciprocal interactions may occur with concomitant use of <e1> DRUG1 </e1> and drugs that increase or inhibit the cytochrome P450 system (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , though this has not been studied 	Antizol	cimetidine
other	 Single doses of either DRUG0 or DRUG0 <e1> DRUG1 </e1> bind the <e2> DRUG2 </e2> and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively . 	resins	hydrochlorothiazide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e1> DRUG1 </e1> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diflunisal	glucagon
other	 - a DRUG0 ( <e1> DRUG1 </e1> ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	NSAID	nabumetone
other	 Because <e1> DRUG1 </e1> has not been shown to produce any additional effect beyond that obtained with <e2> DRUG2 </e2> alone and because DRUG0 increases the rate of excretion of DRUG0 , the concomitant use of DRUG0 and DRUG0 is not recommended . 	Nalfon	aspirin
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	Motrin	Lodine
other	 DRUG0 , Including Oral , Injectable , Transdermal , and Implantable DRUG0 : An interaction study demonstrated that co-administration of <e1> DRUG1 </e1> and the oral DRUG0 DRUG0 produced average decreases of <e2> DRUG2 </e2> and DRUG0 levels of 14% and 31% , respectively . 	bosentan	norethindrone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , oral DRUG0 (3) , <e2> DRUG2 </e2> , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	mirtazapine	oxcarbazepine
advise	 DRUG0 : <e1> DRUG1 </e1> can be used with low dose <e2> DRUG2 </e2> . 	CELEBREX	aspirin
other	 however , in a study of 12 normal subjects , concurrent administration of DRUG0 decreased DRUG0 protein binding and increased <e1> DRUG1 </e1> plasma clearance from 0.07 L/kg/h without <e2> DRUG2 </e2> to 0.11 L/kg/h with DRUG0 . 	ketoprofen	aspirin
other	 There have been case reports of increased steady-state levels of DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> during concomitant therapy with DRUG0 . 	procainamide	phenytoin
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ;unreliable prothrombin time determinations; DRUG0 ; <e2> DRUG2 </e2> under-dosage . 	rifampin	warfarin sodium
mechanism	 <e1> DRUG1 </e1> have been shown to interfere with the metabolism of <e2> DRUG2 </e2> . 	Quinolones	caffeine
other	 DRUG0 - In subjects who had received 21 days of 40 mg/day racemic DRUG0 , combined administration of <e1> DRUG1 </e1> and DRUG0 (single dose of 1 mg) did not significantly affect the pharmacokinetics of either DRUG0 or <e2> DRUG2 </e2> . 	citalopram	digoxin
other	 In patients taking DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and various chemotherapy agents , no effect was shown on the clearance of <e2> DRUG2 </e2> . 	nifedipine	hydrodolasetron
other	 DRUG0 , DRUG0 , and DRUG0 : Drugs such as <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> may increase the risk of developing peripheral neuropathy or other DRUG0 -associated adverse events by interfering with the renal clearance of DRUG0 (thereby raising systemic exposure) . 	amphotericin	aminoglycosides
mechanism	 DRUG0 , <e1> DRUG1 </e1> , or DRUG0 increased metabolic clearance of <e2> DRUG2 </e2> because of the induction of hepatic enzymes . 	phenytoin	fludrocortisone acetate
other	 Drugs which may enhance the neuromuscular blocking action of DRUG0 include : DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;certain <e2> DRUG2 </e2> , especially the DRUG0 and DRUG0 ; DRUG0 ; DRUG0 salts; DRUG0 ;and DRUG0 . 	halothane	antibiotics
effect	 DRUG0 ( DRUG0 ) : DRUG0 (e.g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> DRUG2 </e2> . 	paroxetine	5-HT1 agonists
other	 <e1> DRUG1 </e1> : DRUG0 have been reported to cause a significant decrease in <e2> DRUG2 </e2> clearance . 	Antibiotics	corticosteroid
mechanism	 In a study in which the 2 mg <e1> DRUG1 </e1> orally disintegrating tablet was administered with and without <e2> DRUG2 </e2> (an DRUG0 with multiple effects on the GI tract) to healthy volunteers , the AUC of DRUG0 was 10% lower and the Cmax of DRUG0 was 20% lower when the orally disintegrating tablet was given with DRUG0 compared to when it was given alone . 	clonazepam	propantheline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	Acetaminophen	tiagabine
other	 DRUG0 : <e1> DRUG1 </e1> s plasma half-life may be prolonged by DRUG0 , since <e2> DRUG2 </e2> and DRUG0 may compete for excretion in the renal tubule . 	Chlorpropamide	allopurinol
other	 Interactions for DRUG0 ( DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> ) : DRUG0 : <e2> DRUG2 </e2> has been reported to reduce intestinal absorption of DRUG0 ; 	Calcidiol	Cholestyramine
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a <e1> DRUG1 </e1> , including DRUG0 , with multivalent cation-containing products such as DRUG0 or DRUG0 DRUG0 , DRUG0 , DRUG0 chewable/buffered tablets or pediatric powder , or products containing DRUG0 , DRUG0 , or <e2> DRUG2 </e2> may substantially decrease the absorption of DRUG0 , resulting in serum and urine levels considerably lower than desired . 	quinolone	zinc
mechanism	 DRUG0 , DRUG0 and other <e1> DRUG1 </e1> have been reported to reduce the tubular secretion of <e2> DRUG2 </e2> in an animal model , possibly increasing the toxicity of DRUG0 . 	NSAIDs	methotrexate
mechanism	 <e1> DRUG1 </e1> has been shown to change the bioavailabillty <e2> DRUG2 </e2> when they are co-administered , which may require DRUG0 dose adjustment . 	Acarbose	digoxin
other	 The concomitant administration of <e1> DRUG1 </e1> and DRUG0 resulted in the need for an unusually high maintenance dose of <e2> DRUG2 </e2> (20 mg per day) in order to produce a therapeutic effect . 	rifampin	warfarin
other	 Reported examples of this interaction include the following : <e1> DRUG1 </e1> s : DRUG0 ( DRUG0 substrate) administered in combination with oral DRUG0 has been reported to produce persistently elevated plasma concentrations of <e2> DRUG2 </e2> resulting in elevated creatinine , despite reduction in dose of DRUG0 . 	Immunosuppressive	cyclosporine
effect	 Blunting of the antihypertensive effect of <e1> DRUG1 </e1> by DRUG0 including <e2> DRUG2 </e2> has been reported . 	beta-adrenoceptor blocking agents	INDOCIN
effect	 Compounds in these categories result in a decreased efficacy of <e1> DRUG1 </e1> : DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 . 	bromocriptine mesylate	haloperidol
effect	 Patients receiving other DRUG0 , <e1> DRUG1 </e1> , DRUG0 , or other DRUG0 (including DRUG0 ) concomitantly with <e2> DRUG2 </e2> and DRUG0 tablets may exhibit an additive CNS depression . 	antipsychotics	hydrocodone
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> DRUG1 </e1> due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	EQUETROTM	clobazam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	allopurinol	quinidine
other	 Like DRUG0 (40 mg/kg) , DRUG0 (40 mg/kg) decreases the intravenous self-administration of DRUG0 and DRUG0 and the oral self-administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> in rats; 	ethanol	nicotine
effect	 Catecholamine-depleting drugs (e.g. , <e1> DRUG1 </e1> ) may have an additive effect when given with <e2> DRUG2 </e2> agents . 	reserpine	beta-blocking
other	 <e1> DRUG1 </e1> : Estimates of steady-state pharmacokinetic parameters for DRUG0 or <e2> DRUG2 </e2> (300 mg TID; 	Phenobarbital	gabapentin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ethacrynic acid	trimethoprim
other	 Before taking DRUG0 , tell your doctor if you are taking any of the following medicines : - DRUG0 or another <e1> DRUG1 </e1> such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , others) , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	salicylate	magnesium salicylate
other	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and <e1> DRUG1 </e1> ) DRUG0 (sometimes prescribed to control blood sugar in type 2 diabetes) <e2> DRUG2 </e2> (used to control inflammation associated with Crohns disease and ulcerative colitis) DRUG0 (a DRUG0 ) DRUG0 There has been concern about the interaction between DRUG0 and DRUG0 . 	primidone	sulfasalazine
other	 The urinary excretion of <e1> DRUG1 </e1> is unaffected by <e2> DRUG2 </e2> , indicating no change in DRUG0 absorption . 	meclofenamate sodium	aspirin
other	 Particular caution should be exercised in using preparations containing <e1> DRUG1 </e1> , DRUG0 , or DRUG0 in combination with <e2> DRUG2 </e2> Gel . 	sulfur	DIFFERIN
other	 <e1> DRUG1 </e1> was more potent in lysing human red blood cells , whereas <e2> DRUG2 </e2> was more potent in inhibiting yeast cell growth; 	filipin	amphotericin B
other	 Endothelium-intact aortic rings from high- <e1> DRUG1 </e1> rats were supersensitive to DRUG0 when compared to vehicle- , <e2> DRUG2 </e2> - and DRUG0 + high- DRUG0 -treated rats (pD2 values = 7.77+/-0.12 , 7.21+/-0.13 , 6.93+/-0.04 and 7.22+/-0.18 , respectively) . 	estradiol	progesterone
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	Dilantin	temazepam
advise	 Additionally , <e1> DRUG1 </e1> should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as DRUG0 , DRUG0 , and <e2> DRUG2 </e2> because of the danger of blocking cardiac contractility when systemic vascular resistance is high . 	BREVIBLOC	norepinephrine
other	 - <e1> DRUG1 </e1> ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Anabolic steroids	oxymetholone
other	 DRUG0 : Two hundred mg of <e1> DRUG1 </e1> (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal , healthy volunteers who had achieved steady-state blood concentrations of <e2> DRUG2 </e2> after being dosed at 400 mg qd . 	caffeine	lomefloxacin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Nizoral	Viracept
other	 Administration of DRUG0 with DRUG0 containing DRUG0 , DRUG0 , or DRUG0 , with DRUG0 , with metal cations such as <e1> DRUG1 </e1> , or with <e2> DRUG2 </e2> containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	iron	multivitamins
other	 Other concomitant therapy Although specific interaction studies were not performed , DRUG0 doses of 1 mg or more were concomitantly used in clinical studies with <e1> DRUG1 </e1> , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	acetaminophen	nitrates
other	 The in vitro anti-cryptosporidial activity of DRUG0 alone and in combination with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> was investigated . 	azithromycin	minocycline
other	 As with other <e1> DRUG1 </e1> , if DRUG0 is to be administered orally with DRUG0 of the DRUG0 or <e2> DRUG2 </e2> type , it is recommended that ECG and blood pressure be monitored . 	agents with b-blocking properties	diltiazem
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Sporanox	Astramorph
other	 <e1> DRUG1 </e1> : The effect of DRUG0 on blood pressure response to <e2> DRUG2 </e2> and DRUG0 was evaluated in men with mild uncomplicated hypertension (n = 10) . 	Beta-adrenergic Blocking Agents	propranolol
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 . 	dopamine agonists	somatostatin analogs
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , <e2> DRUG2 </e2> , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	haloperidol	oxcarbazepine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	chlorpromazine	Stelazine
other	 In a comparison of <e1> DRUG1 </e1> tolerance in dogs anesthetized with DRUG0 , DRUG0 , or DRUG0 , the dosage of DRUG0 needed to cause ventricular tachycardia was significantly higher , as was the LD50 of DRUG0 , with DRUG0 or DRUG0 than with <e2> DRUG2 </e2> . 	digitalis	pentobarbital
other	 Similarly dialyzed were <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> , both alone at therapeutic concentrations in serum and with DRUG0 at three different concentrations in serum . 	phenobarbital	theophylline
advise	 Therefore , <e1> DRUG1 </e1> should be taken at least 1 hour before or 4-6 hours after a <e2> DRUG2 </e2> to avoid impeding its absorption . 	fenofibrate	bile acid binding resin
other	 Administration of DRUG0 with DRUG0 containing DRUG0 , DRUG0 , or DRUG0 , with <e1> DRUG1 </e1> , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( <e2> DRUG2 </e2> ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	sucralfate	didanosine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> overdosage . 	tolbutamide	warfarin sodium
other	 No depressant effect on blood levels in humans was noted when <e1> DRUG1 </e1> was administered with any of the following drugs : DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 , DRUG0 or DRUG0 . 	colestipol hydrochloride	clindamycin
effect	 In particular , convulsions have been reported when <e1> DRUG1 </e1> is administered with <e2> DRUG2 </e2> and special care should be taken when the treatment regimen includes both of these drugs . 	ethionamide	cycloserine
other	 DRUG0 may interact with DRUG0 (e.g. , <e1> DRUG1 </e1> ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , local DRUG0 (e.g. , DRUG0 and DRUG0 ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	Tylenol	Chloromycetin
effect	 <e1> DRUG1 </e1> , DRUG0 and DRUG0 may enhance the effects of : other DRUG0 s , DRUG0 , general DRUG0 , DRUG0 such as <e2> DRUG2 </e2> , DRUG0 , or other DRUG0 , causing increased CNS depression . 	Butalbital	chlordiazepoxide
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a DRUG0 , including <e1> DRUG1 </e1> , with multivalent cation-containing products such as DRUG0 or DRUG0 <e2> DRUG2 </e2> , DRUG0 , DRUG0 chewable/buffered tablets or pediatric powder , or products containing DRUG0 , DRUG0 , or DRUG0 may substantially decrease the absorption of DRUG0 , resulting in serum and urine levels considerably lower than desired . 	ciprofloxacin	antacids
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , <e1> DRUG1 </e1> , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	oxcarbazepine	triazolam
effect	 DRUG0 ( DRUG0 ) (e.g. , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> DRUG2 </e2> . 	fluvoxamine	5-HT1 agonists
other	 Oral <e1> DRUG1 </e1> : <e2> DRUG2 </e2> , when given once daily for 14 days as a 100-mg capsule with an oral DRUG0 containing 35 mcg of DRUG0 and 1 mg of DRUG0 , decreased the AUC of DRUG0 by 43% , and decreased the AUC of DRUG0 by 8%; 	contraceptives	Aprepitant
other	 <e1> DRUG1 </e1> , including <e2> DRUG2 </e2> , may enhance the effects of the oral DRUG0 DRUG0 or its derivatives . 	Quinolones	nalidixic acid
other	 <e1> DRUG1 </e1> : The effect of DRUG0 on the anticoagulant effect of DRUG0 (1 - 8 mg/day) was studied in healthy subjects by coadministration of <e2> DRUG2 </e2> 40 mg BID for 7 days . 	Warfarin	BEXTRA
other	 <e1> DRUG1 </e1> : Studies in animals demonstrate that the acute toxicity of DRUG0 is enhanced by the DRUG0 <e2> DRUG2 </e2> . 	MAO Inhibitors	phenelzine
effect	 Immediate and Extended Release Tablets The hypoglycemic action of <e1> DRUG1 </e1> may be potentiated by certain drugs including DRUG0 , some DRUG0 and other drugs that are highly protein bound , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	sulfonylureas	sulfonamides
other	 DRUG0 Injection should not be mixed with <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or DRUG0 , since it has been reported that these drugs are incompatible with <e2> DRUG2 </e2> and a precipitate may form . 	doxorubicin	heparin
advise	 Therefore , the combination of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> is not recommended . 	ketoprofen	probenecid
other	 Coadministration of DRUG0 and <e1> DRUG1 </e1> 1/35  increased the exposure of DRUG0 and <e2> DRUG2 </e2> by 20% and 34% , respectively . 	Ortho-Novum	ethinyl estradiol
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clonazepam	contraceptives
other	 These drugs include the DRUG0 and other <e1> DRUG1 </e1> , DRUG0 , phe-nothiazines , DRUG0 , <e2> DRUG2 </e2> , oral DRUG0 , DRUG0 , DRUG0 , sympathomimet-ics , DRUG0 , and DRUG0 . 	diuretics	estrogens
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	carbamazepine	rifampin
other	 Effects of <e1> DRUG1 </e1> on other Antiepilepsy Drugs ( DRUG0 ) : <e2> DRUG2 </e2> : DRUG0 had no effect on the steady-state plasma concentrations of DRUG0 in patients with epilepsy . 	GABITRIL	Phenytoin
other	 The blood pressure effect of DRUG0 tended to be greater in patients on <e1> DRUG1 </e1> than in patients on no other <e2> DRUG2 </e2> therapy . 	atenolol	antihypertensive
other	 Interactions for DRUG0 ( DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> ) : DRUG0 : <e2> DRUG2 </e2> has been reported to reduce intestinal absorption of DRUG0 ; 	Calcidiol	Cholestyramine
effect	 The hypoglycemic action of <e1> DRUG1 </e1> may be potentiated by certain drugs including DRUG0 and other drugs that are highly protein bound , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	sulfonylurea	sulfonamides
other	 <e1> DRUG1 </e1> - and DRUG0 -containing DRUG0 , administered concomitantly with DRUG0 , significantly decreased the bioavailability (48%) of <e2> DRUG2 </e2> . 	Magnesium	lomefloxacin
other	 Before taking DRUG0 , tell your doctor if you are taking any of the following medicines : - DRUG0 or another <e1> DRUG1 </e1> such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , others) , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	salicylate	Arthropan
other	 <e1> DRUG1 </e1> : DRUG0 is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of <e2> DRUG2 </e2> . 	Theophylline	methylxanthines
other	 In a comparison of DRUG0 tolerance in dogs anesthetized with DRUG0 , DRUG0 , or DRUG0 , the dosage of <e1> DRUG1 </e1> needed to cause ventricular tachycardia was significantly higher , as was the LD50 of DRUG0 , with DRUG0 or <e2> DRUG2 </e2> than with DRUG0 . 	ouabain	Innovar
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( DRUG0 ) other DRUG0 DRUG0 DRUG0 DRUG0 ( DRUG0 ) <e1> DRUG1 </e1> ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 <e2> DRUG2 </e2> DRUG0 birth control pills sleeping pills thyroid medications 	cimetidine	lithium
effect	 Patients receiving other <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or other DRUG0 (including DRUG0 ) concomitantly with <e2> DRUG2 </e2> and DRUG0 tablets may exhibit an additive CNS depression . 	narcotic analgesics	hydrocodone
other	 DRUG0 , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , certain DRUG0 , <e2> DRUG2 </e2> , DRUG0 and DRUG0 , thereby delaying elimination and increasing blood levels of these drugs . 	chlordiazepoxide	lidocaine
other	 DRUG0 50 mg QD or DRUG0 / DRUG0 50/100 mg QD was co-administered with <e1> DRUG1 </e1> (500 mcg BID) for 5 days (following 2 days of <e2> DRUG2 </e2> use at half dose) . 	TIKOSYN	diuretic
other	 The similarity of the DRUG0 -associated adverse event profile between Study 1 (without co-administered DRUG0 ) and Study 2 (with co-administered <e1> DRUG1 </e1> ) indicates that this alteration in clearance does not necessitate reduction of the <e2> DRUG2 </e2> dose to maintain safety , General) . 	AVONEX	TYSABRI
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Trileptal	Kaletra
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (1) , DRUG0 , DRUG0 , grapefruit juice , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	erythromycin	isoniazid
mechanism	 When <e1> DRUG1 </e1> is added to <e2> DRUG2 </e2> therapy , plasma DRUG0 levels may increase two-fold or more in some patients , if DRUG0 dosage is not reduced . 	amiodarone	flecainide
other	 Administration of <e1> DRUG1 </e1> concomitantly with DRUG0 has been associated with an increase in <e2> DRUG2 </e2> -induced toxicity , possibly due to decreased synthesis of renal prostacyclin . 	non-steroidal anti-inflammatory drugs	cyclosporine
other	 <e1> DRUG1 </e1> : The concomitant administration of DRUG0 with the <e2> DRUG2 </e2> DRUG0 has , on rare occasions , resulted in severe hypoglycemia . 	Glyburide	sulfonylurea
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> overdosage . 	quinidine	warfarin sodium
other	 Oral DRUG0 : DRUG0 , when given once daily for 14 days as a 100-mg capsule with an oral DRUG0 containing 35 mcg of DRUG0 and 1 mg of DRUG0 , decreased the AUC of <e1> DRUG1 </e1> by 43% , and decreased the AUC of <e2> DRUG2 </e2> by 8%; 	ethinyl estradiol	norethindrone
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of <e1> DRUG1 </e1> : DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (e.g. , in oral DRUG0 ) . 	insulin	progestogens
other	 Pharmacokinetic data from these patients demonstrated a decrease in <e1> DRUG1 </e1> clearance of approximately 33% when DRUG0 was administered following <e2> DRUG2 </e2> . 	paclitaxel	cisplatin
other	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and DRUG0 ) DRUG0 (sometimes prescribed to control blood sugar in type 2 diabetes) DRUG0 (used to control inflammation associated with Crohns disease and ulcerative colitis) DRUG0 (a DRUG0 ) <e1> DRUG1 </e1> There has been concern about the interaction between DRUG0 and <e2> DRUG2 </e2> . 	Methotrexate	folic acid
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	ethchlorvynol	contraceptives
effect	 The concomitant administration of <e1> DRUG1 </e1> including DRUG0 with <e2> DRUG2 </e2> (a DRUG0 ) has , on rare occasions , resulted in severe hypoglycemia . 	quinolones	glyburide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clobazam	topiramate
other	 Such individuals are referred to as poor metabolizers of drugs such as DRUG0 , DRUG0 , the <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	tricyclic antidepressants	clozapine
other	 Other Drugs : In healthy volunteers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , hormone replacement therapy (a combination of conjugated DRUG0 and <e1> DRUG1 </e1> ) , DRUG0 DRUG0 and DRUG0 s) and <e2> DRUG2 </e2> did not affect the pharmacokinetics of DRUG0 . 	medroxyprogesterone	theophylline
other	 - a DRUG0 ( <e1> DRUG1 </e1> ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	NSAID	indomethacin
other	 Patients receiving other DRUG0 , <e1> DRUG1 </e1> , DRUG0 , or other <e2> DRUG2 </e2> (including DRUG0 ) concomitantly with DRUG0 and DRUG0 tablets may exhibit an additive CNS depression . 	antipsychotics	CNS depressants
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	fluoxetine	niacinamide
mechanism	 It is known that CYP1A2 is inhibited by several medicinal products , including <e1> DRUG1 </e1> , and such medicinal products could theoretically adversely influence the clearance of <e2> DRUG2 </e2> . 	fluvoxamine	anagrelide
effect	 Administration of <e1> DRUG1 </e1> to patients receiving DRUG0 or <e2> DRUG2 </e2> such as DRUG0 which sensitize the myocardium , may induce cardiac arrhythmia. . 	epinephrine	halogenated hydrocarbon general anesthetics
other	 Addition or deletion of any drug from the therapeutic regimen of patients receiving oral <e1> DRUG1 </e1> may affect patient response to the <e2> DRUG2 </e2> . 	anticoagulants	anticoagulant
effect	 Other depressasnts such as DRUG0 , <e1> DRUG1 </e1> , and DRUG0 may enhance CNS depression when administered with <e2> DRUG2 </e2> . 	barbiturates	ethchlorvynol
mechanism	 <e1> DRUG1 </e1> modifies DRUG0 metabolism with increased serum levels of <e2> DRUG2 </e2> . 	DIAMOX	phenytoin
other	 This appears to be the only clinically relevant interaction of this kind with DRUG0 , although theoretically , coadministration of other drugs known to alter cardiac conduction (eg , <e1> DRUG1 </e1> or DRUG0 , DRUG0 , DRUG0 or DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) might also contribute to a prolongation of the QTc interval . 	anti-arrhythmic	phenothiazines
other	 DRUG0 can interact with <e1> DRUG1 </e1> or other DRUG0 (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , DRUG0 or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and <e2> DRUG2 </e2> (concurrent use with DRUG0 may prolong and intensify the anticholinergic and CNS depressant effects of DRUG0 ) . 	alcohol	monoamine oxidase (MAO) inhibitors
other	 The present work involved the administration of both <e1> DRUG1 </e1> and <e2> DRUG2 </e2> to groups of rats , followed by determination of the homocysteine excretion rate in urine . 	ethynyl estradiol	levonorgestrel
mechanism	 In patients given very high doses (3900 mg) of <e1> DRUG1 </e1> daily , increases in serum DRUG0 levels were seen when <e2> DRUG2 </e2> , 150 mg b.i.d. , was administered concurrently . 	aspirin	nizatidine
other	 <e1> DRUG1 </e1> containing DRUG0 and DRUG0 reduce the oral absorption of <e2> DRUG2 </e2> by 75% . 	Antacids	enoxacin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , <e1> DRUG1 </e1> , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	insulin	rifampin
other	 DRUG0 may interact with the following medications : DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Tylenol	protease inhibitors
other	 Co-administration of single 25-mg dose <e1> DRUG1 </e1> had no effect on the pharmacokinetics of total <e2> DRUG2 </e2> . 	warfarin	lenalidomide
mechanism	 DRUG0 : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 have been shown to decrease plasma levels of <e2> DRUG2 </e2> ; 	nelfinavir	combination hormonal contraceptives
mechanism	 DRUG0 : Co-administration of <e1> DRUG1 </e1> 500 mg b.i.d . for 6 days decreased the plasma concentrations of both DRUG0 (a CYP2C9 substrate) and <e2> DRUG2 </e2> (a CYP3A4 substrate) by 29 and 38% , respectively . 	bosentan	R-warfarin
other	 Interaction of <e1> DRUG1 </e1> with Other Drugs : DRUG0 : Co-administration of <e2> DRUG2 </e2> (800 mg/day) to patients taking DRUG0 chronically had no effect on DRUG0 pharmacokinetics . 	GABITRIL	cimetidine
mechanism	 There have been greater than 2-fold increases in previously stable plasma levels of other DRUG0 , including <e1> DRUG1 </e1> , when <e2> DRUG2 </e2> has been administered in combination with these agents . 	nortriptyline	fluoxetine hydrochloride
other	 These drugs include the DRUG0 and other DRUG0 , <e1> DRUG1 </e1> , DRUG0 , thyroid products , DRUG0 , oral <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	corticosteroids	contraceptives
other	 In clinical trials , <e1> DRUG1 </e1> was used with DRUG0 , <e2> DRUG2 </e2> , DRUG0 , oral DRUG0 , and supplemental DRUG0 .In a pharmacokinetic substudy in patients with congestive heart failure receiving DRUG0 or DRUG0 in whom therapy with DRUG0 was initiated , apparent oral clearance values for DRUG0 (n = 23) and DRUG0 (n = 30) were decreased by 13% and 15% , respectively , on the second day of therapy and had returned to baseline values by day 87 . 	FLOLAN	diuretics
other	 Interactions may also occur with the following : DRUG0 / <e1> DRUG1 </e1> , drugs used to treat an overactive thyroid , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 pain medication (e.g. , DRUG0 ) , drugs used to aid sleep , drowsiness-causing DRUG0 (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	anti-anxiety drugs	guanadrel
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	protease inhibitors	zonisamide
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	pertechnetate	mitotane
other	 Interactions may also occur with the following : DRUG0 / DRUG0 , drugs used to treat an overactive thyroid , DRUG0 (e.g. , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 pain medication (e.g. , <e2> DRUG2 </e2> ) , drugs used to aid sleep , drowsiness-causing DRUG0 (e.g. , DRUG0 ) , any other drugs that may make you drowsy . 	cabergoline	codeine
mechanism	 Drugs that cause significant sustained elevation in gastric pH ( DRUG0 such as DRUG0 or <e1> DRUG1 </e1> ) may reduce plasma concentrations of <e2> DRUG2 </e2> and therefore potentially may reduce efficacy . 	cimetidine	IRESSA
other	 Other concomitant therapy Although specific interaction studies were not performed , DRUG0 doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	analgesics	HMG-CoA reductase inhibitors
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	diazoxide
other	 Patients receiving other DRUG0 , DRUG0 , DRUG0 , or other DRUG0 (including DRUG0 ) concomitantly with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> tablets may exhibit an additive CNS depression . 	hydrocodone	acetaminophen
other	 Potential drug interactions between DRUG0 and other DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) were also assessed by evaluating the serum concentrations of DRUG0 and these DRUG0 during placebo-controlled clinical studies . 	phenobarbital	valproate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	mirtazapine	tramadol
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	methadone	contraceptives
other	 Use with <e1> DRUG1 </e1> : The use of DRUG0 to control hypertension in patients on <e2> DRUG2 </e2> has been reported to induce severe leukopenia . 	Angiotensln Converting Enzyme Inhibitors	azathioprine
other	 <e1> DRUG1 </e1> and DRUG0 (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving DRUG0 25 to 50 mg also received DRUG0 or <e2> DRUG2 </e2> ( DRUG0 / DRUG0 ) . 	ACE Inhibitors	angiotensin II receptor antagonists
effect	 DRUG0 : Concurrent administration of <e1> DRUG1 </e1> (an DRUG0 ) and another <e2> DRUG2 </e2> has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone . 	anakinra	TNF-blocking agent
other	 Drugs That Should Not Be Coadministered With DRUG0 DRUG0 : DRUG0 , DRUG0 DRUG0 : DRUG0 , <e1> DRUG1 </e1> Antimigraine : DRUG0 DRUG0 : DRUG0 DRUG0 <e2> DRUG2 </e2> , DRUG0 GI motility agents : DRUG0 	terfenadine	midazolam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	pyrazolones	tolbutamide
advise	 Consequently , <e1> DRUG1 </e1> should be avoided in patients receiving DRUG0 and <e2> DRUG2 </e2> , which are very potent inhibitors of CYP3A . 	estazolam	itraconazole
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Nizoral	protease inhibitors
other	 In patients taking <e1> DRUG1 </e1> and DRUG0 concomitantly , <e2> DRUG2 </e2> toxicity may develop . 	diclofenac	lithium
other	 The effect of <e1> DRUG1 </e1> on <e2> DRUG2 </e2> was not evaluated . 	gabapentin	cimetidine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxyphenbutazone	sulindac
effect	 DRUG0 ( DRUG0 ) : DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with <e2> DRUG2 </e2> . 	sertraline	5-HT1 agonists
other	 Pharmacoeconomic analyses indicate that <e1> DRUG1 </e1> does not significantly increase , and may even decrease , the overall direct treatment costs of schizophrenia , compared with <e2> DRUG2 </e2> . 	olanzapine	haloperidol
effect	 Injection : <e1> DRUG1 </e1> injection , like other injectable DRUG0 , produces depression of the central nervous system when administered with DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and other DRUG0 .When DRUG0 is used concomitantly with injectable DRUG0 , an increased incidence of sedation , hallucinations , and irrational behavior has been observed . 	Lorazepam	MAO inhibitors
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	fluphenazine	promethazine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , <e1> DRUG1 </e1> , iodinated cholestographic agents , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	insulin	iodine-containing compounds
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Topamax	Prelone
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> DRUG1 </e1> doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	finasteride	analgesics
mechanism	 DRUG0 : In normal volunteers , a small decrease in DRUG0 levels was observed when multiple doses of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> were administered concomitantly . 	diflunisal	aspirin
other	 DRUG0 / <e1> DRUG1 </e1> / DRUG0 / DRUG0 : Co-administration of DRUG0 with DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> is likely to lead to an enhancement of effects . 	Sedatives	opioids
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : <e1> DRUG1 </e1> and related DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 . 	androgens	phenytoin
other	 Multivalent Cation-Containing Products : Concurrent administration of a DRUG0 , including DRUG0 , with multivalent cation-containing products such as DRUG0 or DRUG0 DRUG0 , <e1> DRUG1 </e1> , DRUG0 chewable/buffered tablets or pediatric powder , or products containing DRUG0 , <e2> DRUG2 </e2> , or DRUG0 may substantially decrease the absorption of DRUG0 , resulting in serum and urine levels considerably lower than desired . 	sucralfate	iron
other	 Therefore , administration of DRUG0 with <e1> DRUG1 </e1> containing <e2> DRUG2 </e2> , DRUG0 , or DRUG0 ; 	antacids	calcium
effect	 Drugs that have been reported to diminish oral <e1> DRUG1 </e1> response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	anticoagulant	alcohol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> overdosage . 	bromelains	warfarin sodium
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as <e1> DRUG1 </e1> , DRUG0 , DRUG0 (acidic) or DRUG0 (basic) , as well as DRUG0 DRUG0 , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and <e2> DRUG2 </e2> , and DRUG0 . 	phenylbutazone	progestins
other	 <e1> DRUG1 </e1> and <e2> DRUG2 </e2> did not change fasting or overload glycemia . 	Imipramine	clonazepam
other	 Therapeutic concentrations of <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 andtolbutamide did not alter <e2> DRUG2 </e2> protein binding . 	digoxin	ketorolac tromethamine
effect	 DRUG0 (eg , DRUG0 ) and other drugs , including ether , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with <e2> DRUG2 </e2> Parenteral . 	gallamine	Coly-Mycin M
other	 - <e1> DRUG1 </e1> (e.g. , DRUG0 ) Use of DRUG0 with <e2> DRUG2 </e2> may increase the chance of side effects affecting the liver and/or the blood 	Methyldopa	sulfapyridine
other	 DRUG0 , <e1> DRUG1 </e1> : In normal volunteers (n=9) , pretreatment with DRUG0 or DRUG0 did not affect DRUG0 pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of <e2> DRUG2 </e2> resulted with DRUG0 . 	Ranitidine	flurbiprofen
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	amiodarone	levodopa
mechanism	 Administration of <e1> DRUG1 </e1> with other CYP3A4 inhibitors (e.g. , <e2> DRUG2 </e2> 500 mg BID , DRUG0 240 mg QD , DRUG0 1200 mg TID , DRUG0 200 mg QD) resulted in increases in Cmax of DRUG0 ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold . 	eplerenone	erythromycin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 (5) , DRUG0 , and DRUG0 . 	bupropion	valproate
other	 DRUG0 : Coadministration of DRUG0 with <e1> DRUG1 </e1> resulted in an 83% increase in DRUG0 plasma AUC and a 51% increase in <e2> DRUG2 </e2> plasma A.C . 	VIRACEPT	indinavir
other	 <e1> DRUG1 </e1> antagonize the effects of <e2> DRUG2 </e2> . 	Anticholinergics	antiglaucoma agents
mechanism	 DRUG0 : <e1> DRUG1 </e1> may induce the metabolism of <e2> DRUG2 </e2> causing menstrual changes; 	Griseofulvin	combination hormonal contraceptives
effect	 This could lead to decreased DRUG0 serum levels or increase the risk of <e1> DRUG1 </e1> toxicity when <e2> DRUG2 </e2> is withdrawn . 	salicylate	corticosteroid
other	 <e1> DRUG1 </e1> : Because <e2> DRUG2 </e2> does not affect the pharmacokinetics of DRUG0 , interactions with other DRUG0 metabolized via the same cytochrome isozymes are not expected . 	Antipyrine	atorvastatin
other	 <e1> DRUG1 </e1> ( DRUG0 ) (e.g. , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with DRUG0 . 	Selective serotonin reuptake inhibitors	fluoxetine
mechanism	 Oral doses of <e1> DRUG1 </e1> (10-20 mg/kg) , via alcohol dehydrogenase inhibition , significantly reduced the rate of elimination of <e2> DRUG2 </e2> (by approximately 40%) given to healthy volunteers in moderate doses . 	Antizol	ethanol
effect	 - The action of DRUG0 and <e1> DRUG1 </e1> may be enhanced by <e2> DRUG2 </e2> or DRUG0 . 	insulin	Bezalip
mechanism	 Coadministration with <e1> DRUG1 </e1> increased exposure of <e2> DRUG2 </e2> (AUC) by 46% . 	valdecoxib	omeprazole
other	 <e1> DRUG1 </e1> : Coadministration of DRUG0 with <e2> DRUG2 </e2> resulted in a 152% increase in DRUG0 plasma AUC and very little change in DRUG0 plasma A.C . 	Ritonavir	VIRACEPT
other	 DRUG0 such as DRUG0 (e.g. , <e1> DRUG1 </e1> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , and DRUG0 (e.g. , DRUG0 ) : Using these medicines with DRUG0 may increase the chance of side effects . 	Marplan	Eldepryl
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) , DRUG0 salts , DRUG0 , local <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	bacitracin	anesthetics
effect	 DRUG0 / DRUG0 / DRUG0 / DRUG0 : Co-administration of <e1> DRUG1 </e1> with DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> is likely to lead to an enhancement of effects . 	PRECEDEX	opioids
other	 No interaction was noted with the DRUG0 DRUG0 in two multiple-dose interaction studies when <e1> DRUG1 </e1> was coadministered with a DRUG0 / <e2> DRUG2 </e2> (n=29) . 	entacapone	dopa decarboxylase inhibitor
effect	 A rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of <e1> DRUG1 </e1> ( DRUG0 ) and agents for migraine therapy , such as DRUG0 ( DRUG0 ) and <e2> DRUG2 </e2> . 	selective serotonin reuptake inhibitors	dihydroergotamine
other	 When DRUG0 is co-administered with inducers of drug clearance , such as DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , or DRUG0 , use of a daily dose of 70 mg of <e2> DRUG2 </e2> should be considered 	dexamethasone	CANCIDAS
other	 Based on adult data , lower doses of DRUG0 may be needed following coadministration of drugs which are reported to decrease DRUG0 elimination (e.g. , <e1> DRUG1 </e1> and DRUG0 ) and higher DRUG0 doses may be needed following coadministration of drugs that increase DRUG0 elimination (e.g. , <e2> DRUG2 </e2> and DRUG0 ) . 	cimetidine	phenobarbital
other	 May interact with the following : DRUG0 (these medicines may make your condition worse and prevent the <e1> DRUG1 </e1> from working properly) and DRUG0 , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 (these medicines may increase the risk of heart problems) . 	adrenergic bronchodilators	quinidine
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	glucocorticoids	praziquantel
mechanism	 DRUG0 : In a study of healthy volunteers , <e1> DRUG1 </e1> significantly reduced the bioavailability of <e2> DRUG2 </e2> . 	chloroquine	ampicillin
other	 DRUG0 : In a clinical pharmacology study , coadministration of an DRUG0 ( DRUG0 , DRUG0 , and DRUG0 ) with DRUG0 reduced serum levels and urinary excretion of <e1> DRUG1 </e1> as compared with <e2> DRUG2 </e2> administered alone , suggesting that DRUG0 may impair absorption of DRUG0 . 	fosinoprilat	fosinopril
effect	 DRUG0 ( <e1> DRUG1 </e1> ) and <e2> DRUG2 </e2> may interfere with the effect of each other when administered concurrently . 	beta-blockers	BROVANA
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	haloperidol	metoprolol
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> DRUG1 </e1> : DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	ORENCIA	NSAIDs
other	 Oral <e1> DRUG1 </e1> : DRUG0 (40 mg BID) did not induce the metabolism of the combination oral DRUG0 <e2> DRUG2 </e2> / DRUG0 (1 mg /35 mcg combination , DRUG0 1/35 ) . 	Contraceptives	norethindrone
other	 Concurrent administration of drugs possessing nephrotoxic (e.g. , DRUG0 , DRUG0 ) , myelotoxic (e.g. , <e1> DRUG1 </e1> chemotherapy) , cardiotoxic (e.g. , <e2> DRUG2 </e2> ) or hepatotoxic (e.g. , DRUG0 , DRUG0 ) effects with DRUG0 may increase toxicity in these organ systems . 	cytotoxic	doxorubicin
other	 Patients who begin taking <e1> DRUG1 </e1> or who increase their DRUG0 dose or any other <e2> DRUG2 </e2> while taking DRUG0 , DRUG0 , or DRUG0 may develop toxicity characteristics for these drugs . 	diclofenac	NSAID
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , <e1> DRUG1 </e1> , others) , DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	Nuprin	Oruvail
other	 [A pharmacological analysis of the effect of DRUG0 on stimulated gastric secretion] Chronic experiments on dogs with gastric fistulas were carried out to study the influence of DRUG0 and DRUG0 on <e1> DRUG1 </e1> - and <e2> DRUG2 </e2> -induced gastric acid secretion . 	pentagastrin	histamine
other	 - <e1> DRUG1 </e1> : Interaction studies in humans have shown <e2> DRUG2 </e2> to have no effect on DRUG0 metabolism or on plasma prothrombin activity . 	Anticoagulants	bumetanide
other	 In several well-controlled studies , <e1> DRUG1 </e1> was administered together with <e2> DRUG2 </e2> with no drug interactions reported . 	guanfacine	diuretics
other	 DRUG0 : Other DRUG0 drugs , such as DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 , have been used concurrently with <e2> DRUG2 </e2> . 	disopyramide	amiodarone
other	 Interactions for DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 ) : DRUG0 : <e2> DRUG2 </e2> has been reported to reduce intestinal absorption of DRUG0 ; 	Vitamin D3	Cholestyramine
other	 However , administration of <e1> DRUG1 </e1> (90 mg kg(-1) body weight) to rats 2 hours prior to DRUG0 (100 mg kg(-1) body weight) was ineffective in preventing <e2> DRUG2 </e2> synthesis and did not diminish fluoride or citrate accumulation in vivo . 	4-methylpyrazole	(-)-erythro-fluorocitrate
other	 Concomitant administration of DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or an <e2> DRUG2 </e2> / DRUG0 oral DRUG0 produced minor changes in the pharmacokinetics of DRUG0 , which were considered to be without clinical significance . 	calcium carbonate	estrogen
mechanism	 In healthy subjects receiving <e1> DRUG1 </e1> (1 gm daily) for one week , plasma <e2> DRUG2 </e2> levels increased by about 30% and half-life increased by about 10% . 	cimetidine	flecainide
other	 DRUG0 may interact with DRUG0 , DRUG0 s , <e1> DRUG1 </e1> (allergy , cold , and sinus medicines) , diabetic drugs , DRUG0 , DRUG0 , DRUG0 like <e2> DRUG2 </e2> or DRUG0 , and high blood pressure medications . 	decongestant drugs	Aleve
mechanism	 DRUG0 : <e1> DRUG1 </e1> is known to interact with the metabolism or renal tubular excretion of many drugs (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 agents , DRUG0 , and DRUG0 ) . 	Probenecid	clofibrate
other	 DRUG0 , DRUG0 , and <e1> DRUG1 </e1> : Drugs such as <e2> DRUG2 </e2> , DRUG0 , and DRUG0 may increase the risk of developing peripheral neuropathy or other DRUG0 -associated adverse events by interfering with the renal clearance of DRUG0 (thereby raising systemic exposure) . 	Aminoglycosides	amphotericin
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , <e2> DRUG2 </e2> , and DRUG0 . 	bupropion	ziprasidone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anabolic steroids	clofibrate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (5) , DRUG0 , and DRUG0 . 	cyclosporin	warfarin
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Thorazine	thioridazine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e2> DRUG2 </e2> , DRUG0 . 	delavirdine	verapamil
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	doxycycline	protease inhibitors
other	 <e1> DRUG1 </e1> : Since DRUG0 is a DRUG0 , it is possible that DRUG0 , such as the <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 ) or DRUG0 , may diminish the effectiveness of DRUG0 . 	Dopamine Antagonists	neuroleptics
other	 Drug Interactions : <e1> DRUG1 </e1> may interact with some drugs , like DRUG0 ( DRUG0 ) : DRUG0 could theoretically affect DRUG0 pharmacodynamics - DRUG0 - Eproxindine - DRUG0 : DRUG0 and DRUG0 cause additive CNS depression - DRUG0 : DRUG0 increases the effect of <e2> DRUG2 </e2> 	Flupenthixol	Tricyclic antidepressants
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	carbamazepine	iodine-containing compounds
mechanism	 Multivalent Cation-Containing Products : Concurrent administration of a <e1> DRUG1 </e1> , including DRUG0 , with multivalent cation-containing products such as DRUG0 or DRUG0 DRUG0 , DRUG0 , <e2> DRUG2 </e2> chewable/buffered tablets or pediatric powder , or products containing DRUG0 , DRUG0 , or DRUG0 may substantially decrease the absorption of DRUG0 , resulting in serum and urine levels considerably lower than desired . 	quinolone	VIDEX
other	 <e1> DRUG1 </e1> (CNS) drugs including DRUG0 , DRUG0 , DRUG0 , DRUG0 , blood pressure medications ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , motion sickness medications , DRUG0 , DRUG0 , DRUG0 , sleeping pills and DRUG0 	Central nervous system depressant	methyldopa
other	 In vitro data suggest that <e1> DRUG1 </e1> , when compared to <e2> DRUG2 </e2> , has a less pronounced effect on the biotransformation system responsible for the metabolism of DRUG0 . 	itraconazole	ketoconazole
mechanism	 Acid-catalyzed ethanolysis of <e1> DRUG1 </e1> in anhydrous and aqueous <e2> DRUG2 </e2> solutions . 	temazepam	ethanol
other	 In separate single or multiple dose pharmacokinetic interaction studies with DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> , the bioavailability of DRUG0 was not altered by coadministration of DRUG0 with any one of these drugs . 	propanolol	warfarin
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , DRUG0 , DRUG0 , DRUG0 , and DRUG0 with DRUG0 plus DRUG0 ) without receiving DRUG0 therapy . 	vincristine	prednisone
effect	 The hypoglycemic effect of <e1> DRUG1 </e1> has been reported to increase when <e2> DRUG2 </e2> is given concurrently . 	tolbutamide	Atromid-S
other	 Drug Interactions : DRUG0 may interact with some drugs , like <e1> DRUG1 </e1> ( DRUG0 ) : <e2> DRUG2 </e2> could theoretically affect DRUG0 pharmacodynamics - DRUG0 - Eproxindine - DRUG0 : DRUG0 and DRUG0 cause additive CNS depression - DRUG0 : DRUG0 increases the effect of DRUG0 	Monoamine oxidase inhibitors	MAOI
other	 These drugs include the DRUG0 and other DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	phenothiazines	calcium channel blocking drugs
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> ) , DRUG0 salts , DRUG0 , local DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	sodium colistimethate	procainamide
other	 - DRUG0 and <e1> DRUG1 </e1> DRUG0 : <e2> DRUG2 </e2> and DRUG0 DRUG0 have the potential of binding DRUG0 and reducing DRUG0 absorption from the gastrointestinal tract 	colestipol	Cholestytamine
other	 DRUG0 and <e1> DRUG1 </e1> Administration of DRUG0 or <e2> DRUG2 </e2> in patients (n=13) and volunteers (n=96) resulted in a rapid and significant decrease in plasma M1 (the active metabolite of DRUG0 ) concentration . 	Charcoal	activated charcoal
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextran	phenyramidol
other	 In addition , <e1> DRUG1 </e1> and DRUG0 induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of <e2> DRUG2 </e2> and oral DRUG0 , resulting in a lower plasma concentration of these drugs . 	oxcarbazepine	dihydropyridine calcium antagonists
other	 Drug/Laboratory Test Interferences : DRUG0 and <e1> DRUG1 </e1> , including <e2> DRUG2 </e2> , or their metabolites may color alkaline urine red-orange , which may interfere with spectrophotometrically determined urinary laboratory tests . 	indanedione anticoagulants	anisindione
other	 - a DRUG0 ( <e1> DRUG1 </e1> ) such as DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	NSAID	Motrin
effect	 DRUG0 : Enhanced bone marrow suppression by <e1> DRUG1 </e1> and other DRUG0 has been reported among patients with neoplastic disease , except leukemia , in the presence of <e2> DRUG2 </e2> . 	cyclophosphamide	allopurinol
other	 DRUG0 : <e1> DRUG1 </e1> (800 mg t.i.d.) co-administered with DRUG0 10 mg resulted in a 16-fold increase in DRUG0 AUC , a 7-fold increase in DRUG0 Cmax and a 2-fold increase in <e2> DRUG2 </e2> half-life . 	Indinavir	vardenafil
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ethacrynic acid	influenza virus vaccine
other	 These drugs include the DRUG0 and other <e1> DRUG1 </e1> , DRUG0 , phe-nothiazines , DRUG0 , DRUG0 , oral DRUG0 , DRUG0 , DRUG0 , sympathomimet-ics , DRUG0 , and <e2> DRUG2 </e2> . 	diuretics	isoniazid
mechanism	 The concomitant use of other CYP3A4 inhibitors such as DRUG0 and <e1> DRUG1 </e1> with transdermal <e2> DRUG2 </e2> may also result in an increase in DRUG0 plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression . 	erythromycin	fentanyl
other	 No depressant effect on blood levels in humans was noted when <e1> DRUG1 </e1> was administered with any of the following drugs : DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 , DRUG0 or DRUG0 . 	colestipol hydrochloride	clindamycin
effect	 <e1> DRUG1 </e1> can reduce the antihypertensive effects of <e2> DRUG2 </e2> and DRUG0 . 	INDOCIN	captopril
other	 These drugs include the DRUG0 and other DRUG0 , DRUG0 , <e1> DRUG1 </e1> , thyroid products , <e2> DRUG2 </e2> , oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	phenothiazines	estrogens
other	 Nephrotoxic agents : Concomitant administration of DRUG0 and agents with nephrotoxic potential [e.g. , intravenous <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , and DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 , intravenous DRUG0 , DRUG0 , and DRUG0 ] is contraindicated . 	aminoglycosides	amphotericin B
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or DRUG0 (basic) , as well as DRUG0 DRUG0 , <e1> DRUG1 </e1> , thyroid and <e2> DRUG2 </e2> preparations , DRUG0 and DRUG0 , and DRUG0 . 	phenobarbital	thyroxine
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (1) , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	azole antifungals	danazol
other	 Some <e1> DRUG1 </e1> /substances are known to accelerate the metabolism of <e2> DRUG2 </e2> by stimulating the synthesis of DRUG0 (enzyme induction) . 	drugs	amiodarone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	indomethacin	prolonged narcotics
mechanism	 <e1> DRUG1 </e1> : Decreases <e2> DRUG2 </e2> effectiveness by enzyme induction . 	Phenobarbital	aspirin
effect	 DRUG0 (e.g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) and DRUG0 may reduce the therapeutic effects of <e2> DRUG2 </e2> . 	risperidone	levodopa
other	 <e1> DRUG1 </e1> , at pH 7.0 , was used to chemically modify exposed histidine residues on <e2> DRUG2 </e2> . 	Diethyl pyrocarbonate	toxin A
other	 Although there are no study data to evaluate the possibility , <e1> DRUG1 </e1> , including DRUG0 and <e2> DRUG2 </e2> , may have an additive effect with DRUG0 on the risk of developing methemoglobinemia . 	nitric oxide donor compounds	nitroglycerin
other	 DRUG0 may decrease thyroidal uptake of <e1> DRUG1 </e1> , a rebound in uptake may occur up to 5 days after sudden withdrawal of <e2> DRUG2 </e2> . 	sodium iodide I131	Carbimazole
other	 In vitro studies evaluating the minimum inhibitory concentration (MIC) of <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 /flucoxacillin , DRUG0 , DRUG0 , and DRUG0 demonstrated no evidence of incompatibility of these <e2> DRUG2 </e2> with DRUG0 . 	vancomycin	antibiotics
other	 Effect of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> on the antinociceptive effect of DRUG0 , DRUG0 and DRUG0 in mice . 	diazepam	midazolam
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ); 	Orudis	Aleve
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Gris-PEG	Viracept
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxolinic acid	triclofos sodium
effect	 DRUG0 / NUTRITION / HERB INTERACTIONS : Food : CNS effects of DRUG0 may be enhanced if <e1> DRUG1 </e1> are used concurrently with <e2> DRUG2 </e2> . 	combination hormonal contraceptives	caffeine
other	 <e1> DRUG1 </e1> , DRUG0 : e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 	Calcium Channel Blockers	nifedipine
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , <e2> DRUG2 </e2> (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	lamotrigine	Phenytoin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	metronidazole	pentoxifylline
other	 <e1> DRUG1 </e1> and <e2> DRUG2 </e2> - DRUG0 may decrease hepatic toxicity in those with DRUG0 overdosage or in those taking DRUG0 . 	Acetaminophen	methotrexate
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	levothyroxine	zonisamide
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	buspirone	theophylline
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (5) , DRUG0 , and DRUG0 . 	amitriptyline	warfarin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ranitidine	tolbutamide
other	 During clinical trials , <e1> DRUG1 </e1> was used concurrently with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and other medications . 	iloprost	antipyretics
effect	 <e1> DRUG1 </e1> may potentiate the effects of <e2> DRUG2 </e2> . 	Imipramine hydrochloride	CNS depressant drugs
effect	 Some reports have shown that the concomitant administration of <e1> DRUG1 </e1> with <e2> DRUG2 </e2> causes hypercalcemia . 	thiazides	vitamin D
other	 DRUG0 and <e1> DRUG1 </e1> (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving <e2> DRUG2 </e2> 25 to 50 mg also received DRUG0 or DRUG0 ( DRUG0 / DRUG0 ) . 	Angiotensin II Receptor Antagonists	INSPRA
other	 Other concomitant therapy Although specific interaction studies were not performed , DRUG0 doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	benzodiazepines	prostaglandin synthetase inhibitors
other	 The fraction of <e1> DRUG1 </e1> absorbed is unaffected by the concomitant administration of a <e2> DRUG2 </e2> ( DRUG0 ) , but the rate of absorption is decreased . 	STADOL NS	nasal vasoconstrictor
other	 Concurrent use of DRUG0 with DRUG0 (e.g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> ) may result in increased DRUG0 effects . 	tranquilizers	antihistamines
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	corticosteroids	isoniazid
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> overdosage . 	sulfinpyrazone	warfarin sodium
other	 DRUG0 , Including Oral , Injectable , Transdermal , and Implantable DRUG0 : An interaction study demonstrated that co-administration of DRUG0 and the oral DRUG0 DRUG0 produced average decreases of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> levels of 14% and 31% , respectively . 	norethindrone	ethinyl estradiol
other	 Oral DRUG0 inhibits the gastrointestinal absorption of <e1> DRUG1 </e1> , oral DRUG0 , DRUG0 and <e2> DRUG2 </e2> . 	penicillin V	5-fluorouracil
other	 The absorption of <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> was significantly decreased when given simultaneously with DRUG0 ; 	tetracycline	gemfibrozil
other	 Coingestion of DRUG0 with <e1> DRUG1 </e1> , DRUG0 with DRUG0 , and <e2> DRUG2 </e2> with DRUG0 at high to toxic concentrations decreases the binding of the target drug . 	theophylline	valproic acid
other	 When coadministered with <e1> DRUG1 </e1> in treatment-naive patients , the recommended dose of <e2> DRUG2 </e2> is 300 mg with DRUG0 100 mg and DRUG0 600 mg (all once daily) . 	SUSTIVA	atazanavir
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of DRUG0 : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	diuretics	terbutaline
other	 The objective of this study was to determine if there is a pharmacokinetic interaction when <e1> DRUG1 </e1> is given with <e2> DRUG2 </e2> or DRUG0 and to determine the effects of these drugs on the erythromycin breath test (ERMBT) . 	amprenavir	rifabutin
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	fluphenazine	Compazine
other	 Oral DRUG0 DRUG0 did not have any clinically important effect on the pharmacokinetics of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	ethinyl estradiol	norethindrone
other	 Concomitant administration of DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or an <e2> DRUG2 </e2> / DRUG0 oral DRUG0 produced minor changes in the pharmacokinetics of DRUG0 , which were considered to be without clinical significance . 	calcium carbonate	estrogen
other	 Products containing <e1> DRUG1 </e1> and other multivalent cations (such as <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) are likely to interfere with absorption of DRUG0 . 	calcium	aluminum
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , <e2> DRUG2 </e2> , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	thiocyanate	insulin
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> DRUG1 </e1> are the following : DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	EQUETROTM	clarithromycin
advise	 The concomitant use of <e1> DRUG1 </e1> or DRUG0 with <e2> DRUG2 </e2> is not recommended . 	H2 blockers	SPRYCEL
other	 Diminished urinary excretion of <e1> DRUG1 </e1> has been reported during the concomitant administration of <e2> DRUG2 </e2> and DRUG0 . 	norfloxacin	probenecid
other	 DRUG0 : The concomitant use of DRUG0 ( DRUG0 transdermal system) with other DRUG0 , including but not limited to other DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (e.g. , DRUG0 ) , general DRUG0 , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death . 	hypnotics	phenothiazines
effect	 DRUG0 at 10(-10) M or <e1> DRUG1 </e1> at about 3 X 10(-9) M inhibits proliferation stimulated by <e2> DRUG2 </e2> . 	retinyl acetate	EGF
other	 DRUG0 may interact with <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	antidepressants	somatropin
other	 Avoid the use of preparations such as DRUG0 and local <e1> DRUG1 </e1> which contain any DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> ) , since it has been reported that DRUG0 can potentiate the effects of catecholamines . 	anesthetics	norepinephrine
other	 When used in therapeutic doses , DRUG0 had a modest effect on the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 (intravenous and oral) , DRUG0 , DRUG0 / DRUG0 or <e2> DRUG2 </e2> . 	midazolam	zidovudine
other	 The pharmacokinetics of <e1> DRUG1 </e1> and its major metabolite DRUG0 were unaffected following co-administration with <e2> DRUG2 </e2> . 	naltrexone	Acamprosate
effect	 Other <e1> DRUG1 </e1> that inhibit prostaglandin synthesis have been shown to interfere with <e2> DRUG2 </e2> in some studies and with DRUG0 . 	nonsteroidal anti-inflammatory drugs	thiazide diuretics
other	 Although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic DRUG0 , including <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> , the effect of DRUG0 gel on the steady-state concentrations of these drugs is not known . 	protease inhibitors	azole antifungals
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	aminoglutethimide	nitroprusside
other	 Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving DRUG0 metabolized similarly to DRUG0 or on the basis of in vitro studies with <e1> DRUG1 </e1> or other DRUG0 (caution is recommended during coadministration with DRUG0 ) : Available data from clinical studies of DRUG0 other than DRUG0 suggest a possible drug interaction with DRUG0 for the following : DRUG0 , DRUG0 , <e2> DRUG2 </e2> such as DRUG0 and DRUG0 , and grapefruit juice . 	alprazolam	macrolide antibiotics
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute <e1> DRUG1 </e1> intake , DRUG0 , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 	alcohol	tolbutamide
effect	 The action of the <e1> DRUG1 </e1> may be potentiated by DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , or other drugs that produce CNS depression . 	benzodiazepines	monoamine oxidase inhibitors
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> may delay intestinal absorption of DRUG0 . 	Ethosuximide	Amphetamines
effect	 <e1> DRUG1 </e1> may decrease the effectiveness of oral DRUG0 , certain DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 . 	Barbiturates	theophylline
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ); 	indomethacin	Aleve
other	 DRUG0 (e . g . DRUG0 and DRUG0 ) : Agents of the DRUG0 , of which DRUG0 ( <e1> DRUG1 </e1> ) Injection , USP is a member , have been shown to interact with <e2> DRUG2 </e2> of the DRUG0 , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction . 	dihydroergotamine mesylate	antibiotics
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	citalopram	tiagabine
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 ); 	Orudis	naproxen
other	 No dose adjustment is necessary when DRUG0 is added to triple-immunosuppression regimens including <e1> DRUG1 </e1> , DRUG0 , and either DRUG0 or <e2> DRUG2 </e2> . 	cyclosporine	mycophenolate mofetil
effect	 DRUG0 : <e1> DRUG1 </e1> may potentiate the toxic effects of <e2> DRUG2 </e2> . 	Thyroid preparations	digitalis
other	 Coadministration of single , oral doses of DRUG0 with <e1> DRUG1 </e1> (10 mg and 800 mg , respectively) , a strong , selective CYP3A4 inhibitor produced a 34% increase in <e2> DRUG2 </e2> s maximal plasma concentrations and a 20% increase in the area under the plasma concentration-time curve . 	erythromycin	zaleplon
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	p-aminosalicylic acid	iodine-containing compounds
mechanism	 The AUC of DRUG0 was decreased an average of 15-fold in 12 healthy subjects given <e1> DRUG1 </e1> and <e2> DRUG2 </e2> -placebo tablets concurrently . 	ciprofloxacin	didanosine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Nizoral	morphine
other	 Therapeutic concentrations of DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 andtolbutamide did not alter <e2> DRUG2 </e2> protein binding . 	ibuprofen	ketorolac tromethamine
other	 Potential drug interactions between <e1> DRUG1 </e1> and other DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and DRUG0 ) were also assessed by evaluating the serum concentrations of DRUG0 and these DRUG0 during placebo-controlled clinical studies . 	Keppra	phenobarbital
other	 The purpose of this study was to evaluate the effect of DRUG0 ( <e1> DRUG1 </e1> ) and DRUG0 ( DRUG0 ) conjugates on the intestinal permeation of DRUG0 ( DRUG0 ) and model peptide drugs , <e2> DRUG2 </e2> and DRUG0 . 	NaCMC	bacitracin
other	 Oral <e1> DRUG1 </e1> : <e2> DRUG2 </e2> (40 mg BID) did not induce the metabolism of the combination oral DRUG0 DRUG0 / DRUG0 (1 mg /35 mcg combination , DRUG0 1/35 ) . 	Contraceptives	Valdecoxib
other	 <e1> DRUG1 </e1> plasma and urine sampling were conducted on Days 1 , 7 , and 21 for <e2> DRUG2 </e2> and on Days 7 and 21 for DRUG0 . 	Antiretroviral	zidovudine
effect	 <e1> DRUG1 </e1> may decrease the effect of DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	Clidinium	levodopa
effect	 There is thus an enhancement effect of <e1> DRUG1 </e1> upon the reaction of placental vessels to <e2> DRUG2 </e2> in vitro . 	PGF2alpha	oxytocin
other	 - a DRUG0 ( <e1> DRUG1 </e1> ) such as <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	MAOI	isocarboxazid
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	androgens	pertechnetate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	prolonged narcotics	pyrazolones
other	 <e1> DRUG1 </e1> : When DRUG0 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of <e2> DRUG2 </e2> , significant hypotension developed in a substantial number of subjects . 	Alpha-blockers	terazosin
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	chloral hydrate	6-mercaptopurine
other	 However , neither <e1> DRUG1 </e1> nor DRUG0 appears to affect <e2> DRUG2 </e2> metabolism . 	phenobarbital	Dantrium
other	 Some <e1> DRUG1 </e1> /substances are known to accelerate the metabolism of DRUG0 by stimulating the synthesis of <e2> DRUG2 </e2> (enzyme induction) . 	drugs	CYP3A4
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	indomethacin	influenza virus vaccine
other	 Drugs which may enhance the neuromuscular blocking action of DRUG0 include : DRUG0 ; DRUG0 ; DRUG0 ;certain DRUG0 , especially the <e1> DRUG1 </e1> and DRUG0 ; DRUG0 ; DRUG0 salts; DRUG0 ;and <e2> DRUG2 </e2> . 	aminoglycosides	quinidine
other	 DRUG0 : Combination DRUG0 may decrease the clearance of some DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) and increase the clearance of others ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) . 	chlordiazepoxide	oxazepam
other	 This drug may interact with DRUG0 or other DRUG0 (may potentiate the CNS depressant effects of either these medications or DRUG0 ) , DRUG0 or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with DRUG0 ) , and <e1> DRUG1 </e1> (concurrent use with DRUG0 may prolong and intensify the anticholinergic and CNS depressant effects of <e2> DRUG2 </e2> ) . 	monoamine oxidase (MAO) inhibitors	antihistamines
other	 Renal function should be monitored carefully if high doses of <e1> DRUG1 </e1> are to be administered with DRUG0 because of the increased potential of nephrotoxicity and ototoxicity of <e2> DRUG2 </e2> . 	aminoglycosides	aminoglycoside antibiotics
other	 Other concomitant therapy Although specific interaction studies were not performed , <e1> DRUG1 </e1> doses of 1 mg or more were concomitantly used in clinical studies with DRUG0 , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	finasteride	benzodiazepines
other	 It may also interact with <e1> DRUG1 </e1> or other DRUG0 or <e2> DRUG2 </e2> , which may intensify the anticholinergic action . 	amantadine	MAOIs
other	 Drug-Drug Interactions Between <e1> DRUG1 </e1> And Other DRUG0 ( <e2> DRUG2 </e2> ) DRUG0 DRUG0 (3000 mg daily) had no effect on the pharmacokinetic disposition of DRUG0 in patients with refractory epilepsy . 	Keppra	AEDs
mechanism	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma <e1> DRUG1 </e1> concentrations include : acute <e2> DRUG2 </e2> intake , DRUG0 , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 	phenytoin	alcohol
other	 [Stimulation by DRUG0 --an analog of the octapeptide cholecystokinin--of <e1> DRUG1 </e1> binding after the long-term administration of DRUG0 ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of DRUG0 (0.25 mg/kg) and DRUG0 (0.25 mg/kg) resulted in the reduced interaction between DRUG0 and low affinity binding sites for <e2> DRUG2 </e2> in subcortical structures , whereas DRUG0 binding with high affinity binding sites for DRUG0 increased both in the frontal cortex and subcortical structures of the forebrain . 	3H-spiroperidol	apomorphine
other	 No significant drug interactions have been reported in studies of DRUG0 given with other drugs such as DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and oral DRUG0 in healthy volunteers , or given with <e2> DRUG2 </e2> to patients with heart failure (NYHA class II and III) . 	hydrochlorothiazide	enalapril
effect	 Clinically significant effects have been reported with the <e1> DRUG1 </e1> when used concomitantly with <e2> DRUG2 </e2> . 	tricyclic antidepressants	cimetidine
advise	 After stopping <e1> DRUG1 </e1> Tablets , at least 2 weeks should be allowed before starting a <e2> DRUG2 </e2> . 	Fluvoxamine	MAOI
other	 <e1> DRUG1 </e1> : A relationship of functional antagonism exists between <e2> DRUG2 </e2> , which promote calcium absorption , and DRUG0 , which inhibit calcium absorption . 	Corticosteroids	vitamin D analogues
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	glucagon	oxyphenbutazone
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all <e1> DRUG1 </e1> (eg , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , other DRUG0 , general DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 ) may result in additive central nervous system depressant effects . 	central nervous system depressants	sedatives
other	 If DRUG0 is given concomitantly with <e1> DRUG1 </e1> , the <e2> DRUG2 </e2> dose should be reduced (by approx . 50%) , because DRUG0 amplifies the therapeutic actions and side-effects of DRUG0 massively . 	opioids	opioid
mechanism	 Administration of <e1> DRUG1 </e1> with DRUG0 containing DRUG0 , DRUG0 , or DRUG0 , with DRUG0 , with metal cations such as DRUG0 , or with DRUG0 containing DRUG0 or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( <e2> DRUG2 </e2> ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	quinolones	didanosine
other	 - DRUG0 and <e1> DRUG1 </e1> DRUG0 : DRUG0 and DRUG0 <e2> DRUG2 </e2> have the potential of binding DRUG0 and reducing DRUG0 absorption from the gastrointestinal tract 	colestipol	resins
effect	 Patients taking <e1> DRUG1 </e1> concomitantly with <e2> DRUG2 </e2> more commonly reported both weight gain and weight loss , compared with patients taking either medication alone . 	Acamprosate	antidepressants
effect	 DRUG0 (e.g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> ) and DRUG0 may reduce the therapeutic effects of <e2> DRUG2 </e2> . 	risperidone	levodopa
other	 Oral <e1> DRUG1 </e1> Multiple doses of <e2> DRUG2 </e2> had no effect on the pharmacokinetics of DRUG0 , the estrogenic component in most oral DRUG0 . 	Contraceptives	cefditoren pivoxil
other	 DRUG0 - and/or DRUG0 -containing DRUG0 , products containing DRUG0 ( DRUG0 ) , DRUG0 containing <e1> DRUG1 </e1> or other metal cations , or <e2> DRUG2 </e2> ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	zinc	Videx
mechanism	 <e1> DRUG1 </e1> may antagonize the effects of the drugs that alter gastrointestinal motility , such as <e2> DRUG2 </e2> . 	Anticholinergic drugs	metoclopramide
other	 - DRUG0 ( DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ]) or 	Tindal	Vesprin
other	 Drug-Drug Interactions Given the primary CNS effects of DRUG0 , caution should be used when DRUG0 is taken in combination with other <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	centrally acting drugs	alcohol
other	 <e1> DRUG1 </e1> : DRUG0 -containing preparations (eg , <e2> DRUG2 </e2> ) may cause hypermagnesemia and should therefore not be taken during therapy with DRUG0 by patients on chronic renal dialysis . 	Magnesium	antacids
other	 Interactions with DRUG0 : DRUG0 (eg , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 ) should NOT be administered to a patient who has received or is receiving a course of therapy with a <e2> DRUG2 </e2> such as DRUG0 . 	butorphanol	pure agonist opioid analgesic
effect	 <e1> DRUG1 </e1> , DRUG0 and DRUG0 may enhance the effects of : other DRUG0 s , DRUG0 , general DRUG0 , DRUG0 such as DRUG0 , <e2> DRUG2 </e2> , or other DRUG0 , causing increased CNS depression . 	Butalbital	sedative-hypnotics
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as <e1> DRUG1 </e1> and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	ampicillin	cyclosporine
other	 <e1> DRUG1 </e1> - and/or DRUG0 -containing DRUG0 , products containing DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 containing DRUG0 or other metal cations , or DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	Magnesium	iron
other	 <e1> DRUG1 </e1> and DRUG0 (and possibly other <e2> DRUG2 </e2> ) and DRUG0 may increase DRUG0 absorption in patients who inactivate DRUG0 by bacterial metabolism in the lower intestine , so that DRUG0 intoxication may result . 	Erythromycin	macrolide antibiotics
other	 In vitro binding studies with human serum proteins indicate that <e1> DRUG1 </e1> binds differently than DRUG0 and does not interact with DRUG0 or <e2> DRUG2 </e2> . 	glipizide	dicumarol
other	 Although DRUG0 have been shown to reduce DRUG0 -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with DRUG0 may reduce the antitumor effectiveness of DRUG0 and thus should be avoided . 12 <e1> DRUG1 </e1> and other <e2> DRUG2 </e2> may potentiate the hypotension seen with DRUG0 . 	Beta-blockers	antihypertensives
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	alprazolam	tiagabine
other	 Antiacid , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , Indanavir , DRUG0 , DRUG0 , Phenobarbitol , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , Ritanovir , DRUG0 . 	Didanosine	Rifampin
other	 <e1> DRUG1 </e1> : Combination DRUG0 may decrease the clearance of some DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) . 	Benzodiazepines	oxazepam
effect	 Recovery of hoof twitch from 50% to 75% took 7.7 +/- 0.7 min for DRUG0 alone and 11.5 +/- 2.7 min for <e1> DRUG1 </e1> plus <e2> DRUG2 </e2> (P = 0.03) . 	atracurium	gentamycin
other	 Pharmacokinetic interaction studies with DRUG0 in adults were conducted with DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and <e2> DRUG2 </e2> . 	ketoconazole	azithromycin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	glucagon
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	aminosalicylic acid	chymotrypsin
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; <e2> DRUG2 </e2> under-dosage . 	contraceptives	warfarin sodium
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with DRUG0 : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	chloroquine	anakinra
other	 DRUG0 - and/or DRUG0 -containing <e1> DRUG1 </e1> , products containing DRUG0 ( DRUG0 ) , DRUG0 containing DRUG0 or other metal cations , or DRUG0 ( <e2> DRUG2 </e2> ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	antacids	didanosine
advise	 Patients on oral <e1> DRUG1 </e1> receiving <e2> DRUG2 </e2> treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their DRUG0 . 	antidiabetic agents	VELCADE
mechanism	 Pharmacokinetic data from these patients demonstrated a decrease in DRUG0 clearance of approximately 33% when <e1> DRUG1 </e1> was administered following <e2> DRUG2 </e2> . 	TAXOL	cisplatin
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , <e2> DRUG2 </e2> , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	dalfopristin	fluvoxamine
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isoenzyme , including other <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and DRUG0 (eg , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 ) , or that inhibit this enzyme (eg , DRUG0 ) , should be approached with caution . 	antidepressants	propafenone
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	carbamazepine	chloral hydrate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ethacrynic acid	miconazole
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> DRUG1 </e1> : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	ORENCIA	chloroquine
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and <e1> DRUG1 </e1> , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	tetracycline	Prelone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	quinidine
other	 Clinical studies with DRUG0 have identified potentially significant interactions with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	fluconazole	lithium
other	 It is structurally distinct from the other currently available DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> ) , leading to unique biopharmaceutical properties relative to the other agents of this class . 	simvastatin	pravastatin
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all DRUG0 (eg , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , other DRUG0 , general DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and <e2> DRUG2 </e2> ) may result in additive central nervous system depressant effects . 	alcohol	antihistamines
mechanism	 The interaction is a consequence of blocking hepatic metabolism of <e1> DRUG1 </e1> by <e2> DRUG2 </e2> , a highly potent CYP3A4 inhibitor , which also inhibits CYP2C9 . 	vardenafil	ritonavir
advise	 <e1> DRUG1 </e1> dose should not exceed a maximum of 25 mg in a 48- hour period in patients receiving concomitant <e2> DRUG2 </e2> therapy . 	Sildenafil	indinavir
mechanism	 Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 (eg , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) may have elevated plasma concentrations when coadministered with <e2> DRUG2 </e2> ; 	carbamazepine	saquinavir
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	estrogens	furosemide
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	androgens	chloral hydrate
other	 <e1> DRUG1 </e1> , a DRUG0 , is a <e2> DRUG2 </e2> which has proven efficacy against the positive and negative symptoms of schizophrenia . 	Olanzapine	second generation (atypical) antipsychotic agent
effect	 - Drugs whose efficacy is impaired by <e1> DRUG1 </e1> include : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , oral DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	phenytoin	estrogens
other	 The risk of a potential interaction between <e1> DRUG1 </e1> and <e2> DRUG2 </e2> concentrates has not been adequately evaluated in preclinical or clinical studies . 	NovoSeven	coagulation factor
other	 DRUG0 : The concomitant use of DRUG0 ( DRUG0 transdermal system) with other DRUG0 , including but not limited to other DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , <e1> DRUG1 </e1> ) , general DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death . 	benzodiazepines	alcohol
other	 In another drug interaction study , co-administration of orally inhaled DRUG0 and oral DRUG0 , a potent inhibitor of cytochrome P450 3A4 , increased the exposure (AUC) of <e1> DRUG1 </e1> by approximately 3.6-fold at steady state , while levels of <e2> DRUG2 </e2> remained unchanged . 	des-ciclesonide	ciclesonide
other	 Also , concomitant administration of <e1> DRUG1 </e1> with products containing DRUG0 , <e2> DRUG2 </e2> containing DRUG0 , or DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels . 	quinolones	multivitamins
effect	 - The action of DRUG0 and <e1> DRUG1 </e1> may be enhanced by <e2> DRUG2 </e2> or DRUG0 . 	insulin	Bezalip
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anabolic steroids	quinine
effect	 However , the systemic administration of some <e1> DRUG1 </e1> has been shown to elevate plasma concentrations of DRUG0 , interfere with the metabolism of DRUG0 , and enhance the effects of the oral DRUG0 DRUG0 and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic <e2> DRUG2 </e2> concomitantly . 	quinolones	cyclosporine
other	 With the morning dose of <e1> DRUG1 </e1> on day 6 , each volunteer received a single intravenous infusion of <e2> DRUG2 </e2> (4 mg/kg) . 	ceftibuten	theophylline
other	 DRUG0 , other DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> are associated with an increase in bleeding . 	thrombolytics	anti platelet agents
mechanism	 However , in the second study , administration of 12 g <e1> DRUG1 </e1> 1 hour before the evening meal and 0.3 mg <e2> DRUG2 </e2> approximately 4 hours after the same evening meal resulted in a decrease in the DRUG0 AUC of less than 8% , and a decrease in Cmax of about 30% when compared to dosing DRUG0 alone . 	cholestyramine	cerivastatin sodium
other	 DRUG0 : Co-administration of DRUG0 with <e1> DRUG1 </e1> 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50% decrease in <e2> DRUG2 </e2> plasma concentrations . 	rifampin	rofecoxib
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , <e1> DRUG1 </e1> ) , local DRUG0 (e.g. , DRUG0 and DRUG0 ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	Chloromycetin	multivitamins
other	 Therefore , co-administration of DRUG0 with other drugs that are metabolized by this isozyme , including DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> and DRUG0 ) , or that inhibit this enzyme (e.g. , DRUG0 ) , should be approached with caution . 	phenothiazines	flecainide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	sulfonamides
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Lipitor	phenylbutazone
other	 When combined with DRUG0 , DRUG0 exhibited strong synergistic activity while only additive effects were observed with the combination of <e1> DRUG1 </e1> (or <e2> DRUG2 </e2> ) and DRUG0 . 	rifampicin	rifabutin
other	 DRUG0 : Coadministration of <e1> DRUG1 </e1> did not have any effect on either the safety or efficacy of <e2> DRUG2 </e2> in the clinical trials . 	calcium channel blockers	ibutilide
effect	 - <e1> DRUG1 </e1> may enhance the CNS depressive effects of DRUG0 , <e2> DRUG2 </e2> and other DRUG0 	Lofexidine	barbiturates
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	Advil	Daypro
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chymotrypsin	tolbutamide
other	 DRUG0 may interact with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 supplements , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	corticotropin	warfarin
other	 The <e1> DRUG1 </e1> metabolite of <e2> DRUG2 </e2> does not appear to be produced by the cytochrome P450 isoenzymes . 	threohydrobupropion	bupropion
other	 The majority of patients in RA clinical studies received one or more of the following concomitant medications with <e1> DRUG1 </e1> : <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	ORENCIA	MTX
effect	 Pharmacodynamic Interactions : The CNS-depressant action of the <e1> DRUG1 </e1> of drugs may be potentiated by DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , the DRUG0 , DRUG0 and DRUG0 , <e2> DRUG2 </e2> and the DRUG0 , and by other DRUG0 . 	benzodiazepine class	monoamine oxidase inhibitors
other	 DRUG0 , DRUG0 and DRUG0 : DRUG0 has no significant pharmacokinetic interactions with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> , and DRUG0 has no significant effect on plasma levels of DRUG0 . 	digoxin	nimodipine
other	 The concomitant intake of DRUG0 and <e1> DRUG1 </e1> does not affect the pharmacokinetics of either <e2> DRUG2 </e2> or DRUG0 . 	Acamprosate	alcohol
other	 <e1> DRUG1 </e1> : DRUG0 : <e2> DRUG2 </e2> , when given as a regimen of 125mg with DRUG0 coadministered orally as 20 mg on Day 1 , and DRUG0 when given as 80 mg/day with DRUG0 coadministered orally as 8 mg on Days 2 through 5 , increased the AUC of DRUG0 , a CYP3A4 substrate by 2.2-fold , on Days 1 and 5 . 	Corticosteroids	Aprepitant
other	 <e1> DRUG1 </e1> s : After repeated co-administration of <e2> DRUG2 </e2> , the AUC of DRUG0 was lowered by 28% [90% CI : 20-33] . 	Calcium Antagonist	Trileptal
mechanism	 DRUG0 containing DRUG0 and <e1> DRUG1 </e1> reduce the oral absorption of <e2> DRUG2 </e2> by 75% . 	magnesium hydroxide	enoxacin
other	 <e1> DRUG1 </e1> : In a clinical pharmacology study , coadministration of an DRUG0 ( DRUG0 , DRUG0 , and DRUG0 ) with DRUG0 reduced serum levels and urinary excretion of DRUG0 as compared with <e2> DRUG2 </e2> administered alone , suggesting that DRUG0 may impair absorption of DRUG0 . 	Antacids	fosinopril
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 . 	thiocyanate	sulfonamides
other	 Coadministration of <e1> DRUG1 </e1> 30 mg and DRUG0 , a CYP2C19 substrate , resulted in a 45% decrease in clearance of <e2> DRUG2 </e2> . 	esomeprazole	diazepam
other	 No interactions have been observed between DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	theophylline	warfarin
mechanism	 Binding to Serum Proteins : The following agents may either inhibit <e1> DRUG1 </e1> binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> and DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	levothyroxine sodium	estrogens
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;inhalation <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	indomethacin	anesthetics
other	 There is limited experience with concomitant DRUG0 such as DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> (both DRUG0 -like and loop) . 	ACE inhibitors	diuretics
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	fluphenazine	thioridazine
mechanism	 DRUG0 : Concomitant administration of <e1> DRUG1 </e1> ORAL and <e2> DRUG2 </e2> resulted in decreased clearance of DRUG0 and significant increases in DRUG0 plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours . 	TORADOL	probenecid
effect	 DRUG0 : Use of <e1> DRUG1 </e1> with DRUG0 and other <e2> DRUG2 </e2> may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed . 	thyroid products	tricyclic antidepressants
other	 While no in vivo drug-drug interaction studies were conducted between DRUG0 and inducers of CYP3A , compounds that are potent CYP3A inducers (such as DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 ) would be expected to decrease <e2> DRUG2 </e2> concentrations . 	phenytoin	estazolam
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , DRUG0 ); 	Advil	Oruvail
advise	 Therefore , co-administration of <e1> DRUG1 </e1> with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	bupropion	imipramine
mechanism	 Single doses of either <e1> DRUG1 </e1> or DRUG0 DRUG0 bind the <e2> DRUG2 </e2> and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively . 	cholestyramine	hydrochlorothiazide
other	 The hypoglycemic action of DRUG0 may be potentiated by certain drugs including <e1> DRUG1 </e1> and other drugs that are highly protein bound , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , and DRUG0 . 	nonsteroidal anti-inflammatory agents	coumarins
other	 These agents , including <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> , have been extensively studied and have demonstrated efficacy and safety profiles comparable to those of other traditional agents for the treatment of complicated or uncomplicated urinary tract infections and prostatitis . 	norfloxacin	lomefloxacin
other	 Decreasing the concentration of DRUG0 , exhibiting 7.3% (m/m) of immobilised <e1> DRUG1 </e1> (CMC-Cys7.3) from 1% (m/v) to 0.5% (m/v) decreased the R-value of <e2> DRUG2 </e2> from 1.8 to 1.2 . 	cysteine	NaFlu
other	 however , it is considered to be unlikely that this decrease of phosphorylated <e1> DRUG1 </e1> concentration is of clinical significance , as DRUG0 is a more efficient substrate for deoxycytidine kinase than <e2> DRUG2 </e2> . 	lamivudine	zalcitabine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	oxolinic acid	trimethoprim
other	 <e1> DRUG1 </e1> (e . g. , DRUG0 ) and DRUG0 containing carbohydrate-splitting enzymes (e . g. , <e2> DRUG2 </e2> , DRUG0 ) may reduce the effect of DRUG0 and should not be taken concomitantly . 	Intestinal adsorbents	amylase
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	nalidixic acid	quinidine
effect	 Because <e1> DRUG1 </e1> may enhance the serotonergic effects of <e2> DRUG2 </e2> , caution should be exercised when DRUG0 and DRUG0 are coadministered . 	lithium	escitalopram
other	 Concomitant treatment with DRUG0 (eg , rt-PA or <e1> DRUG1 </e1> ) may : - increase the risk of bleeding complications - considerably enhance the effect of <e2> DRUG2 </e2> on aPTT prolongation 	streptokinase	REFLUDAN
other	 It is recommended that serum <e1> DRUG1 </e1> levels be monitored frequently if <e2> DRUG2 </e2> is administered concomitantly with DRUG0 . 	lithium	enalapril
other	 <e1> DRUG1 </e1> : Some DRUG0 may increase the concentration of <e2> DRUG2 </e2> in the blood . 	Digoxin	digitalis preparations
other	 <e1> DRUG1 </e1> : DRUG0 pharmacokinetics were not significantly different before and after <e2> DRUG2 </e2> multiple-dose regimens . 	Antipyrine	tiagabine
other	 poor metabolizers of DRUG0 : Interactions of DRUG0 with strong inhibitors of CYP2D6 (such as DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of DRUG0 . 	paroxetine	propafenone
effect	 Patients receiving other DRUG0 , DRUG0 , DRUG0 , or other <e1> DRUG1 </e1> (including DRUG0 ) concomitantly with <e2> DRUG2 </e2> and DRUG0 tablets may exhibit an additive CNS depression . 	CNS depressants	hydrocodone
effect	 DRUG0 / DRUG0 / DRUG0 / DRUG0 : Co-administration of <e1> DRUG1 </e1> with DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> is likely to lead to an enhancement of effects . 	PRECEDEX	opioids
other	 Administration of DRUG0 concomitantly with oral DRUG0 has been shown to result in decreases in serum concentrations of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	amiodarone	desethylamiodarone
other	 DRUG0 may suppress certain CYP450 enzymes , including <e1> DRUG1 </e1> , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	CYP1A2	CYP3A4
other	 BACKGROUND : The effects of combined administration of <e1> DRUG1 </e1> and DRUG0 ( <e2> DRUG2 </e2> ) , a DRUG0 , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by DRUG0 ( DRUG0 ) and the labeling index of intestinal cancers were investigated in male Wistar rats . 	bombesin	verapamil
other	 Other Drugs : In healthy volunteers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , hormone replacement therapy (a combination of conjugated DRUG0 and <e1> DRUG1 </e1> ) , DRUG0 DRUG0 and <e2> DRUG2 </e2> s) and DRUG0 did not affect the pharmacokinetics of DRUG0 . 	medroxyprogesterone	magnesium hydroxide
other	 - a DRUG0 ( DRUG0 ) such as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> ); 	Orudis KT	Aleve
other	 Effects of Other DRUG0 on DRUG0 <e1> DRUG1 </e1> : DRUG0 causes an approximate doubling of the clearance of <e2> DRUG2 </e2> ( DRUG0 ) at steady state and , therefore , the addition of DRUG0 causes an approximate 45% decrease in the steady-state trough concentrations of DRUG0 as compared to the same dose of DRUG0 given as monotherapy . 	Phenytoin	Felbatol
other	 DRUG0 should not be administered concomitantly with potent DRUG0 such as <e1> DRUG1 </e1> and <e2> DRUG2 </e2> as the potential for ototoxicity is enhanced by the combination . 	furosemide	ethacrynic acid
other	 DRUG0 , DRUG0 and <e1> DRUG1 </e1> : Concomitant treatment with DRUG0 , DRUG0 , or DRUG0 may potentiate a possible hypokalemic effect of <e2> DRUG2 </e2> 	Diuretics	beta2-agonists.
other	 certain <e1> DRUG1 </e1> (such as <e2> DRUG2 </e2> ); 	tetracyclic antidepressants	maprotiline
other	 Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing <e1> DRUG1 </e1> (1 microgram/ml) , DRUG0 (10 ng/ml) , and <e2> DRUG2 </e2> (3.7 micrograms/ml or 0.1 IU/ml) . 	transferrin	insulin
mechanism	 DRUG0 : Concomitant administration of <e1> DRUG1 </e1> ORAL and <e2> DRUG2 </e2> resulted in decreased clearance of DRUG0 and significant increases in DRUG0 plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours . 	TORADOL	probenecid
other	 <e1> DRUG1 </e1> : The coadministration of any of the <e2> DRUG2 </e2> should be avoided as this could create possible additive effects and hypercalcemia . 	Vitamin D	vitamin D analogues
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and <e2> DRUG2 </e2> (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	desipramine	Type 1C antiarrhythmics
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	metronidazole	thyroid drugs
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	colistin	quinidine
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> ; DRUG0 under-dosage . 	chloral hydrate	vitamin C
other	 In in vivo studies , 10- to 30-mg/day doses of <e1> DRUG1 </e1> had no significant effect on metabolism by CYP2D6 ( <e2> DRUG2 </e2> ) , CYP2C9 ( DRUG0 ) , CYP2C19 ( DRUG0 , DRUG0 ) , and CYP3A4 ( DRUG0 ) substrates . 	aripiprazole	dextromethorphan
int	 There have been reports of interactions of <e1> DRUG1 </e1> with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 . 	erythromycin	bromocriptine
other	 <e1> DRUG1 </e1> : In vitro data indicate that DRUG0 inhibits the metabolism of <e2> DRUG2 </e2> , which can result in an increase in plasma DRUG0 levels and prolongation of the QT interval on the ECG . 	Antidepressants	cisapride
effect	 A potential interaction between oral <e1> DRUG1 </e1> and oral <e2> DRUG2 </e2> leading to severe hypoglycemia has been reported . 	miconazole	hypoglycemic agents
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chloral hydrate	quinine
advise	 Use lowest possible dose of DRUG0 with careful monitoring , or consider <e1> DRUG1 </e1> that are not primarily metabolized by CYP3A4 , such as DRUG0 , DRUG0 , or DRUG0 in combination with <e2> DRUG2 </e2> . 	HMG-CoA reductase inhibitors	CRIXIVAN
mechanism	 <e1> DRUG1 </e1> significantly decreased the AUC(ss) of <e2> DRUG2 </e2> by 82% , but DRUG0 had no effect on DRUG0 pharmacokinetics . 	Rifampin	amprenavir
other	 It is recommended to avoid concurrent administration of DRUG0 with DRUG0 containing <e1> DRUG1 </e1> for at least 4 hours following <e2> DRUG2 </e2> administration . 	antacids	ethambutol
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> DRUG1 </e1> due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	EQUETROTM	cyclosporin
effect	 With simultaneous dosing of <e1> DRUG1 </e1> 20 mg and <e2> DRUG2 </e2> 10 mg , 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg . 	Vardenafil	terazosin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e1> DRUG1 </e1> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diflunisal	sulfinpyrazone
mechanism	 Single doses of either <e1> DRUG1 </e1> or DRUG0 DRUG0 bind the <e2> DRUG2 </e2> and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively . 	cholestyramine	hydrochlorothiazide
mechanism	 Agents that have been found , or are expected to have decreased plasma levels in the presence of <e1> DRUG1 </e1> due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	EQUETROTM	amitriptyline
other	 Effects of Other DRUG0 on DRUG0 DRUG0 : DRUG0 causes an approximate doubling of the clearance of <e1> DRUG1 </e1> ( DRUG0 ) at steady state and , therefore , the addition of <e2> DRUG2 </e2> causes an approximate 45% decrease in the steady-state trough concentrations of DRUG0 as compared to the same dose of DRUG0 given as monotherapy . 	Felbatol	phenytoin
effect	 Patients receiving other DRUG0 , DRUG0 , DRUG0 , or other <e1> DRUG1 </e1> (including DRUG0 ) concomitantly with <e2> DRUG2 </e2> and DRUG0 tablets may exhibit an additive CNS depression . 	CNS depressants	hydrocodone
advise	 If DRUG0 are required during DRUG0 therapy , <e1> DRUG1 </e1> should be taken at least 2 hours before or after the <e2> DRUG2 </e2> . 	OMNICEF	antacid
other	 <e1> DRUG1 </e1> plasma and urine sampling were conducted on Days 1 , 7 , and 21 for <e2> DRUG2 </e2> and on Days 7 and 21 for DRUG0 . 	Antiretroviral	zidovudine
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or <e1> DRUG1 </e1> (basic) , as well as <e2> DRUG2 </e2> DRUG0 , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and DRUG0 , and DRUG0 . 	propranolol	tetracycline
other	 Injection : <e1> DRUG1 </e1> injection , like other injectable <e2> DRUG2 </e2> , produces depression of the central nervous system when administered with DRUG0 , DRUG0 , DRUG0 , DRUG0 , and other DRUG0 .When DRUG0 is used concomitantly with injectable DRUG0 , an increased incidence of sedation , hallucinations , and irrational behavior has been observed . 	Lorazepam	benzodiazepines
mechanism	 Administration of <e1> DRUG1 </e1> with other CYP3A4 inhibitors (e.g. , <e2> DRUG2 </e2> 500 mg BID , DRUG0 240 mg QD , DRUG0 1200 mg TID , DRUG0 200 mg QD) resulted in increases in Cmax of DRUG0 ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold . 	eplerenone	erythromycin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	atorvastatin	Kadian
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e2> DRUG2 </e2> , DRUG0 . 	fluoxetine	verapamil
other	 DRUG0 - <e1> DRUG1 </e1> containing side chains of N-methylthiotetrazole ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) or methylthiadiazole ( DRUG0 ) can cause vitamin K deficiency and hypoprothrombinemia . 	Cephalosporins	latamoxef
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 . 	Topamax	Theo-Dur
other	 When <e1> DRUG1 </e1> was applied to the muscle in the presence of DRUG0 , both first and second contractile responses to <e2> DRUG2 </e2> were abolished . 	ouabain	PTX
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e1> DRUG1 </e1> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	Compazine	Mellaril
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> overdosage . 	anesthetics	warfarin sodium
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	antibiotics	ibuprofen
other	 These agents include medications such as : DRUG0 , DRUG0 including DRUG0 , sali-cylates , <e1> DRUG1 </e1> (including <e2> DRUG2 </e2> ) , DRUG0 , or DRUG0 . 	NSAIDs	ketorolac tromethamine
other	 Concurrent administration of <e1> DRUG1 </e1> and DRUG0 significantly reduces the level of exposure to DRUG0 , but it is unclear how soon after <e2> DRUG2 </e2> administration DRUG0 may be given safely . 	indinavir	didanosine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chlorpropamide	nalidixic acid
other	 DRUG0 : When a single 125-mg dose of DRUG0 was administered on Day5 of a 10-day regimen of 400 mg/day of <e1> DRUG1 </e1> , a strong CYP3A4 inhibitor , the AUC of <e2> DRUG2 </e2> increased approximately 5-fold and the mean terminal half-life of DRUG0 increased approximately 3-fold . 	ketoconazole	aprepitant
other	 <e1> DRUG1 </e1> : DRUG0 should be used with caution in patients receiving  - DRUG0 blocking agents (e.g. , DRUG0 , a DRUG0 inhibitor) or DRUG0 antagonists (e.g. , DRUG0 , a DRUG0 substrate , and DRUG0 , a <e2> DRUG2 </e2> inhibitor) because of the possible potentiation of bradycardia , sinus arrest , and AV block; 	Antihypertensives	CYP3A4
advise	 Drugs that Lower Seizure Threshold : Concurrent administration of <e1> DRUG1 </e1> and agents (e.g. , <e2> DRUG2 </e2> , other DRUG0 , DRUG0 , systemic DRUG0 , etc.) that lower seizure threshold should be undertaken only with extreme caution . 	WELLBUTRIN	antipsychotics
other	 It may increase excretion of DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> and may also increase the toxicity of DRUG0 . 	lithium	ASA
other	 <e1> DRUG1 </e1> or DRUG0 : Concomitant administration of DRUG0 or DRUG0 decreases the elimination of DRUG0 , most likely by inhibition of renal tubular secretion of <e2> DRUG2 </e2> . 	Probenecid	zalcitabine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anesthetics	pyrazolones
other	 DRUG0 : In a study in 12 patients with congestive heart failure where DRUG0 and DRUG0 were concomitantly administered , <e1> DRUG1 </e1> did not alter the serum levels of <e2> DRUG2 </e2> . 	ketoprofen	digoxin
other	 [Stimulation by DRUG0 --an analog of the octapeptide cholecystokinin--of DRUG0 binding after the long-term administration of DRUG0 ] It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of <e1> DRUG1 </e1> (0.25 mg/kg) and <e2> DRUG2 </e2> (0.25 mg/kg) resulted in the reduced interaction between DRUG0 and low affinity binding sites for DRUG0 in subcortical structures , whereas DRUG0 binding with high affinity binding sites for DRUG0 increased both in the frontal cortex and subcortical structures of the forebrain . 	haloperidol	pyreneperone
other	 The <e1> DRUG1 </e1> study dosed subjects with 1200 mg/day of <e2> DRUG2 </e2> (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg , five times/day of DRUG0 . 	zidovudine	azithromycin
other	 Because <e1> DRUG1 </e1> may enhance the serotonergic effects of DRUG0 , caution should be exercised when <e2> DRUG2 </e2> and DRUG0 are coadministered . 	lithium	LEXAPRO
other	 DRUG0 diminishes the effect of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	coumarin	warfarin
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or <e1> DRUG1 </e1> (basic) , as well as DRUG0 DRUG0 , DRUG0 , thyroid and DRUG0 preparations , <e2> DRUG2 </e2> and DRUG0 , and DRUG0 . 	propranolol	estrogens
other	 DRUG0 / DRUG0 / DRUG0 / DRUG0 : Co-administration of DRUG0 with DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> is likely to lead to an enhancement of effects . 	sedatives	opioids
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ibuprofen	sulfinpyrazone
other	 Although not studied systematically in clinical trials , no drug interactions were observed when DRUG0 , <e1> DRUG1 </e1> , or DRUG0 were administered following varying degrees of recovery from single doses or infusions of <e2> DRUG2 </e2> . 	pancuronium	NIMBEX
other	 DRUG0 , DRUG0 and DRUG0 may enhance the effects of : other DRUG0 s , <e1> DRUG1 </e1> , general DRUG0 , DRUG0 such as DRUG0 , DRUG0 , or other <e2> DRUG2 </e2> , causing increased CNS depression . 	alcohol	CNS depressants
other	 Effect of Other Drugs on the Pharmacokinetics of DRUG0 : Literature reports suggest that <e1> DRUG1 </e1> , an agent that decreases stomach acidity , does not greatly alter <e2> DRUG2 </e2> pharmacokinetics . 	ranitidine	clonazepam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chloral hydrate	chymotrypsin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methylphenidate	tolbutamide
mechanism	 In a multiple-dose study , <e1> DRUG1 </e1> caused a dose-related increase in the mean elimination half-life of <e2> DRUG2 </e2> , thereby decreasing the clearance of DRUG0 by up to 80% and leading to a five-fold increase in the AUC and the half-life of DRUG0 . 	enoxacin	caffeine
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	aminosalicylic acid	sulfonamides
other	 <e1> DRUG1 </e1> , a <e2> DRUG2 </e2> , may antagonize the bactericidal effect of DRUG0 and concurrent use of these drugs should be avoided . 	Tetracycline	bacteriostatic antibiotic
other	 Multivalent Cation-Containing Products : Concurrent administration of a DRUG0 , including DRUG0 , with multivalent cation-containing products such as DRUG0 or DRUG0 DRUG0 , DRUG0 , <e1> DRUG1 </e1> chewable/buffered tablets or pediatric powder , or products containing <e2> DRUG2 </e2> , DRUG0 , or DRUG0 may substantially decrease the absorption of DRUG0 , resulting in serum and urine levels considerably lower than desired . 	VIDEX	calcium
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> . 	clofibrate	vitamin C
other	 Drug/Laboratory Test Interactions <e1> DRUG1 </e1> , including <e2> DRUG2 </e2> , are known to occasionally induce a positive direct Coombs test . 	Cephalosporins	cefotaxime sodium
other	 In a similar study with <e1> DRUG1 </e1> in healthy volunteers , 1 of 24 subjects dosed with <e2> DRUG2 </e2> 20 mg and DRUG0 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg . 	tamsulosin	Vardenafil
effect	 Hypotension : Patients on Diuretic Therapy : Patients on <e1> DRUG1 </e1> and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with <e2> DRUG2 </e2> or DRUG0 . 	diuretics	enalapril
advise	 DRUG0 usually does not alter the plasma levels of DRUG0 , however , serum <e1> DRUG1 </e1> levels should be evaluated after concomitant therapy with <e2> DRUG2 </e2> is initiated . 	digoxin	nicardipine HCl
other	 Example inhibitors include DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	nefazodone	verapamil
other	 Additional reductions in blood pressure may occur when DRUG0 is administered with DRUG0 , <e1> DRUG1 </e1> , or other <e2> DRUG2 </e2> . 	antihypertensive agents	vasodilators
other	 DRUG0 ) and many that are substrates for P450 2D6 (many other DRUG0 , <e1> DRUG1 </e1> , and the DRUG0 <e2> DRUG2 </e2> and DRUG0 ) . 	phenothiazines	propafenone
other	 An interaction study with <e1> DRUG1 </e1> showed no clinically significant effect of <e2> DRUG2 </e2> on DRUG0 pharmacokinetics or anticoagulant activity . 	warfarin	anastrozole
other	 Effects of DRUG0 on Low-Dose DRUG0 A group of 24 nonsmoking , healthy white female volunteers established on an oral DRUG0 regimen containing 30 mg <e1> DRUG1 </e1> and 75 mg <e2> DRUG2 </e2> for at least 3 months received 2400 mg/day of DRUG0 from midcycle (day 15) to midcycle (day 14) of two consecutive oral DRUG0 cycles . 	ethinyl estradiol	gestodene
other	 The co-administration of DRUG0 with IV <e1> DRUG1 </e1> such as DRUG0 , <e2> DRUG2 </e2> , DRUG0 , or IV DRUG0 has not been evaluated (these drugs were not co-administered with DRUG0 in clinical trials) . 	vasodilators	nitroprusside
mechanism	 DRUG0 : It has been reported that <e1> DRUG1 </e1> prolongs the half-life of the DRUG0 , <e2> DRUG2 </e2> . 	allopurinol	dicumarol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	naproxen	sulfonamides
other	 DRUG0 such as DRUG0 (e.g. , <e1> DRUG1 </e1> ) , DRUG0 (e.g. , <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 ) : Using these medicines with DRUG0 may increase the chance of side effects . 	Marplan	Nardil
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	clofibrate	meclofenamic acid
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of <e1> DRUG1 </e1> : DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	insulin	somatropin
other	 Protein Binding In vitro , DRUG0 interferes minimally or not at all with the protein binding of DRUG0 (20% decrease in binding) , DRUG0 , <e1> DRUG1 </e1> (10% decrease in binding) , or <e2> DRUG2 </e2> . 	prednisolone	warfarin
other	 DRUG0 : The effect of steady-state <e1> DRUG1 </e1> l50 mg bid on the pharmacokinetics of a single dose of <e2> DRUG2 </e2> (375 mg) as 442 mg DRUG0 was evaluated in 12 healthy non-smoking , male volunteers . 	fluvoxamine	Theophylline
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Trileptal	phenylbutazone
other	 There was no evidence of drug interactions in clinical studies in which <e1> DRUG1 </e1> was administered concurrently with other drugs , including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	dobutamine	acetaminophen
effect	 In both species , <e1> DRUG1 </e1> , but not DRUG0 , antagonized the rate-decreasing effects of <e2> DRUG2 </e2> on FI and FR responding . 	(-)-NANM	morphine
other	 Tell your doctor if you are taking any of the following drugs : DRUG0 s ( <e1> DRUG1 </e1> ) other DRUG0 DRUG0 DRUG0 DRUG0 ( <e2> DRUG2 </e2> ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	Coumadin	Tegretol
effect	 There have been reports of DRUG0 -related side-effects in patients on concomitant <e1> DRUG1 </e1> - <e2> DRUG2 </e2> therapy . 	theophylline	quinolone
other	 Since higher doses of <e1> DRUG1 </e1> (400 mg daily) may result in higher increases in Cmax and AUC , a single 2.5 mg dose of <e2> DRUG2 </e2> should not be exceeded in a 24-hour period when used in combination with DRUG0 400 mg daily . 	ketoconazole	Vardenafil
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute DRUG0 intake , <e1> DRUG1 </e1> , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 	amiodarone	methylphenidate
other	 In clinical studies performed with DRUG0 , the concomitant use of oral DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> did not significantly affect the pharmacokinetics/pharmacodynamics of DRUG0 . 	acetylsalicylic acid	digoxin
other	 Agents that are CYP inducers that have been found , or are expected , to decrease plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (2) , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 Thus , if a patient has been titrated to a stable dosage on DRUG0 , and then begins a course of treatment with one of these CYP3A4 inducers , it is reasonable to expect that a dose increase for <e2> DRUG2 </e2> may be necessary . 	primidone	EQUETROTM
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : <e1> DRUG1 </e1> (e.g. , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 , DRUG0 , DRUG0 drugs (e.g. , DRUG0 ) , DRUG0 , DRUG0 . 	aminoglycosides	amikacin
effect	 Both the sedative and anticholinergic effects of the <e1> DRUG1 </e1> are also additive to those of <e2> DRUG2 </e2> . 	major tranquilizers	desipramine
effect	 The action of the <e1> DRUG1 </e1> may be potentiated by DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , or other drugs that produce CNS depression . 	benzodiazepines	antihistamines
other	 <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> may increase plasma levels of DRUG0 , potentially resulting in adverse effects . 	Cimetidine	erythromycin
mechanism	 plasma levels of several closely related DRUG0 have been reported to be increased by the concomitant administration of DRUG0 or hepatic enzyme inhibitors (e.g. , DRUG0 , <e1> DRUG1 </e1> ) and decreased by the concomitant administration of hepatic enzyme inducers (e.g. , DRUG0 , DRUG0 ) , and such an effect may be anticipated with <e2> DRUG2 </e2> as well . 	fluoxetine	CMI
other	 When DRUG0 was applied to the muscle in the presence of <e1> DRUG1 </e1> , both first and second contractile responses to <e2> DRUG2 </e2> were abolished . 	phentolamine	PTX
other	 <e1> DRUG1 </e1> and DRUG0 DRUG0 : Absorption of DRUG0 is impaired in the presence of <e2> DRUG2 </e2> . 	Cholestyramine	anionic exchange resins
other	 <e1> DRUG1 </e1> , DRUG0 and other <e2> DRUG2 </e2> ; 	alcohol	CNS depressants
mechanism	 <e1> DRUG1 </e1> may also decrease the absorption of <e2> DRUG2 </e2> , which can lead to a deficiency . 	Aminosalicylic acid	vitamin B12
other	 DRUG0 : In a single dose study (n=6) , ingestion of an DRUG0 containing 1.7-gram of DRUG0 with 500-mg of DRUG0 increased the Cmax and AUC of DRUG0 by 125% and 36% , respectively .  A number of compounds are inhibitors of CYP2C9 including DRUG0 , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> . 	lovastatin	trimethoprim
other	 DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> The in vitro binding of <e2> DRUG2 </e2> to plasma proteins is only slightly reduced by DRUG0 (99.5% control vs 99.3%) when DRUG0 plasma concentrations reach 5 to10 m g/mL . 	Heparin	warfarin
other	 - Drugs whose efficacy is impaired by DRUG0 include : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , oral DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 . 	estrogens	rifampin
other	 Other concomitant therapies : In clinical trials , the safety profile in subjects treated with DRUG0 concomitantly with DRUG0 , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> (including DRUG0 ) , or DRUG0 was similar to that of subjects taking placebo with these concomitant medications . 	hypnotics	sedatives
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and <e2> DRUG2 </e2> . 	risperidone	zonisamide
other	 DRUG0 (e . g. , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , etc.) : in vitro and animal studies with the combination of <e2> DRUG2 </e2> and DRUG0 suggest that DRUG0 may induce fungal resistance to DRUG0 . 	clotrimazole	amphotericin B
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	danazol	ketoconazole
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;inhalation DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	indomethacin	mefenamic acid
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	aminoglutethimide	dopamine
other	 Additive depressant effect when used with general DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and other <e2> DRUG2 </e2> . 	hypnotics	opiate analgesics
other	 These medications have included DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , intravenous and oral DRUG0 , DRUG0 , and <e2> DRUG2 </e2> . 	angiotensin converting enzyme inhibitors	aspirin
other	 DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 The in vitro binding of DRUG0 to plasma proteins is only slightly reduced by <e2> DRUG2 </e2> (99.5% control vs 99.3%) when DRUG0 plasma concentrations reach 5 to10 m g/mL . 	Digoxin	ketorolac tromethamine
other	 In clinical studies , <e1> DRUG1 </e1> has been co-administered with other anti-asthma medications , including inhaled and oral <e2> DRUG2 </e2> , and inhaled DRUG0 , with no evidence of increased frequency of adverse events or laboratory abnormalities . 	Tilade	bronchodilators
effect	 Other depressasnts such as DRUG0 , DRUG0 , and <e1> DRUG1 </e1> may enhance CNS depression when administered with <e2> DRUG2 </e2> . 	MAOIs	ethchlorvynol
other	 It is recommended that plasma <e1> DRUG1 </e1> levels be monitored when <e2> DRUG2 </e2> is coadministered with DRUG0 . 	lithium	ketoprofen
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	quinidine	quinine
int	 A pharmacokinetic interaction between <e1> DRUG1 </e1> and <e2> DRUG2 </e2> has been observed during studies involving renal and cardiac transplant patients . 	diltiazem	cyclosporine
other	 Co-administration of <e1> DRUG1 </e1> did not significantly affect the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 or DRUG0 . 	aliskiren	metformin
other	 There was no evidence of drug interactions in clinical studies in which <e1> DRUG1 </e1> was administered concurrently with other drugs , including DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	dobutamine	isosorbide dinitrate
other	 DRUG0 may interact with the following medications : DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Tylenol	Neoral
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> . 	ethionamide	thiazide diuretics
other	 Coadministration of <e1> DRUG1 </e1> (10 mg BID for 7 days) with DRUG0 (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of <e2> DRUG2 </e2> . 	valdecoxib	glyburide
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , DRUG0 (e.g. , <e1> DRUG1 </e1> ) , local <e2> DRUG2 </e2> (e.g. , DRUG0 and DRUG0 ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	Chloromycetin	anesthetics
other	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and <e1> DRUG1 </e1> ) DRUG0 (sometimes prescribed to control blood sugar in type 2 diabetes) <e2> DRUG2 </e2> (used to control inflammation associated with Crohns disease and ulcerative colitis) DRUG0 (a DRUG0 ) DRUG0 There has been concern about the interaction between DRUG0 and DRUG0 . 	primidone	sulfasalazine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	chlorpromazine	Sparine
advise	 Before taking <e1> DRUG1 </e1> , tell your doctor if you are taking any of the following medicines : - DRUG0 or another DRUG0 such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , others) , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( DRUG0 ); 	glimepiride	choline salicylate
advise	 however , as with other DRUG0 , concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> is not generally recommended because of the potential of increased adverse effects . 	Lodine	aspirin
other	 Drugs which may enhance the neuromuscular blocking action of DRUG0 include : <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ;certain DRUG0 , especially the <e2> DRUG2 </e2> and DRUG0 ; DRUG0 ; DRUG0 salts; DRUG0 ;and DRUG0 . 	enflurane	aminoglycosides
other	 DRUG0 may interact with DRUG0 , <e1> DRUG1 </e1> s , <e2> DRUG2 </e2> (allergy , cold , and sinus medicines) , diabetic drugs , DRUG0 , DRUG0 , DRUG0 like DRUG0 or DRUG0 , and high blood pressure medications . 	blood thinner	decongestant drugs
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> DRUG1 </e1> are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	EQUETROTM	delavirdine
other	 <e1> DRUG1 </e1> : Coadministration of <e2> DRUG2 </e2> with DRUG0 causes an increase in DRUG0 plasma concentrations , In 12 otherwise healthy male volunteers ingesting DRUG0 , the steady-state trough (Cmin) DRUG0 concentration was 14.2 micrograms/mL . 	Phenobarbital	felbamate
advise	 Concomitant administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> is not recommended because DRUG0 is displaced from its binding sites during the concomitant administration of DRUG0 , resulting in lower plasma concentrations and peak plasma levels . 	naproxen	aspirin
mechanism	 DRUG0 : Doses of <e1> DRUG1 </e1> ( DRUG0 ) 1 g/day have been reported to increase plasma concentration of <e2> DRUG2 </e2> by ~47% , possibly by inhibiting conjugation; 	ascorbic acid	synthetic estrogens
effect	 The administration of local DRUG0 containing DRUG0 or <e1> DRUG1 </e1> to patients receiving <e2> DRUG2 </e2> or DRUG0 may produce severe , prolonged hypertension . 	norepinephrine	monoamine oxidase inhibitors
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , DRUG0 , DRUG0 , DRUG0 , and DRUG0 with DRUG0 plus DRUG0 ) without receiving <e2> DRUG2 </e2> therapy . 	vincristine	antiretroviral
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (e.g. , in oral <e2> DRUG2 </e2> ) . 	estrogens	contraceptives
other	 DRUG0 should be used with care when DRUG0 or inhibitors of AV conduction , such as certain <e1> DRUG1 </e1> (particularly of the DRUG0 [ DRUG0 ] and DRUG0 [ DRUG0 ] classes) , or DRUG0 , such as <e2> DRUG2 </e2> , are used concurrently . 	calcium antagonists	disopyramide
advise	 Special consideration should be given to the administration of <e1> DRUG1 </e1> in patients receiving <e2> DRUG2 </e2> or other drugs that could cause or potentiate hypotension . 	ETHYOL	antihypertensive medications
other	 In patients taking <e1> DRUG1 </e1> and DRUG0 concomitantly , <e2> DRUG2 </e2> toxicity may develop . 	diclofenac	lithium
mechanism	 Although no clinical studies have been conducted , it is likely that the metabolism of <e1> DRUG1 </e1> may be affected by the known CYP3A4 inducers (such as DRUG0 , DRUG0 , DRUG0 ) , CYP3A4 inhibitors (azole antimycotics e.g. , <e2> DRUG2 </e2> ; 	levobupivacaine	ketoconazole
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	miconazole	oxolinic acid
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; <e2> DRUG2 </e2> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	diazoxide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	amiodarone	ranitidine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	androgens	phenytoin
other	 DRUG0 should be used with care when DRUG0 or inhibitors of AV conduction , such as certain <e1> DRUG1 </e1> (particularly of the DRUG0 [ <e2> DRUG2 </e2> ] and DRUG0 [ DRUG0 ] classes) , or DRUG0 , such as DRUG0 , are used concurrently . 	calcium antagonists	verapamil
other	 <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , or DRUG0 ) , <e2> DRUG2 </e2> supplements , or DRUG0 -containing salt substitutes may lead to significant increases in serum DRUG0 . 	Potassium-sparing diuretics	potassium
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chlorpropamide	clofibrate
other	 DRUG0 such as DRUG0 (e.g. , <e1> DRUG1 </e1> ) , DRUG0 (e.g. , DRUG0 ) , <e2> DRUG2 </e2> (e.g. , DRUG0 ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 ) : Using these medicines with DRUG0 may increase the chance of side effects . 	Marplan	procarbazine
other	 <e1> DRUG1 </e1> : Potentiation of DRUG0 -type ( DRUG0 and DRUG0 substrate) DRUG0 response is almost always seen in patients receiving <e2> DRUG2 </e2> and can result in serious or fatal bleeding . 	Anticoagulants	amiodarone
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 ) , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	danazol	isoniazid
other	 Administration of DRUG0 with DRUG0 containing DRUG0 , DRUG0 , or <e1> DRUG1 </e1> , with DRUG0 , with metal cations such as DRUG0 , or with DRUG0 containing <e2> DRUG2 </e2> or DRUG0 , or with formulations containing divalent and trivalent cations such as DRUG0 ( DRUG0 ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of DRUG0 , resulting in systemic concentrations considerably lower than desired . 	calcium	iron
other	 <e1> DRUG1 </e1> did not inhibit the antitumor activity of four DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) in four murine models . 	Dolasetron mesylate	doxorubicin
effect	 The effects of <e1> DRUG1 </e1> are antagonized by <e2> DRUG2 </e2> such as DRUG0 and DRUG0 . 	adenosine	methylxanthines
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , <e2> DRUG2 </e2> ]) or 	mesoridazine	Temaril
other	 In patients taking <e1> DRUG1 </e1> and DRUG0 concomitantly , <e2> DRUG2 </e2> toxicity may develop . 	diclofenac	lithium
other	 If DRUG0 is to be combined with other DRUG0 such as DRUG0 or DRUG0 / <e1> DRUG1 </e1> , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of DRUG0 and DRUG0 (e.g. , DRUG0 or <e2> DRUG2 </e2> ) are additive . 	hypnotics	diazepam
other	 <e1> DRUG1 </e1> , such as <e2> DRUG2 </e2> , DRUG0 and DRUG0 , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly . 	Slow-channel calcium blockers	verapamil
other	 The purpose of this study was to evaluate the effect of DRUG0 ( <e1> DRUG1 </e1> ) and DRUG0 ( DRUG0 ) conjugates on the intestinal permeation of <e2> DRUG2 </e2> ( DRUG0 ) and model peptide drugs , DRUG0 and DRUG0 . 	NaCMC	sodium fluorescein
mechanism	 <e1> DRUG1 </e1> , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , certain DRUG0 , DRUG0 , DRUG0 and DRUG0 , thereby delaying elimination and increasing blood levels of these drugs . 	Tagamet	phenytoin
other	 <e1> DRUG1 </e1> : No significant differences were observed in the steady-state pharmacokinetics of <e2> DRUG2 </e2> or DRUG0 with the addition of DRUG0 given as a single dose . 	Warfarin	R-warfarin
effect	 <e1> DRUG1 </e1> may enhance the effects of <e2> DRUG2 </e2> . 	Amphetamines	tricyclic antidepressants
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 . 	Lipitor	Theo-Dur
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	sympathomimetic agents	thyroid hormones
other	 Effects of <e1> DRUG1 </e1> on other Antiepilepsy Drugs ( DRUG0 ) : <e2> DRUG2 </e2> : DRUG0 had no effect on the steady-state plasma concentrations of DRUG0 in patients with epilepsy . 	GABITRIL	Phenytoin
other	 Therefore , co-administration of DRUG0 with drugs that are metabolized by CYP2D6 isoenzyme including certain DRUG0 (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , and DRUG0 (e.g. , DRUG0 , DRUG0 ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication . 	fluoxetine	thioridazine
other	 Drug Interactions : The central DRUG0 syndrome can occur when DRUG0 agents such as DRUG0 are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain <e1> DRUG1 </e1> such as DRUG0 , the DRUG0 and other DRUG0 , DRUG0 , certain <e2> DRUG2 </e2> such as the DRUG0 salts , and DRUG0 . 	narcotic analgesics	antiarrhythmics
other	 Concomitant administration of DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or an <e2> DRUG2 </e2> / DRUG0 oral DRUG0 produced minor changes in the pharmacokinetics of DRUG0 , which were considered to be without clinical significance . 	calcium carbonate	estrogen
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	amiodarone	rifampin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , <e2> DRUG2 </e2> , DRUG0 ( DRUG0 ) , and DRUG0 . 	Atromid-S	temazepam
other	 <e1> DRUG1 </e1> - and DRUG0 -containing <e2> DRUG2 </e2> , administered concomitantly with DRUG0 , significantly decreased the bioavailability (48%) of DRUG0 . 	Magnesium	antacids
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> and other DRUG0 can inhibit the activity of DRUG0 . 	Diuretics	Diclofenac
other	 DRUG0 : Coadministration of <e1> DRUG1 </e1> with DRUG0 causes an increase in <e2> DRUG2 </e2> plasma concentrations , In 12 otherwise healthy male volunteers ingesting DRUG0 , the steady-state trough (Cmin) DRUG0 concentration was 14.2 micrograms/mL . 	felbamate	phenobarbital
other	 DRUG0 : Coadministration of DRUG0 (using an experimental soft-gelatin capsule formulation of DRUG0 1200mg) with <e1> DRUG1 </e1> resulted in an 18% increase in DRUG0 plasma AUC and a 4-fold increase in <e2> DRUG2 </e2> plasma A.C . 	VIRACEPT	saquinavir
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> DRUG1 </e1> are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	EQUETROTM	niacinamide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	anabolic steroids	ibuprofen
other	 The results indicate that a spinal <e1> DRUG1 </e1> -sensitive endorphinergic system is involved in the production of DRUG0 but not DRUG0 -induced tail-flick inhibition , and suggest that intraventricular <e2> DRUG2 </e2> and DRUG0 elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 	naloxone	beta-endorphin
other	 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> , as well as other DRUG0 , probably reduces the tubular secretion of DRUG0 based on in vitro studies in rabbit kidney slices . 	Methotrexate	Ibuprofen
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	asparaginase	estrogen-containing compounds
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	diazepam	mitotane
other	 The combination of therapeutic doses of intravenous <e1> DRUG1 </e1> and DRUG0 in <e2> DRUG2 </e2> a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia . 	dantrolene sodium	halothane
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	antifungals	Fortovase
other	 <e1> DRUG1 </e1> DRUG0 are inhibited by <e2> DRUG2 </e2> . 	Adrenergic blockers	amphetamines
other	 Endothelium-intact aortic rings from high- <e1> DRUG1 </e1> rats were supersensitive to DRUG0 when compared to vehicle- , <e2> DRUG2 </e2> - and DRUG0 + high- DRUG0 -treated rats (pD2 values = 7.77+/-0.12 , 7.21+/-0.13 , 6.93+/-0.04 and 7.22+/-0.18 , respectively) . 	estradiol	progesterone
other	 <e1> DRUG1 </e1> , Including Oral , Injectable , Transdermal , and Implantable DRUG0 : An interaction study demonstrated that co-administration of DRUG0 and the oral <e2> DRUG2 </e2> DRUG0 produced average decreases of DRUG0 and DRUG0 levels of 14% and 31% , respectively . 	Hormonal Contraceptives	hormonal contraceptive
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , <e1> DRUG1 </e1> (acidic) or DRUG0 (basic) , as well as DRUG0 <e2> DRUG2 </e2> , DRUG0 , thyroid and DRUG0 preparations , DRUG0 and DRUG0 , and DRUG0 . 	thiazide diuretics	penicillin G
other	 In rats , simultaneous ingestion of <e1> DRUG1 </e1> and DRUG0 in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that DRUG0 may react with <e2> DRUG2 </e2> in the rat stomach to form a nitrosamine , which is tumorigenic . 	disulfiram	nitrites
other	 Binding to Serum Proteins : The following agents may either inhibit DRUG0 binding to serum proteins or alter the concentrations of serum binding proteins : DRUG0 and related DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 . 	asparaginase	salicylates
other	 <e1> DRUG1 </e1> and oral DRUG0 : Concomitant administration of DRUG0 and/or other oral DRUG0 with <e2> DRUG2 </e2> must be avoided because of the risk of hypervitaminosis A . 	Vitamin A	acitretin
other	 However , there are limited in vivo data suggesting a modest CYP2D6 inhibitory effect for <e1> DRUG1 </e1> , i.e. , coadministration of DRUG0 (20 mg/day for 21 days) with the <e2> DRUG2 </e2> DRUG0 (single dose of 50 mg) , a substrate for CYP2D6 , resulted in a 40% increase in Cmax and a 100% increase in AUC of DRUG0 . 	escitalopram	tricyclic antidepressant
effect	 In addition to bleeding associated with DRUG0 and DRUG0 , drugs that alter platelet function (such as DRUG0 , <e1> DRUG1 </e1> and DRUG0 ) may increase the risk of bleeding if administered prior to , during , or after <e2> DRUG2 </e2> therapy . 	dipyridamole	Activase
other	 Thus , concomitant therapy with <e1> DRUG1 </e1> and <e2> DRUG2 </e2> should not require dosage adjustment of either drug . 	warfarin	Lodine
other	 <e1> DRUG1 </e1> s : <e2> DRUG2 </e2> should be administered at least 2 hours after or 6 hours before dosing with DRUG0 because plasma concentrations of DRUG0 are decreased when administered with DRUG0 containing DRUG0 , DRUG0 , or DRUG0 . 	Quinolone Antibiotic	VIDEX
other	 Medications can interfere with folate utilization , including : DRUG0 (such as DRUG0 , and DRUG0 ) DRUG0 (sometimes prescribed to control blood sugar in type 2 diabetes) DRUG0 (used to control inflammation associated with Crohns disease and ulcerative colitis) <e1> DRUG1 </e1> (a DRUG0 ) DRUG0 There has been concern about the interaction between DRUG0 and <e2> DRUG2 </e2> . 	triamterene	folic acid
other	 Drugs That Should Not Be Coadministered With DRUG0 <e1> DRUG1 </e1> : <e2> DRUG2 </e2> , DRUG0 DRUG0 : DRUG0 , DRUG0 Antimigraine : DRUG0 DRUG0 : DRUG0 DRUG0 DRUG0 , DRUG0 GI motility agents : DRUG0 	Antiarrhythmics	amiodarone
effect	 DRUG0 , DRUG0 , DRUG0 salts , and <e1> DRUG1 </e1> may either potentiate or weaken the blood-glucose-lowering effect of <e2> DRUG2 </e2> . 	alcohol	insulin
other	 <e1> DRUG1 </e1> : The administration of <e2> DRUG2 </e2> to normal volunteers receiving DRUG0 decreased the renal clearance and significantly increased the plasma levels of DRUG0 . 	Nonsteroidal Anti-Inflammatory Drugs	diflunisal
other	 Haemodynamic effects of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> were additive when DRUG0 was co-administered but not under basal conditions . 	glucose	insulin
effect	 - Drugs whose efficacy is impaired by <e1> DRUG1 </e1> include : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	phenytoin	contraceptives
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e1> DRUG1 </e1> ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;oral DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; DRUG0 ; DRUG0 under-dosage . 	cholestyramine	paraldehyde
other	 Cytochrome P-450 inducers , such as <e1> DRUG1 </e1> , DRUG0 and DRUG0 , induce DRUG0 metabolism , causing an approximately 30% decrease in plasma <e2> DRUG2 </e2> levels . 	phenytoin	clonazepam
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	clofibrate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diazoxide	miconazole
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	fenoprofen	mefenamic acid
other	 - a <e1> DRUG1 </e1> (water pill) such as DRUG0 ( DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 ( DRUG0 ) , and others; 	diuretic	Hydrodiuril
other	 - Drugs whose efficacy is impaired by DRUG0 include : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 . 	coumarin	rifampin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	pentoxifylline	quinine
other	 Nephrotoxic agents : Concomitant administration of DRUG0 and agents with nephrotoxic potential [e.g. , intravenous DRUG0 (e.g. , DRUG0 , DRUG0 , and DRUG0 ) , <e1> DRUG1 </e1> , DRUG0 , intravenous DRUG0 , <e2> DRUG2 </e2> , and DRUG0 ] is contraindicated . 	amphotericin B	vancomycin
other	 DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 The in vitro binding of DRUG0 to plasma proteins is only slightly reduced by DRUG0 (99.5% control vs 99.3%) when <e2> DRUG2 </e2> plasma concentrations reach 5 to10 m g/mL . 	Digoxin	ketorolac
other	 However , since DRUG0 , DRUG0 , and <e1> DRUG1 </e1> are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of DRUG0 or DRUG0 with <e2> DRUG2 </e2> . 	bisphosphonates	Ibandronate
other	 Drugs That Should Not Be Coadministered With DRUG0 <e1> DRUG1 </e1> : DRUG0 , DRUG0 DRUG0 : DRUG0 , DRUG0 Antimigraine : <e2> DRUG2 </e2> DRUG0 : DRUG0 DRUG0 DRUG0 , DRUG0 GI motility agents : DRUG0 	Antiarrhythmics	ergot derivatives
other	 DRUG0 - and/or DRUG0 -containing DRUG0 , products containing DRUG0 ( <e1> DRUG1 </e1> ) , DRUG0 containing DRUG0 or other metal cations , or DRUG0 ( <e2> DRUG2 </e2> ) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after DRUG0 . 	iron	didanosine
other	 Drugs That Should Not Be Coadministered With DRUG0 DRUG0 : DRUG0 , DRUG0 DRUG0 : <e1> DRUG1 </e1> , DRUG0 Antimigraine : DRUG0 DRUG0 : DRUG0 DRUG0 DRUG0 , DRUG0 GI motility agents : <e2> DRUG2 </e2> 	astemizole	cisapride
effect	 The action of the <e1> DRUG1 </e1> may be potentiated by DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , or other drugs that produce CNS depression . 	benzodiazepines	psychotropic medications
other	 In separate single or multiple dose pharmacokinetic interaction studies with DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and <e1> DRUG1 </e1> , the bioavailability of <e2> DRUG2 </e2> was not altered by coadministration of DRUG0 with any one of these drugs . 	warfarin	fosinoprilat
advise	 Nevertheless , caution is indicated in the coadministration of <e1> DRUG1 </e1> with any of the <e2> DRUG2 </e2> and also in switching from one class to the other . 	TCAs	SSRIs
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	methyldopa	phenyramidol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cinchophen	trimethoprim
other	 Tell your doctor if you are taking any of the following drugs : <e1> DRUG1 </e1> s ( DRUG0 ) other <e2> DRUG2 </e2> DRUG0 DRUG0 DRUG0 ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 ( DRUG0 ) intraconazole ( DRUG0 ) DRUG0 ( DRUG0 ) DRUG0 DRUG0 DRUG0 birth control pills sleeping pills thyroid medications 	blood thinner	antidepressants
other	 <e1> DRUG1 </e1> : DRUG0 does not affect the pharmacokinetics of DRUG0 when coadministered with <e2> DRUG2 </e2> . 	Cimetidine	MONUROL
other	 [The GABA-ergic system and brain edema] It has been shown in rats with experimental toxic and traumatic edemas that DRUG0 (1 mg/kg) removes the antiedematous action of DRUG0 , DRUG0 , <e1> DRUG1 </e1> and <e2> DRUG2 </e2> and reduces the action of DRUG0 . 	phenibut	amizyl
other	 Coadministration of <e1> DRUG1 </e1> and drugs that induce CYP3A may decrease <e2> DRUG2 </e2> plasma concentrations and reduce its therapeutic effect . 	VIRACEPT	nelfinavir
other	 poor metabolizers of <e1> DRUG1 </e1> : Interactions of DRUG0 with strong inhibitors of CYP2D6 (such as <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 ) have not been studied , but these drugs would be expected to increase blood levels of the R(+) enantiomer of DRUG0 . 	debrisoquin	quinidine
mechanism	 Previous studies have demonstrated a significant reduction in the oral bioavailability of <e1> DRUG1 </e1> and DRUG0 when administered concomitantly with an intravenous <e2> DRUG2 </e2> such as DRUG0 . 	trovafloxacin	opiate
other	 Oral DRUG0 : <e1> DRUG1 </e1> , when given once daily for 14 days as a 100-mg capsule with an oral <e2> DRUG2 </e2> containing 35 mcg of DRUG0 and 1 mg of DRUG0 , decreased the AUC of DRUG0 by 43% , and decreased the AUC of DRUG0 by 8%; 	Aprepitant	contraceptive
other	 The oral DRUG0 doses should be reduced by approximately 50% when coadministered with <e1> DRUG1 </e1> , to achieve exposures of <e2> DRUG2 </e2> similar to those obtained when it is given without DRUG0 . 	Aprepitant	dexamethasone
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	clonazepam	contraceptives
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	alcohol	nalidixic acid
other	 When used in therapeutic doses , DRUG0 had a modest effect on the pharmacokinetics of DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 (intravenous and oral) , DRUG0 , DRUG0 / <e2> DRUG2 </e2> or DRUG0 . 	sildenafil	sulfamethoxazole
other	 To investigate the effects of antimicrobial combinations of <e1> DRUG1 </e1> with four kinds of DRUG0 ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 and DRUG0 ) , the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain . 	GL	cefazolin
other	 Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as DRUG0 include certain DRUG0 (e . g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , and DRUG0 ) , DRUG0 salts , DRUG0 , local DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	colistin	procainamide
other	 DRUG0 , other <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> are associated with an increase in bleeding . 	anticoagulants	anti platelet agents
advise	 Particular caution is recommended when administering <e1> DRUG1 </e1> with CYP3A4 substrates that have a narrow therapeutic window (e.g. , DRUG0 or <e2> DRUG2 </e2> ) . 	Gleevec	pimozide
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	phenytoin	sulfonamides
advise	 DRUG0 , or other products containing DRUG0 or DRUG0 , DRUG0 or <e1> DRUG1 </e1> should not be administered concomitantly with , or within 2 hours of , the administration of <e2> DRUG2 </e2> , because they may interfere with absorption resulting in lower serum and urine levels of DRUG0 . 	sucralfate	norfloxacin
other	 DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> have no influence in vitro on the protein binding of DRUG0 in human serum . 	cephalothin	sulfamethoxazole
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	buspirone	tramadol
other	 In general , these are drugs that have one or more pharmacologic activities similar to DRUG0 , including <e1> DRUG1 </e1> such as DRUG0 and DRUG0 , <e2> DRUG2 </e2> and DRUG0 . 	anti-arrhythmic agents	cardiac glycosides
mechanism	 Concomitant use of <e1> DRUG1 </e1> and drugs that inhibit CYP3A4 (eg , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) may increase exposure to DRUG0 and should be avoided . 	SPRYCEL	erythromycin
other	 However , other published reports describe modest elevations (less than two-fold) of <e1> DRUG1 </e1> and metabolite concentrations when DRUG0 was taken with DRUG0 , <e2> DRUG2 </e2> , and DRUG0 . 	clozapine	fluoxetine
other	 Other concomitant therapy Although specific interaction studies were not performed , DRUG0 doses of 1 mg or more were concomitantly used in clinical studies with <e1> DRUG1 </e1> , DRUG0 , a-blockers , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , cardiac DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 (also referred to as DRUG0 ) , and DRUG0 without evidence of clinically significant adverse interactions . 	acetaminophen	H2 antagonists
other	 As <e1> DRUG1 </e1> , the predominant plasma substrate , is only a weak inducer of UDP-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through UDP-glucuronyl transferase (e.g. , DRUG0 , <e2> DRUG2 </e2> ) . 	MHD	lamotrigine
mechanism	 DRUG0 -Concomitant intake of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> may reduce the absorption of DRUG0 . 	colestipol	vitamin K
effect	 The concurrent use of two or more drugs with anticholinergic activity--such as an DRUG0 (eg , DRUG0 ) , an <e1> DRUG1 </e1> (eg , DRUG0 ) , and/or a DRUG0 (eg , <e2> DRUG2 </e2> )--commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia . 	antiparkinsonian drug	amitriptyline
other	 The principal drugs given (number of patients in parentheses) were : DRUG0 (115) , DRUG0 and DRUG0 (103) , DRUG0 (52) , oral DRUG0 (45) , cough and cold preparations (45) , <e1> DRUG1 </e1> (38) , DRUG0 (29) , DRUG0 (24) , oral DRUG0 (18) , DRUG0 (13) , <e2> DRUG2 </e2> (10) , and DRUG0 (10) . 	NSAIDs	insulin
mechanism	 Although there was no effect of DRUG0 on the plasma AUC of DRUG0 or DRUG0 determined on Day 3 , there was a 34% decrease in <e1> DRUG1 </e1> (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with <e2> DRUG2 </e2> . 	S(-)warfarin	Aprepitant
other	 <e1> DRUG1 </e1> or DRUG0 ( DRUG0 and related drugs , <e2> DRUG2 </e2> and DRUG0 ) enhanced hypokalemia . 	Amphotericin B	ethacrynic acid
other	 DRUG0 should be used with care when <e1> DRUG1 </e1> or inhibitors of AV conduction , such as certain DRUG0 (particularly of the DRUG0 [ <e2> DRUG2 </e2> ] and DRUG0 [ DRUG0 ] classes) , or DRUG0 , such as DRUG0 , are used concurrently . 	myocardial depressants	verapamil
advise	 However , since DRUG0 , DRUG0 , and DRUG0 are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of <e1> DRUG1 </e1> or DRUG0 with <e2> DRUG2 </e2> . 	aspirin	Ibandronate
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 . 	Sandimmune	Theo-Dur
other	 DRUG0 : <e1> DRUG1 </e1> had no effect on the steady-state plasma concentrations of <e2> DRUG2 </e2> or its epoxide metabolite in patients with epilepsy . 	Tiagabine	carbamazepine
other	 - DRUG0 ( DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e1> DRUG1 </e1> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , <e2> DRUG2 </e2> [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ] , DRUG0 [e.g. , DRUG0 ]) or 	promazine	trifluoperazine
other	 The effect of <e1> DRUG1 </e1> on <e2> DRUG2 </e2> plasma concentrations has not been evaluated . 	cyclosporine	diltiazem
other	 Drug Interactions : a . Drugs Enhancing <e1> DRUG1 </e1> Effect : Oral <e2> DRUG2 </e2> : DRUG0 may prolong the one-stage prothrombin time . 	Heparin	anticoagulants
other	 DRUG0 : In healthy subjects given single 500 mg doses of <e1> DRUG1 </e1> and DRUG0 , plasma <e2> DRUG2 </e2> mean cmax and AUC increased by an average of 34% and 24% , respectively , and DRUG0 mean renal clearance decreased by 14% . 	cephalexin	metformin
other	 Co-administration of <e1> DRUG1 </e1> and DRUG0 or other agents interfering with neuromuscular transmission (e.g. , DRUG0 ) should only be performed with caution as the effect of the <e2> DRUG2 </e2> may be potentiated . 	BOTOX	toxin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / <e2> DRUG2 </e2> ;unreliable prothrombin time determinations; DRUG0 overdosage . 	ranitidine	sulfamethoxazole
other	 Before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : DRUG0 (e.g. , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> , DRUG0 , DRUG0 drugs (e.g. , <e2> DRUG2 </e2> ) , DRUG0 , DRUG0 . 	amphotericin B	ibuprofen
other	 Exposed histidines on <e1> DRUG1 </e1> are available for <e2> DRUG2 </e2> chelation , and these have been exploited in the development of a novel purification protocol for DRUG0 using DRUG0 -chelating chromatography . 	toxin A	zinc
other	 Given the anticonvulsant properties of DRUG0 , <e1> DRUG1 </e1> may reduce the thyroid function as has been reported with other <e2> DRUG2 </e2> . 	EQUETROTM	anticonvulsants
effect	 Higher concentrations of DRUG0 (10(-8) - 10(-6) M) or <e1> DRUG1 </e1> (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of <e2> DRUG2 </e2> . 	retinyl acetate	EGF
other	 Because of the increased risk of adverse reactions in patients who have been taking DRUG0 on a regular basis , it is particularly important that physicians query patients or their guardians carefully about DRUG0 , <e1> DRUG1 </e1> and DRUG0 use as part of the history prior to any procedure in which the use of <e2> DRUG2 </e2> is planned . 	alcohol	ROMAZICON
other	 The intensity , uniformity and time course of DRUG0 interference by <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 and DRUG0 were systematically investigated in 16 patients receiving <e2> DRUG2 </e2> therapy . 	phenobarbital	coumarin
other	 DRUG0 / DRUG0 / <e1> DRUG1 </e1> / DRUG0 : Co-administration of <e2> DRUG2 </e2> with DRUG0 , DRUG0 , DRUG0 , and DRUG0 is likely to lead to an enhancement of effects . 	Hypnotics	PRECEDEX
other	 The clinical significance of this reduction is not known , hence DRUG0 is not recommended to be ingested simultaneously with <e1> DRUG1 </e1> / <e2> DRUG2 </e2> -containing DRUG0 . 	magnesium	aluminum
other	 Effect of Other Drugs on the Pharmacokinetics of <e1> DRUG1 </e1> : Literature reports suggest that <e2> DRUG2 </e2> , an agent that decreases stomach acidity , does not greatly alter DRUG0 pharmacokinetics . 	Clonazepam	ranitidine
other	 The effectiveness of DRUG0 -only pills is reduced by hepatic enzyme-inducing drugs such as the <e1> DRUG1 </e1> DRUG0 , DRUG0 , and DRUG0 , and the DRUG0 <e2> DRUG2 </e2> . 	anticonvulsants	rifampin
other	 <e1> DRUG1 </e1> : Combination DRUG0 may decrease the clearance of some DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) and increase the clearance of others ( DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) . 	Benzodiazepines	oxazepam
other	 The incidence of upper gastrointestinal events in patients concomitantly taking <e1> DRUG1 </e1> or DRUG0 was similar in patients taking <e2> DRUG2 </e2> 2.5 mg daily (21.7%) and 150 mg once monthly (22.0%) . 	aspirin	ibandronate
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	b-adrenergic blocking agents	phenytoin
mechanism	 Similarly , <e1> DRUG1 </e1> decreased the rate of elimination of <e2> DRUG2 </e2> (by approximately 50%) by the same mechanism . 	ethanol	Antizol
other	 If DRUG0 is to be combined with other <e1> DRUG1 </e1> such as DRUG0 or DRUG0 / DRUG0 , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of <e2> DRUG2 </e2> and DRUG0 (e.g. , DRUG0 or DRUG0 ) are additive . 	psychotropic agents	desipramine
mechanism	 DRUG0 : <e1> DRUG1 </e1> increases both free and bound <e2> DRUG2 </e2> by reducing the plasma clearance of DRUG0 to about one-third , as well as decreasing its protein binding . 	Probenecid	ketoprofen
other	 DRUG0 - Combined administration of a single dose of <e1> DRUG1 </e1> (600 mg) , both a CYP3A4 substrate and a potent inhibitor of CYP3A4 , and <e2> DRUG2 </e2> (20 mg) did not affect the pharmacokinetics of either DRUG0 or DRUG0 . 	ritonavir	escitalopram
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	indomethacin	quinine
other	 Because of DRUG0 s tendency to cause renal impairment , the use of DRUG0 should be avoided in combination with potentially nephrotoxic drugs such as <e1> DRUG1 </e1> , DRUG0 and intravenous <e2> DRUG2 </e2> unless the potential benefits outweigh the risks to the patient . 	aminoglycosides	pentamidine
other	 DRUG0 : In a pharmacokinetic study , maximum plasma concentrations of DRUG0 were considerably lower in epileptic patients on long-term <e1> DRUG1 </e1> therapy (eg , DRUG0 , <e2> DRUG2 </e2> , or DRUG0 ) than in healthy volunteers . 	anticonvulsant	carbamazepine
advise	 <e1> DRUG1 </e1> should be used with care when DRUG0 or inhibitors of AV conduction , such as certain DRUG0 (particularly of the DRUG0 [ DRUG0 ] and DRUG0 [ <e2> DRUG2 </e2> ] classes) , or DRUG0 , such as DRUG0 , are used concurrently . 	ZEBETA	diltiazem
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	perchlorate	ethionamide
other	 DRUG0 and <e1> DRUG1 </e1> (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 (91%) patients receiving <e2> DRUG2 </e2> 25 to 50 mg also received DRUG0 or DRUG0 ( DRUG0 / DRUG0 ) . 	Angiotensin II Receptor Antagonists	INSPRA
other	 Concomitant administration of an <e1> DRUG1 </e1> -containing DRUG0 had no significant effect in the bioavailability of <e2> DRUG2 </e2> . 	aluminum	6MNA
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> . 	cyclosporine	vitamin C
effect	 Risk of Anaphylactic Reaction : Although it is known that patients on <e1> DRUG1 </e1> may be refractory to <e2> DRUG2 </e2> in the treatment of anaphylactic shock , DRUG0 can , in addition , interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks . 	beta-blockers	epinephrine
other	 Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with DRUG0 , <e1> DRUG1 </e1> , and <e2> DRUG2 </e2> . 	diltiazem	verapamil
other	 These include DRUG0 , <e1> DRUG1 </e1> , and some DRUG0 (e.g . <e2> DRUG2 </e2> , rifamipicin , DRUG0 and DRUG0 ) . 	cholestyramine	erythromycin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	amiodarone	ethacrynic acid
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	monoamine oxidase inhibitors	sulfinpyrazone
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	methyldopa
other	 In addition , studies in healthy volunteers have shown that DRUG0 does not affect the pharmacokinetics or pharmacodynamics of DRUG0 , or the pharmacokinetics of DRUG0 (40 mg twice daily) , DRUG0 , <e1> DRUG1 </e1> , or oral <e2> DRUG2 </e2> . 	theophylline	contraceptives
other	 Do not mix <e1> DRUG1 </e1> and <e2> DRUG2 </e2> in the same syringe . 	TORADOL	morphine
effect	 Drug Interactions : The central DRUG0 syndrome can occur when DRUG0 agents such as <e1> DRUG1 </e1> are administered concomitantly with drugs that have secondary DRUG0 actions , e.g. , certain <e2> DRUG2 </e2> such as DRUG0 , the DRUG0 and other DRUG0 , DRUG0 , certain DRUG0 such as the DRUG0 salts , and DRUG0 . 	AKINETON	narcotic analgesics
other	 DRUG0 ) and many that are substrates for P450 2D6 (many other <e1> DRUG1 </e1> , DRUG0 , and the <e2> DRUG2 </e2> DRUG0 and DRUG0 ) . 	antidepressants	Type 1C antiarrhythmics
other	 It is recommended that serum <e1> DRUG1 </e1> levels be monitored frequently if <e2> DRUG2 </e2> is administered concomitantly with DRUG0 . 	lithium	enalapril
other	 Drugs which may enhance the neuromuscular blocking action of DRUG0 include : DRUG0 ; DRUG0 ; DRUG0 ;certain DRUG0 , especially the <e1> DRUG1 </e1> and DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> salts; DRUG0 ;and DRUG0 . 	aminoglycosides	magnesium
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	antithyroid drugs	resorcinol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chlorpropamide	tolbutamide
mechanism	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of <e1> DRUG1 </e1> are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	EQUETROTM	nefazodone
other	 <e1> DRUG1 </e1> or DRUG0 ( DRUG0 and related drugs , <e2> DRUG2 </e2> and DRUG0 ) enhanced hypokalemia . 	Amphotericin B	ethacrynic acid
other	 If <e1> DRUG1 </e1> is to be combined with other DRUG0 such as DRUG0 or DRUG0 / DRUG0 , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of DRUG0 and DRUG0 (e.g. , <e2> DRUG2 </e2> or DRUG0 ) are additive . 	desipramine hydrochloride	chlordiazepoxide
other	 - a <e1> DRUG1 </e1> ( DRUG0 ) such as DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , or DRUG0 ( <e2> DRUG2 </e2> ); 	monoamine oxidase inhibitor	Nardil
other	 DRUG0 may interact with the following medications : <e1> DRUG1 </e1> ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	acetaminophen	Norvir
other	 DRUG0 : DRUG0 CONTRAINDICATED since the coadministration of this product with <e1> DRUG1 </e1> in an <e2> DRUG2 </e2> regimen reduces the plasma concentrations of DRUG0 . 	saquinavir	antiretroviral
other	 <e1> DRUG1 </e1> : In vitro and/or in vivo data show that DRUG0 , DRUG0 , and DRUG0 markedly inhibit the metabolism of DRUG0 , which can result in an increase in plasma <e2> DRUG2 </e2> levels and prolongation of the QT interval on the ECG . 	Antibiotics	cisapride
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( <e2> DRUG2 </e2> ) , and DRUG0 . 	Crixivan	Theo-Dur
advise	 The daily dose of <e1> DRUG1 </e1> should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and nefazadone) . 	ENABLEX	ritonavir
other	 Immediate and Extended Release Tablets The hypoglycemic action of DRUG0 may be potentiated by certain drugs including DRUG0 , some <e1> DRUG1 </e1> and other drugs that are highly protein bound , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 . 	azoles	salicylates
other	 Effects of DRUG0 on Low-Dose <e1> DRUG1 </e1> A group of 24 nonsmoking , healthy white female volunteers established on an oral <e2> DRUG2 </e2> regimen containing 30 mg DRUG0 and 75 mg DRUG0 for at least 3 months received 2400 mg/day of DRUG0 from midcycle (day 15) to midcycle (day 14) of two consecutive oral DRUG0 cycles . 	Combination Oral Contraceptives	contraceptive
effect	 These results suggest that the analgesic effect of <e1> DRUG1 </e1> may be diminished when it is administered shortly after <e2> DRUG2 </e2> nasal spray , but by 30 minutes any such reduction in effect should be minimal . 	STADOL NS	sumatriptan
mechanism	 DRUG0 s : DRUG0 should be administered at least 2 hours after or 6 hours before dosing with DRUG0 because plasma concentrations of <e1> DRUG1 </e1> are decreased when administered with DRUG0 containing DRUG0 , DRUG0 , or <e2> DRUG2 </e2> . 	ciprofloxacin	aluminum
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	bromelains	diazoxide
other	 DRUG0 : Available data suggest that there is no significant effect of <e1> DRUG1 </e1> on the clearance of DRUG0 at steady state , Therefore , the addition of DRUG0 is not expected to cause a clinically important effect on <e2> DRUG2 </e2> ( DRUG0 ) plasma concentrations . 	valproate	Felbatol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	influenza virus vaccine	triclofos sodium
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral DRUG0 (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	cyclosporin	risperidone
advise	 If you are also using a DRUG0 inhaler , take <e1> DRUG1 </e1> first and then wait about 15 minutes before using the <e2> DRUG2 </e2> inhaler . 	bitolterol	steroid
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect of DRUG0 : DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	sympathomimetic agents	terbutaline
other	 Blunting of the antihypertensive effect of DRUG0 by <e1> DRUG1 </e1> including <e2> DRUG2 </e2> has been reported . 	non-steroidal antiinflammatory drugs	INDOCIN
other	 To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma (HIV-NHL) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the DRUG0 , DRUG0 , DRUG0 , and DRUG0 (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e. , DRUG0 , DRUG0 , DRUG0 , and DRUG0 with DRUG0 plus <e1> DRUG1 </e1> ) without receiving <e2> DRUG2 </e2> therapy . 	bleomycin	antiretroviral
other	 The most commonly occurring drug interactions are listed below : - Drugs that may increase plasma DRUG0 concentrations include : acute DRUG0 intake , <e1> DRUG1 </e1> , chboramphenicol , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 	amiodarone	sulfonamides
other	 DRUG0 DRUG0 may delay or reduce the absorption of concomitant oral medication such as DRUG0 , DRUG0 , DRUG0 (acidic) or DRUG0 (basic) , as well as DRUG0 DRUG0 , <e1> DRUG1 </e1> , thyroid and <e2> DRUG2 </e2> preparations , DRUG0 and DRUG0 , and DRUG0 . 	phenobarbital	thyroxine
other	 DRUG0 , including <e1> DRUG1 </e1> , may enhance the effects of the oral <e2> DRUG2 </e2> DRUG0 or its derivatives . 	nalidixic acid	anticoagulant
other	 Agents that are CYP3A4 inhibitors that have been found , or are expected , to increase plasma levels of DRUG0 are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , <e1> DRUG1 </e1> , DRUG0 , grapefruit juice , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (1) , DRUG0 , DRUG0 . 	fluoxetine	protease inhibitors
effect	 <e1> DRUG1 </e1> used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of DRUG0 , <e2> DRUG2 </e2> (only in the tail-flick test) and DRUG0 . 	Midazolam	metamizol
other	 These drugs include the DRUG0 and other DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , oral DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and DRUG0 . 	phenothiazines	nicotinic acid
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Nizoral	protease inhibitors
advise	 Due to a theoretical risk of a pharmacodynamic interaction , use of DRUG0 -containing or <e1> DRUG1 </e1> (like DRUG0 or DRUG0 ) and <e2> DRUG2 </e2> within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS) . 	ergot-type medications	FROVA
other	 Exposed histidines on DRUG0 are available for <e1> DRUG1 </e1> chelation , and these have been exploited in the development of a novel purification protocol for <e2> DRUG2 </e2> using DRUG0 -chelating chromatography . 	zinc	toxin A
effect	 Although neither DRUG0 nor <e1> DRUG1 </e1> affected the proliferation of prostatic epithelium in RPMI1640 containing DRUG0 alone , they modify the mitogenic effect of <e2> DRUG2 </e2> and DRUG0 . 	retinyl acetate	EGF
other	 Therefore , interactions could occur following concomitant administration of <e1> DRUG1 </e1> (e.g. , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) . 	psychotropic drugs	antiemetics
other	 Other Drugs : In healthy volunteers , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , hormone replacement therapy (a combination of conjugated <e2> DRUG2 </e2> and DRUG0 ) , DRUG0 DRUG0 and DRUG0 s) and DRUG0 did not affect the pharmacokinetics of DRUG0 . 	amlodipine	estrogens
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , <e1> DRUG1 </e1> , iodinated cholestographic agents , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	insulin	levodopa
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	allopurinol	phenyramidol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	cinchophen	mefenamic acid
other	 Drugs that have been reported to diminish oral DRUG0 response , ie , decreased prothrom-bin time response , in man significantly include : DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ;diet high in DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ;oral DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ;unreliable prothrombin time determinations; <e2> DRUG2 </e2> ; DRUG0 under-dosage . 	meprobamate	vitamin C
other	 DRUG0 may interact with DRUG0 (e.g. , DRUG0 ) , <e1> DRUG1 </e1> (e.g. , DRUG0 ) , local DRUG0 (e.g. , DRUG0 and DRUG0 ) , DRUG0 ( DRUG0 )-containing preparations (e.g. , sunscreens and some <e2> DRUG2 </e2> ) , DRUG0 (e.g. , DRUG0 ) , DRUG0 (sulfa medicines) , DRUG0 (use of these medicines during the test period will affect the test results) , and pancreatic supplements (use of pancreatic supplements may give false test results) . 	chloramphenicol	multivitamins
mechanism	 therefore , it is theoretically possible that <e1> DRUG1 </e1> may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g . DRUG0 , DRUG0 esters , <e2> DRUG2 </e2> salts , DRUG0 ) . 	lansoprazole	iron
other	 Increased plasma concentrations of <e1> DRUG1 </e1> , DRUG0 , and <e2> DRUG2 </e2> cause QT prolongation and have been associated with torsades de pointes-type ventricular tachycardia , sometimes fatal . 	terfenadine	cisapride
mechanism	 Co-administration of <e1> DRUG1 </e1> , a strong inhibitor of CYP3A4 , increased <e2> DRUG2 </e2> exposure following a single 90 mg dose of DRUG0 by 2.3 fold . 	ketoconazole	cinacalcet
other	 <e1> DRUG1 </e1> (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) and DRUG0 may reduce the therapeutic effects of DRUG0 . 	Dopamine D2 receptor antagonists	butyrophenones
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( <e2> DRUG2 </e2> , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	Phenobarbital	Astramorph
other	 <e1> DRUG1 </e1> : Based on reports of profound hypotension and loss of consciousness when DRUG0 was administered with DRUG0 , the concomitant use of DRUG0 with drugs of the <e2> DRUG2 </e2> (including , for example , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 ) is contraindicated . 	5HT3 Antagonists	5HT3 antagonist class
advise	 Close supervision and careful adjustment of dosage are required when <e1> DRUG1 </e1> is administered with DRUG0 or <e2> DRUG2 </e2> . 	Anafranil	sympathomimetic drugs
other	 In vitro studies indicate CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of DRUG0 to <e1> DRUG1 </e1> and <e2> DRUG2 </e2> , respectively . 	desbutyl levobupivacaine	3-hydroxy levobupivacaine
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	amiodarone	metoclopramide
other	 The serum concentration of <e1> DRUG1 </e1> increased dramatically from 16.6 to 49.1 microg/mL when <e2> DRUG2 </e2> was coadministered , although the daily dosage of DRUG0 and other DRUG0 had not changed . 	phenytoin	fluvoxamine
other	 The following are examples of substances that may reduce the blood-glucose-lowering effect : DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> (e.g. , DRUG0 , <e2> DRUG2 </e2> , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (e.g. , in oral DRUG0 ) . 	sympathomimetic agents	salbutamol
other	 DRUG0 / <e1> DRUG1 </e1> , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / DRUG0 , DRUG0 / <e2> DRUG2 </e2> , DRUG0 / DRUG0 , and DRUG0 / DRUG0 . 	theophylline	lidocaine
other	 <e1> DRUG1 </e1> : In a study in healthy volunteers , a one-week course of DRUG0 at 400 mg b.i.d . with a single 5 mg dose of <e2> DRUG2 </e2> on the sixth day showed an increase in DRUG0 mean peak plasma concentrations (36%) and significant increase in area under the curve (50%) . 	Cimetidine	isradipine
other	 - <e1> DRUG1 </e1> and DRUG0 DRUG0 : DRUG0 and <e2> DRUG2 </e2> DRUG0 have the potential of binding DRUG0 and reducing DRUG0 absorption from the gastrointestinal tract 	Cholestyramine	colestipol
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	ethionamide	iodine-containing compounds
other	 Thyroid Physiology : The following agents may alter thyroid hormone or TSH levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered TSH secretion : DRUG0 , DRUG0 , DRUG0 , DRUG0 and related anabolic hormones , complex anions ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 and DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , hepatic enzyme inducers , DRUG0 , iodinated cholestographic agents , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 . 	heparin	lovastatin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> . 	Agenerase	vitamin C
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; <e1> DRUG1 </e1> ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	diflunisal	glucagon
other	 In separate single or multiple dose pharmacokinetic interaction studies with DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , and DRUG0 , the bioavailability of DRUG0 was not altered by coadministration of <e2> DRUG2 </e2> with any one of these drugs . 	nifedipine	fosinopril
other	 <e1> DRUG1 </e1> : (oral agents and DRUG0 ) - dosage adjustment of the <e2> DRUG2 </e2> may be required . 	Antidiabetic drugs	antidiabetic drug
other	 Concurrent administration of <e1> DRUG1 </e1> and DRUG0 significantly reduces the level of exposure to DRUG0 , but it is unclear how soon after <e2> DRUG2 </e2> administration DRUG0 may be given safely . 	indinavir	didanosine
other	 If DRUG0 is to be combined with other DRUG0 such as <e1> DRUG1 </e1> or DRUG0 / DRUG0 , careful consideration should be given to the pharmacology of the agents employed since the DRUG0 effects of DRUG0 and DRUG0 (e.g. , <e2> DRUG2 </e2> or DRUG0 ) are additive . 	tranquilizers	chlordiazepoxide
other	 The availability of potent <e1> DRUG1 </e1> ( DRUG0 )-based regimens for DRUG0 therapy and concerns regarding DRUG0 ( <e2> DRUG2 </e2> )-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection . 	non-nucleoside reverse transcriptase inhibitor	PI
advise	 Therefore , <e1> DRUG1 </e1> should be administered with caution with intranasal <e2> DRUG2 </e2> . 	ketoconazole	ciclesonide
other	 DRUG0 and DRUG0 (and possibly other <e1> DRUG1 </e1> ) and <e2> DRUG2 </e2> may increase DRUG0 absorption in patients who inactivate DRUG0 by bacterial metabolism in the lower intestine , so that DRUG0 intoxication may result . 	macrolide antibiotics	tetracycline
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , DRUG0 such as DRUG0 and DRUG0 , <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	anticonvulsants	rifadin
effect	 Hypotension : Patients on Diuretic Therapy : Patients on <e1> DRUG1 </e1> and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with DRUG0 or <e2> DRUG2 </e2> . 	diuretics	enalaprilat
other	 Concomitant administration of DRUG0 and <e1> DRUG1 </e1> , DRUG0 , DRUG0 , or an <e2> DRUG2 </e2> / DRUG0 oral DRUG0 produced minor changes in the pharmacokinetics of DRUG0 , which were considered to be without clinical significance . 	calcium carbonate	estrogen
other	 Concomitant DRUG0 , <e1> DRUG1 </e1> , DRUG0 , and DRUG0 chemotherapy plus <e2> DRUG2 </e2> therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma . 	doxorubicin	highly active antiretroviral
other	 Interactions with Other CNS Agents : Concurrent use of DRUG0 with all DRUG0 (eg , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , other DRUG0 , general DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 and DRUG0 ) may result in additive central nervous system depressant effects . 	hypnotics	phenothiazines
other	 DRUG0 : In a clinical pharmacology study , coadministration of an DRUG0 ( DRUG0 , DRUG0 , and DRUG0 ) with DRUG0 reduced serum levels and urinary excretion of <e1> DRUG1 </e1> as compared with DRUG0 administered alone , suggesting that <e2> DRUG2 </e2> may impair absorption of DRUG0 . 	fosinoprilat	antacids
mechanism	 Drugs that induce hepatic enzymes such as <e1> DRUG1 </e1> , DRUG0 and DRUG0 may increase the clearance of <e2> DRUG2 </e2> and may require increases in DRUG0 dose to achieve the desired response . 	phenobarbital	corticosteroids
int	 Therefore , <e1> DRUG1 </e1> has the potential for interaction with DRUG0 and <e2> DRUG2 </e2> . 	linezolid	serotonergic agents
other	 <e1> DRUG1 </e1> : DRUG0 , DRUG0 , <e2> DRUG2 </e2> 	Anticonvulsants	phenytoin
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; <e2> DRUG2 </e2> ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	ibuprofen
advise	 Hypersensitivity Reactions : Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg , DRUG0 for injection concentrate and <e1> DRUG1 </e1> for injection concentrate) should not be treated with <e2> DRUG2 </e2> . 	teniposide	TAXOL
other	 DRUG0 , <e1> DRUG1 </e1> (e.g. , DRUG0 ) , DRUG0 and <e2> DRUG2 </e2> , DRUG0 , DRUG0 , and other drugs having anticholinergic activity . 	narcotic analgesics	nitrites
other	 Other Drugs : In healthy volunteers , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , hormone replacement therapy (a combination of conjugated DRUG0 and DRUG0 ) , DRUG0 DRUG0 and DRUG0 s) and DRUG0 did not affect the pharmacokinetics of <e2> DRUG2 </e2> . 	amlodipine	TIKOSYN
other	 <e1> DRUG1 </e1> (such as <e2> DRUG2 </e2> ) and DRUG0 can suppress the DRUG0 rgic renal and mesenteric vasodilation induced with low dose DRUG0 infusion . 	Butyrophenones	haloperidol
other	 In a study involving healthy subjects receiving <e1> DRUG1 </e1> and DRUG0 concurrently , plasma DRUG0 levels were increased about 20% and <e2> DRUG2 </e2> levels were increased about 30% compared to control values . 	TAMBOCOR	propranolol
other	 Animals dosed with <e1> DRUG1 </e1> did not display the 2-3 hour lag phase in either <e2> DRUG2 </e2> synthesis or in citrate and fluoride accumulation characteristic of animals dosed with DRUG0 . 	1,3-difluoroacetone	(-)-erythro-fluorocitrate
other	 Interactions may occur with the following : adrenocorticoids (cortisone-like medicine) , DRUG0 ( DRUG0 s) , DRUG0 , DRUG0 ( DRUG0 may decrease the effects of these medicines) , DRUG0 (using these medicines with <e1> DRUG1 </e1> may result in increased CNS depressant effects) , DRUG0 , DRUG0 (using these medicines with DRUG0 may change the amount of either medicine that you need to take) , and oral <e2> DRUG2 </e2> containing DRUG0 ( DRUG0 may decrease the effectiveness of these oral DRUG0 , and you may need to change to a different type of birth control) . 	barbiturates	contraceptives
other	 - a DRUG0 ( DRUG0 ) such as <e1> DRUG1 </e1> ( DRUG0 , DRUG0 , DRUG0 , others) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , and <e2> DRUG2 </e2> ( DRUG0 , DRUG0 , DRUG0 ); 	ibuprofen	naproxen
other	 DRUG0 , Including Oral , Injectable , Transdermal , and Implantable DRUG0 : An interaction study demonstrated that co-administration of <e1> DRUG1 </e1> and the oral DRUG0 DRUG0 produced average decreases of <e2> DRUG2 </e2> and DRUG0 levels of 14% and 31% , respectively . 	bosentan	norethindrone
other	 <e1> DRUG1 </e1> s : DRUG0 should be administered at least 2 hours after or 6 hours before dosing with DRUG0 because plasma concentrations of DRUG0 are decreased when administered with DRUG0 containing <e2> DRUG2 </e2> , DRUG0 , or DRUG0 . 	Quinolone Antibiotic	magnesium
other	 <e1> DRUG1 </e1> - In subjects who had received 21 days of 40 mg/day racemic DRUG0 , combined administration of 400 mg/day DRUG0 for 8 days resulted in an increase in <e2> DRUG2 </e2> AUC and Cmax of 43% and 39% , respectively . 	Cimetidine	citalopram
other	 DRUG0 may potentiate the hypotensive effects of <e1> DRUG1 </e1> and the anticholinergic effects of <e2> DRUG2 </e2> -type drugs . 	antihypertensive drugs	atropine
other	 DRUG0 : As with other DRUG0 , co-administration of DRUG0 with <e1> DRUG1 </e1> resulted in an increase in the plasma exposure of <e2> DRUG2 </e2> , with a 49% increase in mean Cmax , a 122% increase in mean AUC , and a 53% increase in half-life . 	cefditoren pivoxil	cefditoren
mechanism	 Cytochrome P-450 inducers , such as DRUG0 , DRUG0 and <e1> DRUG1 </e1> , induce <e2> DRUG2 </e2> metabolism , causing an approximately 30% decrease in plasma DRUG0 levels . 	phenobarbital	clonazepam
other	 DRUG0 May Have a Clinically Important Interaction with the Following Other Drugs : DRUG0 : When <e1> DRUG1 </e1> and DRUG0 were administered several hours apart so that peak concentrations of each would coincide , DRUG0 did not increase the impairment of mental and motor skills caused by <e2> DRUG2 </e2> . 	Duloxetine	alcohol
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; <e1> DRUG1 </e1> ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	chlorpropamide	triclofos sodium
other	 DRUG0 : DRUG0 ( <e1> DRUG1 </e1> substrate) in combination with <e2> DRUG2 </e2> has been associated with reports of myopathy/rhabdomyolysis . 	CYP3A4	amiodarone
other	 DRUG0 - In subjects who had received 21 days of 40 mg/day racemic DRUG0 , combined administration of <e1> DRUG1 </e1> and <e2> DRUG2 </e2> (single dose of 1 mg) did not significantly affect the pharmacokinetics of either DRUG0 or DRUG0 . 	citalopram	digoxin
other	 DRUG0 may interact with the following medications : DRUG0 ( DRUG0 ) , <e1> DRUG1 </e1> such as DRUG0 and DRUG0 , DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 ) , <e2> DRUG2 </e2> ( DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 ) , HIV drugs classified as DRUG0 ( DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 ) , DRUG0 ( DRUG0 , DRUG0 , DRUG0 ) , DRUG0 , DRUG0 ( DRUG0 ) , DRUG0 ( DRUG0 ) , St . Johns wort , DRUG0 , DRUG0 ( DRUG0 ) , and DRUG0 . 	antibiotics	clofibrate
other	 Drugs that reportedly may increase oral DRUG0 response , ie , increased prothrombin response , in man include : DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e1> DRUG1 </e1> ; DRUG0 ;dietary deficiencies; DRUG0 ; DRUG0 ;drugs affecting blood elements; DRUG0 ; DRUG0 ; DRUG0 ;hepatotoxic drugs; DRUG0 ; DRUG0 ; DRUG0 ;inhalation DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; <e2> DRUG2 </e2> ; DRUG0 ;prolonged hot weather; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 *; DRUG0 ; DRUG0 ; DRUG0 , long acting; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 ; DRUG0 / DRUG0 ;unreliable prothrombin time determinations; DRUG0 overdosage . 	dextrothyroxine	phenyramidol
other	 <e1> DRUG1 </e1> : DRUG0 is known to interact with the metabolism or renal tubular excretion of many drugs (e.g. , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e2> DRUG2 </e2> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 agents , DRUG0 , and DRUG0 ) . 	Probenecid	benzodiazepines
other	 Agents that have been found , or are expected to have decreased plasma levels in the presence of DRUG0 due to induction of CYP enzymes are the following : DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , <e1> DRUG1 </e1> , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , oral <e2> DRUG2 </e2> (3) , DRUG0 , DRUG0 (4) , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 , DRUG0 (5) , DRUG0 , and DRUG0 . 	desipramine	contraceptives
effect	 It is concluded that <e1> DRUG1 </e1> is not a short-acting drug and that concomitant use with <e2> DRUG2 </e2> would be expected to prolong further the duration of its action on the central nervous system . 	ketamine	halothane
